0000711404-16-000030.txt : 20160603 0000711404-16-000030.hdr.sgml : 20160603 20160603160857 ACCESSION NUMBER: 0000711404-16-000030 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20160430 FILED AS OF DATE: 20160603 DATE AS OF CHANGE: 20160603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COOPER COMPANIES INC CENTRAL INDEX KEY: 0000711404 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 942657368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08597 FILM NUMBER: 161695765 BUSINESS ADDRESS: STREET 1: 6140 STONERIDGE MALL RD STREET 2: STE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: 9254603600 MAIL ADDRESS: STREET 1: 6140 STONERIDGE MALL ROAD STREET 2: SUITE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: COOPERVISION INC DATE OF NAME CHANGE: 19870701 10-Q 1 coo_20160430-10qq22016.htm 10-Q Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________________________________
FORM 10-Q
_____________________________________________________________
ý
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For Quarterly Period Ended April 30, 2016
o
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from              to             
Commission File Number 1-8597
_____________________________________________________________
The Cooper Companies, Inc.
(Exact name of registrant as specified in its charter)
_____________________________________________________________
Delaware
94-2657368
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
6140 Stoneridge Mall Road, Suite 590, Pleasanton, CA 94588
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code (925) 460-3600
_____________________________________________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (check one).
Large accelerated filer
ý
 
Accelerated filer
o
Non-accelerated filer
o
(Do not check if a smaller reporting company)
Smaller reporting company
o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.):    Yes  o    No  ý
Indicate the number of shares outstanding of each of issuer’s classes of common stock, as of the latest practicable date.
Common Stock, $.10 par value
 
48,448,341 Shares
Class
 
Outstanding at April 30, 2016




 
 
 

INDEX
 
 
 
Page No.
PART I.
 
 
 
 
Item 1.
 
 
 
 
 
Consolidated Statements of Income - Three and Six Months Ended April 30, 2016 and 2015
 
 
 
 
Consolidated Statements of Comprehensive Income - Three and Six Months Ended April 30, 2016 and 2015
 
 
 
 
Consolidated Condensed Balance Sheets - April 30, 2016 and October 31, 2015
 
 
 
 
Consolidated Condensed Statements of Cash Flows - Six Months Ended April 30, 2016 and 2015
 
 
 
 
 
 
 
Item 2.
 
 
 
Item 3.
 
 
 
Item 4.
 
 
 
PART II.
 
 
 
 
Item 1.
 
 
 
Item 1A.
 
 
 
Item 2.
 
 
 
Item 6.
 
 
 
 

2



 
 
 

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Consolidated Statements of Income
Periods Ended April 30,
(In thousands, except for earnings per share)
(Unaudited)
 
Three Months
 
Six Months
  
2016
 
2015
 
2016
 
2015
Net sales
$
483,793

 
$
434,676

 
$
933,433

 
$
879,847

Cost of sales
185,295

 
166,960

 
372,971

 
335,780

Gross profit
298,498

 
267,716

 
560,462

 
544,067

Selling, general and administrative expense
177,659

 
167,583

 
351,263

 
341,118

Research and development expense
16,696

 
16,819

 
31,458

 
32,932

Amortization of intangibles
14,312

 
12,316

 
30,515

 
25,911

Operating income
89,831

 
70,998

 
147,226

 
144,106

Interest expense
7,611

 
4,692

 
12,886

 
8,633

Other (income) expense, net
(418
)
 
(686
)
 
972

 
1,016

Income before income taxes
82,638

 
66,992

 
133,368

 
134,457

Provision for income taxes
8,183

 
5,855

 
7,172

 
11,571

Net income
74,455

 
61,137

 
126,196

 
122,886

Less: net income attributable to noncontrolling interests
330

 
424

 
715

 
994

Net income attributable to Cooper stockholders
$
74,125

 
$
60,713

 
$
125,481

 
$
121,892

Earnings per share attributable to Cooper stockholders - basic
$
1.53

 
$
1.25

 
$
2.59

 
$
2.52

Earnings per share attributable to Cooper stockholders - diluted
$
1.52

 
$
1.23

 
$
2.57

 
$
2.48

Number of shares used to compute earnings per share:

 

 
 
 
 
Basic
48,428

 
48,463

 
48,365

 
48,330

Diluted
48,853

 
49,163

 
48,838

 
49,139

See accompanying notes.

3



 
 
 

THE COOPER COMPANIES, INC. AND SUBSIDIARIES

Consolidated Statements of Comprehensive Income (Loss)
Periods Ended April 30,
(In thousands)
(Unaudited)
 
Three Months
 
Six Months
  
2016
 
2015
 
2016
 
2015
Net income
$
74,455

 
$
61,137

 
$
126,196

 
$
122,886

Other comprehensive income (loss):

 

 

 

Foreign currency translation adjustment
52,273

 
34,367

 
(61,525
)
 
(79,251
)
Change in value of derivative instruments, net of tax provision of $30 in 2015

 

 

 
47

Change in minimum pension liability, net of tax
7

 
7

 
14

 
14

Other comprehensive income (loss)
52,280

 
34,374

 
(61,511
)
 
(79,190
)
Comprehensive income
126,735

 
95,511

 
64,685

 
43,696

Less: comprehensive income attributable to noncontrolling interests
751

 
1,105

 
745

 
584

Comprehensive loss attributable to Cooper stockholders
$
125,984

 
$
94,406

 
$
63,940

 
$
43,112

See accompanying notes.

4



 
 
 

THE COOPER COMPANIES, INC. AND SUBSIDIARIES

Consolidated Condensed Balance Sheets
(In thousands, unaudited)
 
April 30, 2016
 
October 31, 2015
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
44,464

 
$
16,426

Trade accounts receivable, net of allowance for doubtful accounts of $7,765 at April 30, 2016 and $5,956 at October 31, 2015
298,825

 
282,918

Inventories
433,596

 
419,692

Deferred tax assets
41,256

 
41,731

Prepaid expense and other current assets
96,974

 
80,661

Total current assets
915,115

 
841,428

Property, plant and equipment, at cost
1,696,135

 
1,650,730

Less: accumulated depreciation and amortization
731,776

 
683,633

 
964,359

 
967,097

Goodwill
2,233,251

 
2,197,077

Other intangibles, net
437,005

 
411,090

Deferred tax assets
5,969

 
4,510

Other assets
45,554

 
38,662

 
$
4,601,253

 
$
4,459,864

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Short-term debt
$
30,191

 
$
243,803

Accounts payable
105,759

 
116,912

Employee compensation and benefits
59,038

 
67,373

Other current liabilities
127,229

 
140,694

Total current liabilities
322,217

 
568,782

Long-term debt
1,411,182

 
1,105,408

Deferred tax liabilities
37,568

 
31,016

Accrued pension liability and other
85,505

 
80,754

Total liabilities
1,856,472

 
1,785,960

Commitments and contingencies

 

Stockholders’ equity:

 

Preferred stock, 10 cents par value, shares authorized: 1,000; zero shares issued or outstanding

 

Common stock, 10 cents par value, shares authorized: 120,000; issued 51,738 at April 30, 2016 and 51,558 at October 31, 2015
5,174

 
5,156

Additional paid-in capital
1,442,735

 
1,434,705

Accumulated other comprehensive loss
(253,153
)
 
(191,643
)
Retained earnings
1,903,469

 
1,779,440

Treasury stock at cost: 3,290 shares at April 30, 2016 and October 31, 2015
(360,149
)
 
(360,149
)
Total Cooper stockholders' equity
2,738,076

 
2,667,509

Noncontrolling interests
6,705

 
6,395

Stockholders’ equity
2,744,781

 
2,673,904

 
$
4,601,253

 
$
4,459,864

See accompanying notes.

5



 
 
 

THE COOPER COMPANIES, INC. AND SUBSIDIARIES

Consolidated Condensed Statements of Cash Flows
Six Months Ended April 30,
(In thousands)
(Unaudited)
 
2016
 
2015
Cash flows from operating activities:
 
 
 
Net income
$
126,196

 
$
122,886

Depreciation and amortization
101,434

 
87,389

Decrease in operating capital
(61,667
)
 
(65,358
)
Other non-cash items
21,424

 
45,564

Net cash provided by operating activities
187,387

 
190,481

Cash flows from investing activities:
 
 
 
Purchases of property, plant and equipment
(86,332
)
 
(118,365
)
Acquisitions of businesses, net of cash acquired, and other
(145,422
)
 
(752
)
Net cash used in investing activities
(231,754
)
 
(119,117
)
Cash flows from financing activities:
 
 
 
Proceeds from long-term debt
1,367,300

 
483,400

Repayments of long-term debt
(1,250,394
)
 
(658,229
)
Net (repayments of) proceeds from short-term debt
(23,552
)
 
135,514

Repurchase of common stock

 
(15,996
)
Net payments related to share-based compensation awards
(11,525
)
 
(6,662
)
Excess tax benefit from share-based compensation awards
5,005

 

Purchase of shares from noncontrolling interests

 
(8,557
)
Dividends on common stock
(1,452
)
 
(1,448
)
Debt acquisition costs
(12,541
)
 

Distributions to noncontrolling interests
(383
)
 
(816
)
Payment of contingent consideration

 
(2,406
)
Proceeds from construction allowance

 
710

Net cash provided by (used in) financing activities
72,458

 
(74,490
)
Effect of exchange rate changes on cash and cash equivalents
(53
)
 
(4,185
)
Net increase (decrease) in cash and cash equivalents
28,038

 
(7,311
)
Cash and cash equivalents - beginning of period
16,426

 
25,222

Cash and cash equivalents - end of period
$
44,464

 
$
17,911

See accompanying notes.

6

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)


Note 1. General
The Cooper Companies, Inc. (Cooper, we or the Company) is a global medical device company publicly traded on the NYSE Euronext (NYSE: COO). Cooper is dedicated to being A Quality of Life CompanyTM with a focus on delivering shareholder value. Cooper operates through our business units, CooperVision and CooperSurgical.
CooperVision develops, manufactures and markets a broad range of soft contact lenses for the worldwide vision correction market.
CooperSurgical develops, manufactures and markets medical devices and procedure solutions to improve health care delivery to women.
The unaudited consolidated condensed financial statements presented in this report contain all adjustments necessary to present fairly Cooper’s consolidated condensed financial position at April 30, 2016 and October 31, 2015, the consolidated results of its operations for the three and six months ended April 30, 2016 and 2015 and its consolidated condensed cash flows for the six months ended April 30, 2016 and 2015. Most of these adjustments are normal and recurring. However, certain adjustments associated with acquisitions are of a nonrecurring nature. Readers should not assume that the results reported here either indicate or guarantee future performance.
During interim periods, we follow the accounting policies described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2015. Please refer to this when reviewing this Quarterly Report on Form 10-Q.
Management estimates and judgments are an integral part of financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). We believe that the critical accounting policies listed below address the more significant estimates required of Management when preparing our consolidated financial statements in accordance with GAAP. We consider an accounting estimate critical if changes in the estimate may have a material impact on our financial condition or results of operations. We believe that the accounting estimates employed are appropriate and resulting balances are reasonable; however, actual results could differ from the original estimates, requiring adjustment to these balances in future periods. The accounting policies that reflect our more significant estimates, judgments and assumptions and which we believe are the most critical to aid in fully understanding and evaluating our reported financial results are:
Revenue recognition
Net realizable value of inventory
Valuation of goodwill
Business combinations
Income taxes
Share-based compensation
During the fiscal first half of 2016, there were no significant changes in our estimates and critical accounting policies. Please refer to Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended October 31, 2015, for a more complete discussion of our estimates and critical accounting policies.
Accounting Pronouncements Issued Not Yet Adopted

In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which is intended to improve the accounting for share-based payment transactions as part of the FASB’s simplification initiative. The ASU changes the following aspects of the accounting for share-based payment award transactions, including: accounting for income taxes; classification of excess tax benefits on the statement of cash flows; forfeitures; minimum statutory tax withholding requirements; and classification of employee

7

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)

taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. We are currently evaluating the impact of ASU 2016-09, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2017.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-01 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. We are currently evaluating the impact of ASU 2016-02, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2019.

In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes, which requires entities to present all deferred tax assets and liabilities as noncurrent. The amendments in the ASU are effective for the Company in our fiscal year and interim periods beginning on November 1, 2017. The Company does not expect the new guidance to have a material impact on the Company’s consolidated financial statements.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 requires revenue recognition to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 sets forth a new revenue recognition model that requires identifying the contract, identifying the performance obligations, determining the transaction price, allocating the transaction price to performance obligations and recognizing the revenue upon satisfaction of performance obligations. The amendments in the ASU can be applied either retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the update recognized at the date of the initial application along with additional disclosures. We are currently evaluating the impact of ASU 2014-09, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2018.
Accounting Pronouncements Recently Adopted

In April 2015, the FASB issued Accounting Standards Update (ASU) 2015-03, Interest - Imputation of Interest (Subtopic 835-30) Simplifying the Presentation of Debt Issuance Costs. The amendments in this update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for interim and annual reporting periods beginning after December 15, 2016. Early adoption is permitted. We elected to early adopt this guidance as a change in accounting principle on a retrospective basis in the fiscal first quarter ended January 31, 2016. As of January 31, 2016 and October 31, 2015, we have presented debt issuance costs related to our term loans, previously reported in other assets, as direct deductions from the carrying amount of the debt liability. We also presented the debt issuance costs related to our revolving credit facility as a deferred asset within other assets, as is permitted by ASU 2015-15, Imputation of Interest, which was issued in August 2015. Such adoption did not have a material impact to our consolidated financial position.


8

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)

Note 2. Acquisitions

On March 31, 2016 we completed the acquisition of Genesis Genetics Inc., a genetics laboratory specializing in preimplantation genetic screening and preimplantation genetic diagnosis used during the IVF process, headquartered in Plymouth, Michigan. The fair value of the consideration transferred for the acquisition was approximately $60.0 million in cash, $59.3 million net of cash acquired. Our preliminary allocation of the fair value of the purchase price includes $28.6 million in identifiable intangible assets, consisting of $25.2 million for customer relationships and $3.4 million for trade names; $27.6 million in goodwill; and $3.8 million in identifiable net assets.

On February 8, 2016, we completed the acquisition of The Pipette Company, a manufacturer and distributor of micro pipettes for the Assisted Reproductive Technology market headquartered in Adelaide, Australia. The fair value of the consideration transferred for the acquisition was approximately $20.2 million in cash, $19.6 million net of cash acquired. Our preliminary allocation of the fair value of the purchase price includes $5.6 million in identifiable intangible assets, consisting of $5.2 million for customer relationships and $0.4 million for trade names; $14.7 million in goodwill; and $0.2 million in identifiable net liabilities.
On December 17, 2015, we completed the acquisition of Research Instruments Limited, a manufacturer and supplier of in vitro fertilization (IVF) medical devices and systems headquartered in Cornwall, United Kingdom. The fair value of the consideration transferred for the acquisition was approximately $53.6 million in cash, $50.0 million net of cash acquired. Our preliminary allocation of the fair value of the purchase price includes $10.3 million in identifiable intangible assets, consisting of $6.2 million for developed technology, $2.2 million of trade names and $1.9 million for customer relationships; $36.1 million in goodwill; and $7.3 million in identifiable net assets.

We believe these acquisitions strengthen CooperSurgical's fertility business through the addition of new or complementary products and services within IVF and our genetic testing platform.

The pro forma results of operations of these acquisitions have not been presented because the effects of the business combinations described above, individually and in the aggregate, were not material to our consolidated results of operations.


9

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)

Note 3. Restructuring and Integration Costs

2014 Sauflon Integration Plan
During the fiscal fourth quarter of 2014, in connection with the Sauflon acquisition, our CooperVision business unit initiated restructuring and integration activities to optimize operational synergies of the combined companies. These activities include workforce reductions, consolidation of duplicative facilities and product rationalization. We estimate that the total restructuring costs under this plan will be $125.0 million. These costs include approximately $95.0 million associated with assets, including product rationalization and related equipment disposals and accelerated depreciation, about $27.0 million associated with employee termination costs, and about $3.0 million associated with facility lease termination costs. We are substantially complete with activities related to operating expenses, and we expect to incur costs related to the manufacturing activities through the end of fiscal 2016.    

In the three and six month periods ended April 30, 2016, we recorded in cost of sales $4.2 million and $14.7 million of expense, respectively, arising from production-related asset disposals and accelerated depreciation on equipment, primarily related to our hydrogel lenses, based on our review of products, materials and manufacturing processes of Sauflon. We recorded in cost of sales, employee termination costs of $0.7 million and $0.5 million in the three and six month periods ended April 30, 2016, respectively. We recorded $0.1 million of employee termination costs and $0.3 million for lease termination costs in selling, general and administrative expense in the six months ended April 30, 2016. We also recorded in research and development expense $0.1 million of employee termination costs in the six months ended April 30, 2016. In addition, CooperVision incurred $2.1 million and $10.0 million of integration costs included in operating expenses in the three and six month periods ended April 30, 2016, respectively.

In the three and six month periods ended April 30, 2015, we recorded in cost of sales $5.2 million and $13.9 million of expense, respectively, arising from production-related asset disposals and accelerated depreciation on equipment, primarily related to our hydrogel lenses, based on our review of products, materials and manufacturing processes of Sauflon. In the three month period ended April 30, 2015, we reduced the accrued employee termination costs in selling, general and administrative expense by $4.5 million based on estimates of the expected costs and the results of voluntary terminations. We recorded in research and development expense $0.2 million and $0.3 million of employee termination costs in the three and six months ended April 30, 2015, respectively. In addition, CooperVision incurred $8.0 million and $14.1 million of integration costs in the three and six months ended April 30, 2015, respectively, recorded in selling, general and administrative expense.

A summary of the cumulative total restructuring costs by major component recognized to date as of April 30, 2016, is as follows:
(In millions)
Employee-related
 
Facilities-related
 
Product Rationalization
 
Total
Amounts incurred in:
 
 
 
 
 
 
 
Year ended October 31, 2014
$
20.3

 
$
0.5

 
$
15.3

 
$
36.1

Year ended October 31, 2015
(2.5
)
 
0.4

 
57.7

 
55.6

Six months ended April 30, 2016
0.7

 
0.3

 
14.7

 
15.7

Cumulative amounts incurred as of April 30, 2016
$
18.5

 
$
1.2

 
$
87.7

 
$
107.4



10

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)

The following table summarizes the restructuring activities by major component for the fiscal year ended October 31, 2015 and the six months ended April 30, 2016:
(In millions)
Employee-related
 
Facilities-related
 
Product Rationalization
 
Total
 
 
 
 
 
 
 
 
Balance at October 31, 2014
$
19.9

 
$
0.5

 
$

 
$
20.4

(Reductions) additions during fiscal 2015
(2.5
)
 
0.4

 
57.7

 
55.6

Payments during the fiscal year
(9.0
)
 
(0.4
)
 

 
(9.4
)
Non-cash adjustments (a) (b)
0.2

 
(0.2
)
 
(57.7
)
 
(57.7
)
Balance at October 31, 2015
8.6

 
0.3

 

 
8.9

Additions during the six months ended April 30, 2016
0.7

 
0.3

 
14.7

 
15.7

Payments during the six months ended April 30, 2016
(3.7
)
 
(0.1
)
 

 
(3.8
)
Non-cash adjustments (a) (b)
(0.1
)
 
(0.1
)
 
(14.7
)
 
(14.9
)
Balance at April 30, 2016
$
5.5

 
$
0.4

 
$

 
$
5.9

(a) Non-cash adjustments for employee-related and facilities-related costs represent currency translation adjustment.
(b) Non-cash adjustments for product rationalization represent equipment disposals, inventory write-offs and accelerated depreciation.

Note 4. Inventories
(In millions)
April 30, 2016
 
October 31, 2015
Raw materials
$
85.8

 
$
80.9

Work-in-process
15.6

 
14.5

Finished goods
332.2

 
324.3

 
$
433.6

 
$
419.7

Inventories are stated at the lower of cost or market. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.

11

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)

Note 5. Intangible Assets

Goodwill
(In millions)
CooperVision
 
CooperSurgical
 
Total
Balance at October 31, 2014
$
1,861.5

 
$
359.4

 
$
2,220.9

Net (reductions) additions during the year ended October 31, 2015
(1.2
)
 
17.4

 
16.2

Translation
(32.7
)
 
(7.3
)
 
(40.0
)
Balance at October 31, 2015
1,827.6

 
369.5

 
2,197.1

Net additions during the six-month period ended April 30, 2016
0.1

 
79.2

 
79.3

Translation
(45.7
)
 
2.6

 
(43.1
)
Balance at April 30, 2016
$
1,782.0

 
$
451.3

 
$
2,233.3


We performed our annual impairment assessment in our fiscal third quarter of 2015, and our analysis indicated that we had no impairment of goodwill. As described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2015, we will continue to monitor conditions and changes which could indicate that our recorded goodwill may be impaired.

Other Intangible Assets
 
As of April 30, 2016
 
As of October 31, 2015
(In millions)
Gross Carrying
Amount
 
Accumulated
Amortization
& Translation
 
Gross Carrying
Amount
 
Accumulated
Amortization
& Translation
Trademarks
$
29.9

 
$
5.4

 
$
23.7

 
$
4.4

Technology
332.0

 
127.0

 
318.9

 
114.7

Customer relationships
279.8

 
113.3

 
247.0

 
104.5

License and distribution rights and other
73.3

 
32.3

 
71.7

 
26.6

 
715.0

 
$
278.0

 
661.3

 
$
250.2

Less: accumulated amortization and translation
278.0

 
 
 
250.2

 
 
Other intangible assets, net
$
437.0

 
 
 
$
411.1

 
 
We estimate that amortization expense for our existing other intangible assets at April 30, 2016, will be $59.6 million in fiscal 2016, $56.1 million in fiscal 2017, $54.1 million in fiscal 2018, $51.5 million in fiscal 2019 and $40.9 million in fiscal 2020.

12

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)

Note 6. Debt
(In millions)
April 30, 2016
 
October 31, 2015
Short-term:
 
 
 
Overdraft and other credit facilities
$
31.7

 
$
240.4

Current portion of long-term debt

 
3.8

Less: unamortized debt issuance cost on term loans
(1.5
)
 
(0.4
)
 
$
30.2

 
$
243.8

Long-term:
 
 
 
Credit agreements
$

 
$
109.0

Term loans
1,415.0

 
996.3

Other
0.3

 
0.5

Less: unamortized debt issuance cost on term loans
(4.1
)
 
(0.4
)
 
$
1,411.2

 
$
1,105.4


Revolving Credit and Term Loan Agreement on March 1, 2016 (2016 Credit Agreement)
On March 1, 2016, we entered into a new Revolving Credit and Term Loan Agreement (2016 Credit Agreement), among the Company, CooperVision International Holding Company, LP, the lenders from time to time party thereto and KeyBank National Association, as administrative agent. The 2016 Credit Agreement provides for a multicurrency revolving credit facility in an aggregate principal amount of $1.0 billion and a term loan facility in an aggregate principal amount of $830.0 million, each of which, unless terminated earlier, mature on March 1, 2021. In addition, we have the ability from time to time to request an increase to the size of the revolving credit facility or establish one or more new term loans under the term loan facility in an aggregate amount up to $750.0 million, subject to the discretionary participation of the lenders.
The 2016 Credit Agreement replaced our previous Credit Agreement that was entered into on January 12, 2011, and we terminated the Credit Agreement on March 1, 2016. In connection with the termination, all borrowings outstanding under the Credit Agreement were repaid and all letters of credit outstanding were transferred to the 2016 Credit Agreement. We did not incur any termination or prepayment penalties with respect to replacing the Credit Agreement. We used funds from the new term loan to repay the $200.0 million outstanding principal amount of the two uncommitted revolving lines of credit, entered into on March 24, 2015, as well as to partially repay outstanding amounts under the term loans entered into on August 4, 2014, and September 12, 2013, and for general corporate purposes.

Amounts outstanding under the 2016 Credit Agreement will bear interest, at our option, at either the base rate, which is a rate per annum equal to the greatest of (a) KeyBank’s prime rate, (b) 0.5% in excess of the federal funds effective rate and (c) 1% in excess of the adjusted LIBO rate for a one month interest period on such day, or the adjusted LIBO rate or adjusted foreign currency rate, plus, in each case, an applicable rate of, initially, 0.5% in respect of base rate loans and 1.5% in respect of adjusted LIBO rate or adjusted foreign currency rate loans. Following a specified period after the closing date, the applicable rates will be determined quarterly by reference to a grid based upon our ratio of consolidated net indebtedness to consolidated pro forma EBITDA, as defined in the 2016 Credit Agreement. During the term of the revolving credit facility, we may borrow, repay and re-borrow amounts available under the revolving credit facility, subject to voluntary reduction of the revolving commitment.

We pay an annual commitment fee that ranges from 0.125% to 0.25% of the unused portion of the revolving credit facility depending on certain financial ratios. In addition to the annual commitment fee described above, we are also required to pay certain letter of credit and related fronting fees and other administrative fees pursuant to the terms of the 2016 Credit Agreement.

The 2016 Credit Agreement is not secured by any of the Company's, or any of its subsidiaries’ (including CooperVision International Holding Company’s), assets. All obligations under this facility will be guaranteed by each of the Company’s

13

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)

existing and future direct and indirect domestic material subsidiaries, as defined in the 2016 Credit Agreement. CooperVision International Holding Company is responsible only for its own obligations, if any, and does not guarantee any of the Company’s obligations under the 2016 Credit Agreement.

The facility is not subject to amortization and is not subject to mandatory prepayments prior to maturity. We may prepay loan balances from time to time, in whole or in part, without premium or penalty (other than any related breakage costs).

The 2016 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require us to maintain a certain total leverage ratio and interest coverage ratio, each as defined in the 2016 Credit Agreement. The 2016 Credit Agreement also contains customary events of default, the occurrence of which would permit KeyBank as the administrative agent to declare the principal, accrued interest and other obligations under the agreement to be immediately due and payable.
Pursuant to the terms of the 2016 Credit Agreement and the term loans discussed below, we are also required to maintain specified financial ratios:
The ratio of Consolidated Proforma EBITDA to Consolidated Interest Expense (as defined, Interest Coverage Ratio) be at least 3.00 to 1.00 at all times.
The ratio of Consolidated Funded Indebtedness to Consolidated Proforma EBITDA (as defined, Total Leverage Ratio) be no higher than 3.75 to 1.00.
At April 30, 2016, we were in compliance with the Interest Coverage Ratio at 26.42 to 1.00 and the Total Leverage Ratio at 2.37 to 1.00.
At April 30, 2016, we had $830.0 million outstanding under the term loan and about $1.0 billion available under the revolving credit agreement.
Uncommitted Revolving Lines of Credit on March 24, 2015
On March 24, 2015, we entered into two uncommitted line of credit agreements with TD Bank, N.A. and Santander Bank, N.A. These lines of credit had a termination date of March 24, 2016, and each provided revolving loan amounts to Cooper of up to $100.0 million, at the lender's option, with maturity dates of up to ninety days from the loan origination date. Amounts outstanding under these agreements will bear interest at a rate equal to LIBOR for the period plus, 0.90%, payable in arrears on the last day of the period, as defined in the agreements.
In the fiscal second quarter of 2016, in connection with the refinancing discussed above, we repaid the full outstanding principal amount of the two uncommitted revolving lines of credit. At April 30, 2016, there were no amounts outstanding under these agreements.

$700.0 million Term Loan on August 4, 2014

On August 4, 2014, we entered into a three-year, $700.0 million, senior unsecured term loan agreement by and among the Company, the lenders party thereto and KeyBank National Association as administrative agent. This syndicated credit facility will mature and the balance is payable on August 4, 2017. There is no amortization of principal and we may prepay loan balances from time to time, in whole or in part, without premium or penalty. In August 2014, we utilized this facility to fund the acquisition of Sauflon, as well as to provide working capital and for general corporate purposes. In fiscal second quarter of 2016, we repaid $400.0 million of the outstanding balance using funds from the 2016 Credit Agreement.

Amounts outstanding under this term loan agreement will bear interest, at the Company’s option, at either the base rate, which is a rate per annum equal to the greatest of (a) KeyBank’s prime rate, (b) 0.5% in excess of the federal funds effective rate and (c) 1% in excess of the adjusted Eurodollar rate (currently referred to as LIBOR) for a one-month interest period on such day, or the adjusted Eurodollar rate, plus, in each case, an applicable margin. The applicable margins will be determined quarterly by reference to a grid based upon the Company’s Total Leverage Ratio, as defined in the term loan agreement and consistent with the 2016 Credit Agreement discussed above.

14

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)


This term loan agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the agreement, and consistent with the 2016 Credit Agreement as discussed above. This term loan agreement also contains customary events of default, the occurrence of which would permit the Administrative Agent to declare the principal, accrued interest and other obligations of the Company under the agreement to be immediately due and payable.

On March 1, 2016, we entered into an Amendment and Restatement Agreement (Amended and Restated 2014 Term Loan) to amend and restate in its entirety the Term Loan Agreement, dated as of August 4, 2014, as amended by Amendment No. 1 dated as of August 21, 2015 (2014 Term Loan Agreement), by and among the Company, the lenders party thereto, and KeyBank National Association, as administrative agent. The Amended and Restated 2014 Term Loan modifies certain provisions of the 2014 Term Loan Agreement to, among other things, conform certain restrictive covenants and events of default to the restrictive covenants and events of default contained in our new 2016 Credit Agreement.

At April 30, 2016, we had $300.0 million outstanding under this term loan.

$300.0 million Term Loan on September 12, 2013

On September 12, 2013, the Company entered into a five-year, $300.0 million, senior unsecured term loan agreement by and among the Company; the lenders party thereto and KeyBank National Association, as administrative agent. This syndicated credit facility, as subsequently amended, will mature on September 12, 2018, and will be subject to amortization of principal of 5% per annum payable quarterly beginning October 31, 2016, with the balance payable at maturity. In fiscal second quarter of 2016, we repaid $15.0 million of the outstanding balance using the funds from the 2016 Credit Agreement.

Amounts outstanding under this term loan agreement will bear interest, at the Company's option, at either the base rate, which is a rate per annum equal to the greatest of (a) KeyBank's prime rate, (b) 0.5% in excess of the federal funds effective rate and (c) 1% in excess of the adjusted Eurodollar rate (currently referred to as LIBOR) for a one-month interest period on such day, or the adjusted Eurodollar rate, plus, in each case, an applicable margin. The applicable margins will be determined quarterly by reference to a grid based upon the Company's Total Leverage Ratio, as defined in the term loan agreement, and consistent with the 2016 Credit Agreement discussed above.

This term loan agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the agreement, consistent with the 2016 Credit Agreement discussed above. The agreement also contains customary events of default, the occurrence of which would permit the Administrative Agent to declare the principal, accrued interest and other obligations of the Company under the agreement to be immediately due and payable.

In connection with the Sauflon acquisition, on June 30, 2014, we entered into an amendment to this term loan agreement, dated as of September 12, 2013, by and among (i) the Company, (ii) the lenders from time to time party thereto and (iii) KeyBank National Association, as administrative agent. This term loan amendment modifies certain provisions of the term loan agreement to, among other things, amend certain restrictive covenants and related definitions to allow for certain indebtedness, investments, guaranty obligations, acquisitions, intercompany loans, capital distributions and dispositions of assets made or to be made in connection with the acquisition.

On August 4, 2014, we entered into Amendment No. 2 to this term loan agreement, dated as of September 12, 2013, as amended by Amendment No. 1 dated as of June 30, 2014, by and among the Company, the lenders party thereto and KeyBank National Association, as administrative agent. The term loan amendment modifies certain provisions of the term loan agreement to remove the call premium related to prepayments and/or refinancing of the term loan agreement, effective August 4, 2014.

On March 1, 2016, we entered into an Amendment and Restatement Agreement (Amended and Restated 2013 Term

15

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)

Loan) to amend and restate in its entirety the Term Loan Agreement, dated as of September 12, 2013, as amended by Amendment No. 1 dated as of June 30, 2014, Amendment No. 2 dated as of August 4, 2014 and Amendment No. 3 dated as of August 21, 2015 (2013 Term Loan Agreement), by and among the Company, the lenders party thereto, and KeyBank National Association, as administrative agent. The Amended and Restated 2013 Term Loan modifies certain provisions of the 2013 Term Loan Agreement to, among other things, conform certain restrictive covenants and events of default to the restrictive covenants and events of default contained in our new 2016 Credit Agreement.

At April 30, 2016, we had $285.0 million outstanding under this term loan.

Note 7. Income Taxes
Our effective tax rate (ETR) (provision for income taxes divided by pretax income) for the fiscal first half of 2016 was 5.4%. Our year-to-date results reflect the projected fiscal year ETR, plus any discrete items. The ETR used to record the provision for income taxes for the fiscal first half of 2015 was 8.6%. The decrease in the effective tax rate in the fiscal first half of 2016 was primarily due to a release of reserves associated with a prior year tax filing, a statutory tax rate reduction in the United Kingdom and the retroactive extension of the R&D tax credit.
We recognize the benefit from a tax position only if it is more likely than not that the position would be sustained upon audit based solely on the technical merits of the tax position. At November 1, 2015, Cooper had unrecognized tax benefits of which, if recognized, $29.4 million would impact our ETR. For the six-month period ended April 30, 2016, there were no material changes to the total amount of unrecognized tax benefits.
Interest and penalties of $3.7 million have been reflected as a component of the total liability at November 1, 2015. It is our policy to recognize the items of interest and penalties directly related to income taxes as additional income tax expense.
Included in the balance of unrecognized tax benefits at November 1, 2015, is $10.0 million related to tax positions for which it is reasonably possible that the total amounts could significantly change during the next twelve months. This amount represents a decrease in unrecognized tax benefits related to expiring statutes in various jurisdictions worldwide and relates primarily to transfer pricing matters.
At April 30, 2016, the tax years for which Cooper remains subject to United States Federal income tax assessment upon examination are 2014 through 2015. Cooper remains subject to income tax examinations in other significant tax jurisdictions including the United Kingdom, Japan, France and Australia for the tax years 2012 through 2015.

Note 8. Earnings Per Share
Periods Ended April 30,
Three Months
 
Six Months
(In millions, except per share amounts)
2016
 
2015
 
2016
 
2015
Net income attributable to Cooper stockholders
$
74.1

 
$
60.7

 
$
125.5

 
$
121.9

Basic:

 

 

 

Weighted average common shares
48.4

 
48.5

 
48.4

 
48.3

Basic earnings per common share attributable to Cooper stockholders
$
1.53

 
$
1.25

 
$
2.59

 
$
2.52

Diluted:

 

 
 
 
 
Weighted average common shares
48.4

 
48.5

 
48.4

 
48.3

Effect of potential dilutive common shares
0.5

 
0.7

 
0.4

 
0.8

Diluted weighted average common shares
48.9

 
49.2

 
48.8

 
49.1

Diluted earnings per common share attributable to Cooper stockholders
$
1.52

 
$
1.23

 
$
2.57

 
$
2.48


16

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)

The following table sets forth stock options to purchase Cooper’s common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:
Periods Ended April 30,
Three Months
 
Six Months
(In thousands, except exercise prices)
2016
 
2015
 
2016
 
2015
Numbers of stock option shares excluded
537

 
123

 
537

 
123

Range of exercise prices
$131.60-$162.69

 
$
162.28

 
$131.60-$162.69

 
$
162.28

Numbers of restricted stock units excluded
7

 
1

 
2

 
1


Note 9. Share-Based Compensation Plans
Cooper has several share-based compensation plans that are described in the Company’s Annual Report on Form 10‑K for the fiscal year ended October 31, 2015. The compensation expense and related income tax benefit recognized in our consolidated condensed financial statements for share-based awards were as follows:
Periods Ended April 30,
Three Months
 
Six Months
(In millions)
2016
 
2015
 
2016
 
2015
Selling, general and administrative expense
$
7.0

 
$
6.2

 
$
12.8

 
$
15.9

Cost of sales
0.7

 
0.6

 
1.2

 
1.4

Research and development expense
0.2

 
0.2

 
0.6

 
0.4

Total share-based compensation expense
$
7.9

 
$
7.0

 
$
14.6

 
$
17.7

Related income tax benefit
$
2.3

 
$
2.2

 
$
4.3

 
$
5.6

We capitalized share-based compensation expense as part of the cost of inventory in the amounts of $0.7 million and $1.2 million during the three and six months ended April 30, 2016, respectively; and $0.6 million and $1.4 million during the three and six months ended April 30, 2015, respectively.

Note 10. Stockholders’ Equity
Analysis of Changes in Accumulated Other Comprehensive Income (Loss):
(In millions)
Foreign Currency Translation Adjustment
 
Change in Value of 
Derivative Instruments
 
Minimum Pension Liability
 
Total
Balance at October 31, 2014
$
(92.4
)
 
$
(0.1
)
 
$
(13.7
)
 
$
(106.2
)
Gross change in value during the year ended October 31, 2015
(79.4
)
 

 
(10.0
)
 
(89.4
)
Reclassification adjustments for loss realized in net income

 
0.1

 

 
0.1

Tax effect for the period

 

 
3.9

 
3.9

Balance at October 31, 2015
$
(171.8
)
 
$

 
$
(19.8
)
 
$
(191.6
)
Gross change in value during the six-month period ended April 30, 2016
(61.5
)
 

 
(0.1
)
 
(61.6
)
Reclassification adjustments for loss realized in net income

 

 

 

Tax effect for the period

 

 

 

Balance at April 30, 2016
$
(233.3
)
 
$

 
$
(19.9
)
 
$
(253.2
)

17

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)

Share Repurchases
In December 2011, our Board of Directors authorized the 2012 Share Repurchase Program and subsequently amended the total repurchase authorization to $500.0 million of the Company’s common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Share Repurchase Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements. We did not repurchase shares in the fiscal first half of 2016. In the fiscal first quarter of 2015, we repurchased 100 thousand shares of the Company’s common stock for $16.0 million, at an average purchase price of $159.96 per share. At April 30, 2016, approximately $118.4 million remains authorized for repurchase under the program.
Dividends
We paid a semiannual dividend of approximately $1.5 million or 3 cents per share on February 9, 2016, to stockholders of record on January 22, 2016.

Note 11. Fair Value Measurements
At April 30, 2016 and October 31, 2015, the carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms.
Assets and liabilities are measured and reported at fair value per related accounting standards that define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset’s or liability’s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.
We believe that the balances of our revolving debt and term loans approximated their fair values at April 30, 2016 and October 31, 2015 and are categorized as Level 2 of the fair value hierarchy.
The Company has derivative assets and liabilities that may include interest rate swaps, cross currency swaps and foreign currency forward contracts. The impact of the counterparty’s creditworthiness when in an asset position and Cooper’s creditworthiness when in a liability position has also been factored into the fair value measurement of the derivative instruments. Both the counterparty and Cooper are expected to continue to perform under the contractual terms of the instruments.
We may use interest rate swaps to maintain our desired mix of fixed-rate and variable-rate debt. The swaps exchange fixed and variable rate payments without exchanging the notional principal amount of the debt. We generally have elected to use the income approach to value the derivatives using observable Level 2 market expectations at the measurement date and standard valuation techniques to convert future amounts to a single present amount assuming that participants are motivated but not compelled to transact. Level 2 inputs are limited to quoted prices for similar assets or liabilities in active markets, specifically Eurodollar futures contracts up to three years, and inputs other than quoted prices that are observable for the asset or liability - specifically LIBOR cash and swap rates and credit risk at commonly quoted intervals. Mid-market pricing may be used as a practical expedient for fair value measurements.
We may use foreign exchange forward contracts to minimize, to the extent reasonable and practical, our exposure to the impact of foreign currency fluctuations. We have elected to use the income approach to value the derivatives using observable Level 2 market expectations at the measurement date and standard valuation techniques to convert future

18

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)

amounts to a single present amount assuming that participants are motivated but not compelled to transact. Level 2 inputs for the valuations are limited to quoted prices for similar assets or liabilities in active markets and inputs other than quoted prices that are observable for the asset or liability - specifically LIBOR cash rates, credit risk at commonly quoted intervals, foreign exchange spot rates and forward points. Mid-market pricing is used as a practical expedient for fair value measurements.
The following table sets forth our financial assets and liabilities that were measured at fair value on a recurring basis using Level 2 inputs during the fiscal first six months of 2016, within the fair value hierarchy at April 30, 2016, and fiscal year 2015, within the fair value hierarchy at October 31, 2015:
(In millions)
April 30, 2016
 
October 31, 2015
Assets:
 
 
 
Foreign exchange contracts
$
0.8

 
$
1.3

Liabilities:

 

Foreign exchange contracts
$
0.9

 
$
0.4


Note 12. Employee Benefits
Cooper’s Retirement Income Plan (Plan), a defined benefit plan, covers substantially all full-time United States employees. Our contributions are designed to fund normal cost on a current basis and to fund the estimated prior service cost of benefit improvements. The unit credit actuarial cost method is used to determine the annual cost. Cooper pays the entire cost of the Plan and funds such costs as they accrue. Virtually all of the assets of the Plan are comprised of equities and participation in equity and fixed income funds.
Our results of operations for the three and six months ended April 30, 2016 and 2015 reflect the following components of net periodic pension costs:
Periods Ended April 30,
Three Months
 
Six Months
(In millions)
2016
 
2015
 
2016
 
2015
Service cost
$
2.3

 
$
2.0

 
$
4.6

 
$
4.1

Interest cost
1.2

 
1.1

 
2.5

 
2.1

Expected return on plan assets
(1.6
)
 
(1.5
)
 
(3.3
)
 
(3.0
)
Amortization of prior service cost

 

 

 

Recognized net actuarial loss
0.4

 
0.2

 
0.8

 
0.5

Net periodic pension cost
$
2.3

 
$
1.8

 
$
4.6

 
$
3.7

We contributed $2.5 million to the Plan in the fiscal first half of 2016, and expect to contribute an additional $7.5 million during fiscal 2016. We contributed $2.5 million to the Plan in the fiscal first half of 2015. The expected rate of return on plan assets for determining net periodic pension cost is 8%.

19

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)


Note 13. Contingencies

Since March 2015, over 50 putative class action complaints were filed by contact lens consumers alleging that contact lens manufacturers, in conjunction with their respective Unilateral Pricing Policy (UPP), conspired to reach agreements between each other and certain distributors and retailers regarding the prices at which certain contact lenses could be sold to consumers. The plaintiffs are seeking damages against CooperVision, Inc., other contact lens manufacturers, distributors and retailers, in various courts around the United States. In June 2015, all of the class action cases were consolidated and transferred to the United States District Court for the Middle District of Florida. CooperVision and the other defendants jointly filed a motion to dismiss the complaints which currently is pending, and the actions currently are in discovery. CooperVision denies the allegations and intends to defend the actions vigorously. We are not in a position to assess whether any loss or adverse effect on our financial condition is probable or remote or to estimate the range of potential loss, if any.

Note 14. Business Segment Information
Cooper uses operating income, as presented in our financial reports, as the primary measure of segment profitability. We do not allocate costs from corporate functions to segment operating income. Items below operating income are not considered when measuring the profitability of a segment. We use the same accounting policies to generate segment results as we do for our consolidated results.
Identifiable assets are those used in continuing operations except cash and cash equivalents, which we include as corporate assets. Long-lived assets are property, plant and equipment.
Segment information:
Periods Ended April 30,
Three Months
 
Six Months
(In millions)
2016
 
2015
 
2016
 
2015
CooperVision net sales by category:
 
 
 
 
 
 
 
Toric lens
$
120.5

 
$
107.1

 
$
228.0

 
$
215.6

Multifocal lens
42.5

 
37.9

 
82.9

 
80.4

Single-use sphere lens
97.6

 
85.1

 
188.4

 
169.3

Non single-use sphere and other
130.6

 
129.5

 
256.3

 
263.6

Total CooperVision net sales
391.2

 
359.6

 
755.6

 
728.9

CooperSurgical net sales
92.6

 
75.1

 
177.8

 
150.9

Total net sales
$
483.8

 
$
434.7

 
$
933.4

 
$
879.8

Operating income (loss):
 
 
 
 
 
 
 
CooperVision
$
83.6

 
$
67.7

 
$
136.4

 
$
140.9

CooperSurgical
17.7

 
14.2

 
33.1

 
27.4

Corporate
(11.5
)
 
(10.9
)
 
(22.3
)
 
(24.2
)
Total operating income
89.8

 
71.0

 
147.2

 
144.1

Interest expense
7.6

 
4.7

 
12.9

 
8.6

Other (income) expense, net
(0.4
)
 
(0.7
)
 
1.0

 
1.0

Income before income taxes
$
82.6

 
$
67.0

 
$
133.4

 
$
134.5


20

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Notes to Consolidated Condensed Financial Statements
(Unaudited)

(In millions)
April 30, 2016
 
October 31, 2015
Identifiable assets:
 
 
 
CooperVision
$
3,678.9

 
$
3,714.6

CooperSurgical
817.6

 
674.8

Corporate
104.8

 
70.5

Total
$
4,601.3

 
$
4,459.9

Geographic information:
Periods Ended April 30,
Three Months
 
Six Months
(In millions)
2016
 
2015
 
2016
 
2015
Net sales to external customers by country of domicile:
 
 
 
 
 
 
 
United States
$
221.4

 
$
197.4

 
$
428.2

 
$
401.3

Europe
165.9

 
154.7

 
323.0

 
313.8

Rest of world
96.5

 
82.6

 
182.2

 
164.7

Total
$
483.8

 
$
434.7

 
$
933.4

 
$
879.8

(In millions)
April 30, 2016
 
October 31, 2015
Long-lived assets by country of domicile:
 
 
 
United States
$
500.9

 
$
494.2

Europe
391.6

 
407.9

Rest of world
71.9

 
65.0

Total
$
964.4

 
$
967.1

 
Note 15. Subsequent Event

Subsequent to our fiscal second quarter of 2016, on May 31, 2016, CooperSurgical acquired Reprogenetics UK, a genetics laboratory specializing in service offerings of preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) used during the IVF process, for approximately $12.0 million.

Subsequent to our fiscal second quarter of 2016, on May 25, 2016, CooperSurgical acquired the commercial assets of Recombine Inc., a clinical genetic testing company specializing in carrier screening for approximately $85.0 million.

Subsequent to our fiscal second quarter of 2016, on May 4, 2016, CooperSurgical acquired Kivex Biotec A/S (K-Systems), a manufacturer and distributor of equipment for IVF clinics, for approximately $11.5 million.

21

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




Note numbers refer to “Notes to Consolidated Condensed Financial Statements” in Item 1. Financial Statements.

Forward-Looking Statements
This Quarterly Report on Form 10-Q contains “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995. These include statements relating to plans, prospects, goals, strategies, future actions, events or performance and other statements which are other than statements of historical fact, including all statements regarding acquisitions including the acquired companies' financial position, market position, product development and business strategy, expected cost synergies, expecting timing and benefits of the transaction, difficulties in integrating entities or operations, as well as estimates of our and the acquired entities' future expenses, sales and earnings per share are forward-looking. In addition, all statements regarding anticipated growth in our revenue, anticipated effects of any product recalls, anticipated market conditions, planned product launches and expected results of operations and integration of any acquisition are forward-looking. To identify these statements look for words like “believes,” “expects,” “may,” “will,” “should,” “could,” “seeks,” “intends,” “plans,” “estimates” or “anticipates” and similar words or phrases. Forward-looking statements necessarily depend on assumptions, data or methods that may be incorrect or imprecise and are subject to risks and uncertainties. Among the factors that could cause our actual results and future actions to differ materially from those described in forward-looking statements are:
Adverse changes in the global or regional general business, political and economic conditions, including the impact of continuing uncertainty and instability of certain countries that could adversely affect our global markets.
Foreign currency exchange rate and interest rate fluctuations including the risk of fluctuations in the value of foreign currencies that would decrease our revenues and earnings.
Acquisition-related adverse effects including the failure to successfully obtain the anticipated revenues, margins and earnings benefits of acquisitions; integration delays or costs and the requirement to record significant adjustments to the preliminary fair value of assets acquired and liabilities assumed within the measurement period, required regulatory approvals for an acquisition not being obtained or being delayed or subject to conditions that are not anticipated, adverse impacts of changes to accounting controls and reporting procedures, contingent liabilities or indemnification obligations, increased leverage and lack of access to available financing (including financing for the acquisition or refinancing of debt owed by us on a timely basis and on reasonable terms).
Our indebtedness could adversely affect our financial health, prevent us from fulfilling our debt obligations or limit our ability to borrow additional funds.
A major disruption in the operations of our manufacturing, research and development or distribution facilities, due to technological problems, including any related to our information systems maintenance, enhancements or new system deployments and integrations, integration of acquisitions, natural disasters or other causes.
Disruptions in supplies of raw materials, particularly components used to manufacture our silicone hydrogel lenses.
New U.S. and foreign government laws and regulations, and changes in existing laws, regulations and enforcement guidance, which affect the contact lens industry, specifically, or the medical device and the health care industries generally.
Compliance costs and potential liability in connection with U.S. and foreign health care regulations and federal and state laws pertaining to privacy and security of health information, including product recalls, warning letters, and data security breaches.
Legal costs, insurance expenses, settlement costs and the risk of an adverse decision, prohibitive injunction or settlement related to product liability, patent infringement or other litigation.
Changes in tax laws or their interpretation and changes in statutory tax rates.

22

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




Limitations on sales following product introductions due to poor market acceptance.
New competitors, product innovations or technologies.
Reduced sales, loss of customers and costs and expenses related to recalls.
Failure to receive, or delays in receiving, U.S. or foreign regulatory approvals for products.
Failure of our customers and end users to obtain adequate coverage and reimbursement from third party payors for our products and services.
The requirement to provide for a significant liability or to write off, or accelerate depreciation on, a significant asset, including goodwill.
The success of our research and development activities and other start-up projects.
Dilution to earnings per share from acquisitions or issuing stock.
Changes in accounting principles or estimates.
Environmental risks.
Other events described in our Securities and Exchange Commission filings, including the “Business” and “Risk Factors” sections in our Annual Report on Form 10-K for the fiscal year ended October 31, 2015, as such Risk Factors may be updated in quarterly filings.
We caution investors that forward-looking statements reflect our analysis only on their stated date. We disclaim any intent to update them except as required by law.



23

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




Results of Operations
In this section, we discuss the results of our operations for the fiscal second quarter of 2016 ended April 30, 2016, and the six months then ended and compare them with the same periods of fiscal 2015. We discuss our cash flows and current financial condition under “Capital Resources and Liquidity.” Within the tables presented, percentages are calculated based on the underlying whole-dollar amounts and, therefore, may not recalculate from the rounded numbers used for disclosure purposes.
Second Quarter Highlights
Net sales of $483.8 million, up 11% from $434.7 million
Gross profit $298.5 million, up 11% from $267.7 million
Operating income $89.8 million, up 27% from $71.0 million
Diluted earnings per share of $1.52, up from $1.23 per share
Cash provided by operations $97.8 million, down from $110.6 million
Results in our fiscal second quarter of 2016 include $4.9 million of expenses primarily due to equipment and product rationalization related to acquisitions, $1.4 million of costs associated with the start-up of new manufacturing facilities, and $0.9 million of integration costs, all recorded in cost of sales; $5.6 million of expenses for acquisition, restructuring and integration activities, and $0.6 million of certain legal costs, recorded in operating expenses; as well as $14.3 million for amortization of intangible assets. We also incurred a loss of $0.4 million in the period relating to debt extinguishment, recorded in other expense. The legal costs relate to litigation of the class action complaints filed against CooperVision and other contact lens manufacturers, distributors and retailers relating to Unilateral Pricing Policy (UPP)and related lobbying expenses.
Results in our fiscal second quarter of 2015 included $5.3 million of expenses primarily due to product and equipment rationalization related to acquisitions and $2.5 million of costs associated with the start-up of new manufacturing facilities, recorded in cost of sales; $4.7 million of expenses for restructuring and integration activities and $0.9 million of certain legal costs, recorded in operating expenses; as well as $12.3 million for amortization of intangible assets. The legal costs related to third-party intellectual property claims and litigation as well as litigation relating to UPP described above.
Six-Month Highlights
Net sales of $933.4 million, up 6% from $879.8 million
Gross profit $560.5 million, up 3% from $544.1 million
Operating income $147.2 million, up 2% from $144.1 million
Diluted earnings per share of $2.57, up from $2.48 per share
Cash provided by operations $187.4 million, down from $190.5 million
Results in the six months ended April 30, 2016 include $16.2 million of expenses primarily due to equipment and product rationalization related to acquisitions, $3.7 million of costs associated with the start-up of new manufacturing facilities, and $1.3 million of integration costs, all recorded in cost of sales; $16.5 million of expenses for acquisition, restructuring and integration activities, and $1.4 million of certain legal costs, discussed above, recorded in operating expenses; as well as $30.5 million for amortization of intangible assets. We also incurred losses of $0.9 million in the period related to debt extinguishment and foreign exchange forward contracts related to an acquisition, recorded in other expense.
 

24

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




Results in the six months ended April 30, 2015 included $14.7 million of expenses primarily due to product and equipment rationalization related to recent acquisitions and $2.5 million of costs associated with the start-up of new manufacturing facilities, recorded in costs of sales; $11.2 million of expenses for restructuring and integration activities and the $0.9 million of certain legal costs discussed above, recorded in operating expenses; as well as $25.9 million for amortization of intangible assets.
Outlook

Overall, we remain optimistic about the long-term prospects for the worldwide contact lens and women’s health care markets. However, events affecting the economy as a whole, including the uncertainty and instability of global markets driven by foreign currency and commodity volatility as well as the Affordable Care Act, including the trend of consolidation within the health care industry, impact our current performance and continue to represent a risk to our performance for the remainder of fiscal year 2016.
CooperVision - We compete in the worldwide contact lens market with our spherical, toric and multifocal contact lenses offered in a variety of materials including using silicone hydrogel Aquaform® technology and phosphorylcholine technology (PC) Technology™. We believe that there will be lower contact lens wearer dropout rates as technology improves and enhances the wearing experience through a combination of improved designs and materials and the growth of preferred modalities such as single-use and monthly wearing options. CooperVision is focused on greater worldwide market penetration of recently introduced products and we continue to expand our presence in existing and emerging markets, including through acquisitions.
Sales of contact lenses utilizing silicone hydrogel materials continue to grow and this product material represents about half of the industry. Our ability to compete successfully with a full range of silicone hydrogel products is an important factor to achieving our desired future levels of sales growth and profitability. CooperVision markets monthly and two-week silicone hydrogel spherical and toric lens products under our Biofinity®, clariti® and Avaira® brands and a monthly silicone hydrogel multifocal lens under Biofinity. CooperVision markets single-use silicone hydrogel spherical, toric and multifocal lenses under our clariti 1day brand and a single-use silicone hydrogel spherical lens under MyDay®.
We believe that the global market for single-use contact lenses will continue to grow and our single-use silicone hydrogel products represent an opportunity for our business. Our clariti 1day brand provides the only single-use silicone hydrogel lenses in the marketplace with a complete line of spherical, toric and multifocal contact lenses. We forecast increasing aggregate demand for clariti 1day and MyDay products, as well as future single-use products. To meet this anticipated demand, we plan to continue the implementation of capital projects to invest in increased single-use manufacturing capacity.
CooperSurgical - Our CooperSurgical business competes in the highly fragmented medical device segment of the women's health care market. CooperSurgical has established its market presence and distribution system by developing products and acquiring companies and products that complement its business model. CooperSurgical product sales are categorized based on the point of health care delivery including products used in medical office and surgical procedures by obstetricians and gynecologists (ob/gyns) that represented 56% of CooperSurgical's net sales in the fiscal second quarter of 2016 compared to 66% in the prior year period. CooperSurgical's remaining sales are highly specialized products and services that target in vitro fertilization (IVF) treatment used in fertility that now represent 44% of CooperSurgical's net sales up from 34% in the prior year period. This change in product mix is attributed to recent acquisitions in fertility discussed below.
Beginning in August 2015, we have invested in CooperSurgical's fertility business through the acquisition of companies and product lines for new or complementary products and services for IVF treatment. In May 2016, CooperSurgical acquired the commercial assets of Recombine Inc., a clinical genetic testing company specializing in carrier screening, and Kivex Biotec A/S, a manufacturer and distributor of equipment for IVF clinics, and Reprogenetics UK, a genetics laboratory specializing in service offerings of preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) used during the IVF process. In our fiscal second quarter of 2016, we acquired Genesis Genetics, Inc., a genetics laboratory specializing in PGS and PGD used during the IVF process, and The Pipette Company, a manufacturer and distributor of micro pipettes for the Assisted Reproductive Technology (ART) market. In our fiscal first quarter of 2016, CooperSurgical acquired Research Instruments Limited, a manufacturer and supplier of IVF

25

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




medical devices and systems. Finally, in our fiscal fourth quarter of 2015, CooperSurgical acquired Reprogenetics, a genetics laboratory specializing in service offerings of PGS and PGD used during the IVF process. We intend to continue to invest in CooperSurgical's business through acquisitions of companies and product lines.

Capital Resources - At April 30, 2016, we had $44.5 million in cash, primarily outside the United States, and about $1.0 billion available under our new syndicated revolving credit agreement. The $830.0 million term loan entered on March 1, 2016, $300.0 million of the $700.0 million term loan entered into on August 4, 2014, and $285.0 million of the $300.0 million term loan entered into on September 12, 2013, remain outstanding as of April 30, 2016.

On March 1, 2016, we entered into a new syndicated revolving Credit and Term Loan Agreement with Keybank as administrative agent. This agreement, maturing on March 1, 2021, replaced our previous revolving Credit Agreement, entered into on January, 12, 2011 and provides for a multicurrency revolving credit facility in an aggregate principal amount of $1.0 billion and a term loan facility in the aggregate principal amount of $830.0 million. Concurrently, we used funds from the new term loan to repay the $200.0 million outstanding principal amount of the two uncommitted revolving lines of credit, entered into on March 24, 2015 and the outstanding amounts under the previous Credit Agreement. We also used funds from the new term loan to partially repay outstanding amounts under the term loans entered into on August 4, 2014 and September 12, 2013, and for general corporate purposes. For more information, please see the notes to consolidated condensed financial statements.

Our current cash balance and availability under the existing credit facilities reflects the use of cash outside the United States and the use of credit facilities to fund acquisitions, including recent CooperSurgical acquisitions and the $1.1 billion acquisition of Sauflon in August 2014. We believe that our cash and cash equivalents, cash flow from operating activities and borrowing capacity under the new credit facilities will fund operations both in the next 12 months and in the longer term as well as current and long-term cash requirements for capital expenditures, acquisitions, share repurchases and cash dividends. However, depending on the size or timing of these business activities, we may seek to raise additional debt financing.


26

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




Selected Statistical Information – Percentage of Sales and Growth
 
 
Percentage of Sales
 
2016 vs 2015 % Change
 
Percentage of Sales
 
2016 vs 2015 % Change
Periods Ended April 30,
 
2016
 
2015
 
 
2016
 
2015
 
Net sales
 
100
%
 
100
%
 
11
 %
 
100
%
 
100
%
 
6
 %
Cost of sales
 
38
%
 
38
%
 
11
 %
 
40
%
 
38
%
 
11
 %
Gross profit
 
62
%
 
62
%
 
11
 %
 
60
%
 
62
%
 
3
 %
Selling, general and administrative expense
 
37
%
 
39
%
 
6
 %
 
38
%
 
39
%
 
3
 %
Research and development expense
 
3
%
 
4
%
 
(1
)%
 
3
%
 
4
%
 
(4
)%
Amortization of intangibles
 
3
%
 
3
%
 
16
 %
 
3
%
 
3
%
 
18
 %
Operating income
 
19
%
 
16
%
 
27
 %
 
16
%
 
16
%
 
2
 %
Net Sales
Cooper’s two business units, CooperVision and CooperSurgical, generate all of its sales.
CooperVision develops, manufactures and markets a broad range of soft contact lenses for the worldwide vision correction market.
CooperSurgical develops, manufactures and markets medical devices and procedure solutions to improve health care delivery to women.
Our consolidated net sales grew by $49.1 million or 11%, and $53.6 million or 6%, in the three and six months ended April 30, 2016, respectively:
Periods Ended April 30,
 
Three Months
 
Six Months
($ in millions)
2016
 
2015
 
2016 vs 2015 % Change
 
2016
 
2015
 
2016 vs 2015 % Change
CooperVision
 
$
391.2

 
$
359.6

 
9
%
 
$
755.6

 
$
728.9

 
4
%
CooperSurgical
 
92.6

 
75.1

 
23
%
 
177.8

 
150.9

 
18
%
 
 
$
483.8

 
$
434.7

 
11
%
 
$
933.4

 
$
879.8

 
6
%
CooperVision Net Sales
The contact lens market has two major product categories:
Spherical lenses including lenses that correct near- and farsightedness uncomplicated by more complex visual defects.
Toric and multifocal lenses including lenses that, in addition to correcting near- and farsightedness, address more complex visual defects such as astigmatism and presbyopia by adding optical properties of cylinder and axis, which correct for irregularities in the shape of the cornea.
In order to achieve comfortable and healthy contact lens wear, products are sold with recommended replacement schedules, often defined as modalities, with the primary modalities being single-use, two-week and monthly. CooperVision offers spherical, aspherical, toric, multifocal and toric multifocal lens products in most modalities.
Single-use lenses are designed for daily replacement and frequently replaced lenses are designed for two-week or monthly replacement. Significantly, the market for spherical lenses is growing with value-added spherical lenses to alleviate dry eye symptoms, to add aspherical optical properties, and/or higher oxygen permeable lenses such as silicone hydrogels.


27

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




CooperVision’s silicone hydrogel Biofinity brand spherical, toric and multifocal contact lenses, Avaira brand spherical and toric lenses and MyDay brand spherical lenses, are manufactured using proprietary Aquaform technology to increase oxygen transmissibility for longer wear. Our silicone hydrogel clariti brand spherical, toric and multifocal contact lenses are available in monthly and single-use modalities. We believe the clariti single-use silicone hydrogel lens products provide a competitive advantage in approved markets as clariti is the only single-use silicone hydrogel lens available in all vision correction categories - spherical, toric and multifocal.

CooperVision’s Proclear brand aspheric, toric and multifocal contact lenses, manufactured using PC Technology, help enhance tissue/device compatibility and offer improved lens comfort.

CooperVision's net sales for the fiscal second quarter of 2016 increased 9% from the prior year period. CooperVision net sales growth included increases in total sphere lenses up 8%, representing 54% of net sales, compared to 55% in the prior year period, primarily on growth in sales of clariti, Biofinity and MyDay lenses offset by declines in older hydrogel products. Total toric lenses grew 13%, representing 31% of net sales, compared to 30% in the prior year period, with growth in sales of clariti and Biofinity products. Total multifocal lenses grew 12% representing 11% of net sales, the same as in the prior year period, with growth in sales of Biofinity, clariti and Proclear products. Total silicone hydrogel products, including clariti, Biofinity, Avaira and MyDay, grew 19%, representing 60% of net sales compared to 55% in the prior year period.

CooperVision competes in the worldwide soft contact lens market and services three primary regions: the Americas, EMEA (Europe, Middle East and Africa) and Asia Pacific.

CooperVision Net Sales by Geography
Periods Ended April 30,
 
Three Months
 
Six Months
($ in millions)
 
2016
 
2015
 
2016 vs. 2015
% Change
 
2016
 
2015
 
2016 vs. 2015
% Change
Americas
 
$
165.1

 
$
152.5

 
8
%
 
$
316.5

 
$
310.9

 
2
%
EMEA
 
148.8

 
143.3

 
4
%
 
294.1

 
290.9

 
1
%
Asia Pacific
 
77.3

 
63.8

 
21
%
 
145.0

 
127.1

 
14
%
 
 
$
391.2

 
$
359.6

 
9
%
 
$
755.6

 
$
728.9

 
4
%
Americas net sales growth was primarily due to market gains of silicone hydrogel lenses including Biofinity, clariti, and MyDay, partially offset by the decrease in sales of older hydrogel products. The increase in EMEA net sales growth was primarily driven by market gains of silicone hydrogel lenses including Biofinity, clariti and MyDay. Net sales growth in EMEA was partially offset by the negative impact from the weakening of foreign currencies as compared to the United States dollar. Net sales in the Asia Pacific region grew on market gains of silicone hydrogel lenses, including Biofinity, clariti and MyDay, along with growth in sales of Proclear 1 Day lenses. Net sales growth in the Asia Pacific region benefited in the three month period and was negatively impacted in the six month period by exchange rate changes of the United States dollar compared to the Japanese yen.
CooperVision’s net sales were driven primarily by increases in the volume of lenses sold, including recently introduced silicone hydrogel products and products from the acquisition of Sauflon. While unit growth and product mix have influenced CooperVision’s net sales, average realized prices by product have not materially influenced sales growth.

28

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




CooperSurgical Net Sales
CooperSurgical supplies the market for women's health care with a diversified portfolio of products and services for use in surgical and other medical procedures that are performed primarily by obstetricians and gynecologists in hospitals, surgical centers, fertility clinics and in the medical office. Fertility offerings include highly specialized products and services that target in vitro fertilization (IVF) treatment with a goal to make fertility treatment safer, more efficient and convenient.
Three Months Ended April 30,
($ in millions)
 
2016
 
% Net
Sales
 
2015
 
% Net
Sales
 
2016 vs. 2015
% Change
Office and surgical products
 
$
52.3

 
56
%
 
$
49.9

 
66
%
 
5
%
Fertility
 
40.3

 
44
%
 
25.2

 
34
%
 
60
%
 
 
$
92.6

 
100
%
 
$
75.1

 
100
%
 
23
%
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended April 30,
($ in millions)
 
2016
 
% Net
Sales
 
2015
 
% Net
Sales
 
2016 vs. 2015
% Change
Office and surgical products
 
$
106.4

 
60
%
 
$
100.7

 
67
%
 
6
%
Fertility
 
71.4

 
40
%
 
50.2

 
33
%
 
42
%
 
 
$
177.8

 
100
%
 
$
150.9

 
100
%
 
18
%

CooperSurgical's net sales of medical office and surgical products in the three and six month periods ended April 30, 2016 increased compared to the prior year periods on growth in sales of disposable products used in surgical procedures and recently launched products. The net sales increase in fertility as compared to the prior year period was primarily due to sales of products and services of recently acquired companies. Net sales growth was partially offset by the negative impact from the weakening of foreign currencies as compared to the United States dollar.

CooperSurgical’s sales primarily include women’s health care products and services used in fertility procedures and by gynecologists and obstetricians in the medical office and surgical centers. The balance consists of sales of medical devices outside of women’s health care which CooperSurgical does not actively market. Unit growth and product mix, primarily sales of recently acquired products and services, influenced sales growth.

Cost of Sales/Gross Profit
Gross Profit Percentage of Net Sales
 
Three Months
 
Six Months
Periods Ended April 30,
2016
 
2015
 
2016
 
2015
CooperVision
 
61
%
 
61
%
 
59
%
 
61
%
CooperSurgical
 
64
%
 
63
%
 
64
%
 
64
%
Consolidated
 
62
%
 
62
%
 
60
%
 
62
%
CooperVision's decline in gross margin in the six month period as compared to the prior year period is primarily due to the negative effects of foreign currency changes that unfavorably impacted gross margin as we reported lower net sales due to the weakening of foreign currencies as compared to the United States dollar. Gross margin also was negatively impacted in the six month period compared to the prior year period by an increase of $3.1 million consisting of product and equipment rationalization costs to rationalize products, based on our review of Sauflon's products, materials and manufacturing processes, as well as costs associated with the start-up of new manufacturing facilities. The decrease in gross margin was partially offset by the increase in sales of higher margin products including Biofinity.
CooperSurgical’s increase in gross margin in the three month period as compared to the prior year period is primarily due to favorable product mix from sales of disposable products used in surgical procedures and recently launched products used by gynecologists and obstetricians in the medical office and surgical procedures partially offset by sales in fertility of recently acquired lower margin products and services.

29

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




Selling, General and Administrative Expense (SGA)
Three Months Ended April 30,
($ in millions)
 
2016
 
% Net
Sales
 
2015
 
% Net
Sales
 
2016 vs. 2015 % Change
CooperVision
 
$
133.6

 
34
%
 
$
130.7

 
36
%
 
2
 %
CooperSurgical
 
32.6

 
35
%
 
26.0

 
35
%
 
25
 %
Corporate
 
11.5

 

 
10.9

 

 
5
 %
 
 
$
177.7

 
37
%
 
$
167.6

 
39
%
 
6
 %
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended April 30,
($ in millions)
 
2016
 
% Net
Sales
 
2015
 
% Net
Sales
 
2016 vs. 2015 % Change
CooperVision
 
$
265.9

 
35
%
 
$
262.9

 
36
%
 
1
 %
CooperSurgical
 
63.1

 
35
%
 
54.0

 
36
%
 
17
 %
Corporate
 
22.3

 

 
24.2

 

 
(8
)%
 
 
$
351.3

 
38
%
 
$
341.1

 
39
%
 
3
 %
The increases in CooperVision's SGA in absolute dollars in the three and six month periods as compared to prior year periods were primarily due to investment in sales and marketing, including headcount, to promote our silicone hydrogel products and to reach new customers and support geographic expansions. CooperVision's SGA included $2.1 million and $10.4 million of Sauflon restructuring and integration costs in the three and six month period ended April 30, 2016, respectively, compared to $4.5 million and $10.4 million in the prior year periods, respectively.
The increase in CooperSurgical's SGA in absolute dollars is primarily due to the inclusion of operating expenses of recently acquired companies as well as $3.4 million and $6.2 million of acquisition and integration expenses in our fertility business for the three and six month periods ended April 30, 2016, respectively, compared to $0.9 million and $1.4 million in the prior year periods, respectively. CooperSurgical continues to invest in sales activities to promote our products and to reach new customers.
The increase in Corporate SGA in absolute dollars for the fiscal second quarter of 2016 as compared to the prior year period is primarily due to the timing of share-based compensation grants. The decrease in Corporate SGA in absolute dollars for the six month period ended April 30, 2016 as compared to the prior year period is primarily due to lower share-based compensation costs and efficiencies as a result of cost control measures.
Research and Development Expense (R&D)
Three Months Ended April 30,
($ in millions)
 
2016
 
% Net
Sales
 
2015
 
% Net
Sales
 
2016 vs. 2015 % Change
CooperVision
 
$
12.4

 
3
%
 
$
12.9

 
4
%
 
(4
)%
CooperSurgical
 
4.3

 
5
%
 
3.9

 
5
%
 
10
 %
 
 
$
16.7

 
3
%
 
$
16.8

 
4
%
 
(1
)%
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended April 30,
($ in millions)
 
2016
 
% Net
Sales
 
2015
 
% Net
Sales
 
2016 vs. 2015 % Change
CooperVision
 
$
23.5

 
3
%
 
$
25.6

 
4
%
 
(8
)%
CooperSurgical
 
8.0

 
4
%
 
7.3

 
5
%
 
9
 %
 
 
$
31.5

 
3
%
 
$
32.9

 
4
%
 
(4
)%
The decreases in CooperVision's research and development expense in absolute dollars and as a percentage of sales in the three and six month periods as compared to the prior year periods are primarily due to synergies resulting from the integration of Sauflon. CooperVision's R&D activities are primarily focused on the development of contact lenses and manufacturing improvements.

30

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




The increases in CooperSurgical's research and development expense in absolute dollars in the three and six month periods are primarily due to increased activity to bring newly acquired products to market, increased investment in projects to develop new products and the upgrade of existing products. The decrease in research and development expense as a percent of sales in the six month period is due to the inclusion of the results of operations of several recent acquisitions. CooperSurgical's research and development activities include in vitro fertilization product development and the design and upgrade of surgical procedure devices.
Amortization Expense
Three Months Ended April 30,
($ in millions)
2016
 
% Net
Sales
 
2015
 
% Net
Sales
 
2016 vs. 2015 % Change
CooperVision
$
9.7

 
2
%
 
$
8.8

 
2
%
 
11
%
CooperSurgical
4.6

 
5
%
 
3.5

 
5
%
 
30
%
 
$
14.3

 
3
%
 
$
12.3

 
3
%
 
16
%
 
 
 
 
 
 
 
 
 
 
Six Months Ended April 30,
($ in millions)
2016
 
% Net
Sales
 
2015
 
% Net
Sales
 
2016 vs. 2015 % Change
CooperVision
$
21.7

 
3
%
 
$
18.7

 
3
%
 
16
%
CooperSurgical
8.8

 
5
%
 
7.2

 
5
%
 
22
%
 
$
30.5

 
3
%
 
$
25.9

 
3
%
 
18
%
The sequential increases in amortization are due to acquired intangible assets related to recent acquisitions in CooperSurgical. The increase in CooperVision's amortization expense in the six month period ended April 30, 2016 includes a current period charge of $2.3 million to write off acquired in-process research and development. We expect amortization to be approximately $14.9 million in the fiscal third quarter and $14.1 million in the fiscal fourth quarter primarily due to intangible assets acquired with the recent acquisitions in CooperSurgical, offset by intangible assets which we forecast to become fully amortized.
Restructuring Costs

During the fiscal fourth quarter of 2014 and in connection with the Sauflon acquisition, our CooperVision business unit initiated restructuring and integration activities to optimize operational synergies of the combined companies. The 2014 Sauflon Integration Plan activities include workforce reductions, consolidation of duplicative facilities and product rationalization. We now estimate that the total restructuring costs under this plan will be $125.0 million, as discussed in our notes to consolidated condensed financial statements. We are substantially complete with activities related to operating expenses, and we expect to incur costs related to the manufacturing activities through the end of fiscal 2016.

Pursuant to the 2014 Sauflon Integration Plan, in the three and six month periods ended April 30, 2016, we recorded in cost of sales $4.2 million and $14.7 million of expense, respectively, arising from production-related asset disposals and accelerated depreciation on equipment, primarily related to our hydrogel lenses, based on our review of products, materials and manufacturing processes of Sauflon. We recorded in cost of sales, employee termination costs of $0.7 million and $0.5 million in the three and six month periods ended April 30, 2016, respectively. We recorded $0.1 million of employee termination costs and $0.3 million for lease termination costs in selling, general and administrative expense in the six months ended April 30, 2016. We also recorded in research and development expense $0.1 million of employee termination costs in the six months ended April 30, 2016. In addition, CooperVision incurred $2.1 million and $10.0 million of integration costs included in operating expenses in the three and six month periods ended April 30, 2016, respectively.

31

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




Operating Income
Three Months Ended April 30,
($ in millions)
 
2016
 
% Net
Sales
 
2015
 
% Net
Sales
 
2016 vs. 2015 % Change
CooperVision
 
$
83.6

 
21
%
 
$
67.7

 
19
%
 
23
 %
CooperSurgical
 
17.7

 
19
%
 
14.2

 
19
%
 
25
 %
Corporate
 
(11.5
)
 

 
(10.9
)
 

 
(5
)%
 
 
$
89.8

 
19
%
 
$
71.0

 
16
%
 
27
 %
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended April 30,
($ in millions)
 
2016
 
% Net
Sales
 
2015
 
% Net
Sales
 
2016 vs. 2015 % Change
CooperVision
 
$
136.4

 
18
%
 
$
140.9

 
19
%
 
(3
)%
CooperSurgical
 
33.1

 
19
%
 
27.4

 
18
%
 
21
 %
Corporate
 
(22.3
)
 

 
(24.2
)
 

 
8
 %
 
 
$
147.2

 
16
%
 
$
144.1

 
16
%
 
2
 %
Consolidated operating income in the fiscal 2016 periods increased in absolute dollars compared to the prior year periods primarily due to the increase in consolidated net sales in the three and six month periods. CooperVision's operating income in the six month period decreased in absolute dollars and as a percentage of net sales primarily due to restructuring, integration and amortization costs primarily related to Sauflon, as discussed above, recorded in cost of sales and operating expenses. CooperSurgical's operating income in the fiscal 2016 periods increased in absolute dollars reflecting the increase in sales of higher margin legacy products as a result of our investment in sales and promotional activities to reach new customers as well as recently launched products.
Interest Expense
Three Months Ended April 30,
($ in millions)
2016
 
% Net
Sales
 
2015
 
% Net
Sales
 
2016 vs. 2015 % Change
Interest expense
$
7.6

 
2
%
 
$
4.7

 
1
%
 
62
%
 
 
 
 
 
 
 
 
 
 
Six Months Ended April 30,
($ in millions)
2016
 
% Net
Sales
 
2015
 
% Net
Sales
 
2016 vs. 2015 % Change
Interest expense
$
12.9

 
1
%
 
$
8.6

 
1
%
 
49
%

Interest expense increased in absolute dollars and as a percentage of sales in the three month period and in absolute dollars in the six month period as compared to the prior year periods reflecting higher average debt as a result of debt incurred in connection with recent acquisitions as well as the August 2014 acquisition of Sauflon. Current period debt outstanding includes the $830.0 million term loan entered on March 1, 2016, $300.0 million of the $700.0 million term loan entered into on August 4, 2014, and $285.0 million of the $300.0 million term loan entered into on September 12, 2013.
Other (Income) Expense, Net
Periods Ended April 30,
 
Three Months
 
Six Months
($ In millions)
 
2016
 
2015
 
2016
 
2015
Foreign exchange (gain) loss
 
$
(0.7
)
 
$
(0.8
)
 
$
0.9

 
$
0.7

Other, net
 
0.3

 
0.1

 
0.1

 
0.3

 
 
$
(0.4
)
 
$
(0.7
)
 
$
1.0

 
$
1.0


32

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




Provision for Income Taxes
We recorded income tax expense of $7.2 million in the fiscal first half of 2016 compared to $11.6 million in the prior year period. Our effective tax rate (ETR) (provision for income taxes divided by pretax income) for the fiscal first half of 2016 was 5.4%. Our year-to-date results reflect the projected fiscal year ETR, plus any discrete items. The ETR used to record the provision for income taxes for the fiscal first half of 2015 was 8.6%. The decrease in the effective tax rate in the fiscal first half of 2016 was primarily due to a release of reserves associated with a prior year tax filing, a statutory tax rate reduction in the United Kingdom and the retroactive extension of the R&D tax credit.

The ETR is below the United States statutory rate as a majority of our taxable income is earned in foreign jurisdictions with lower tax rates. The ratio of domestic taxable income to worldwide taxable income has decreased over recent fiscal years effectively lowering the overall tax rate due to the fact that the tax rates in the majority of foreign jurisdictions where we operate are significantly lower than the statutory rate in the United States.

The impact on our provision for income taxes of income earned in foreign jurisdictions being taxed at rates different than the United States federal statutory rate was a benefit of approximately $37.3 million and a foreign effective tax rate of a benefit of approximately 5.5% in our fiscal first half of 2016 compared to a benefit of $40.2 million and a foreign effective tax rate of approximately 2.3% in our fiscal first half of 2015. See the notes to consolidated condensed financial statements for additional information.
Share Repurchase
In December 2011, our Board of Directors authorized a share repurchase program and subsequently amended the total repurchase authorization to $500.0 million. The program has no expiration date and may be discontinued at any time. We did not repurchase any shares during the fiscal first half of 2016. At April 30, 2016, we had remaining authorization to repurchase about $118.4 million of our common stock. See the notes to consolidated condensed financial statements for additional information.
Share-Based Compensation Plans
Cooper has several share-based compensation plans that are described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2015. The compensation expense and related income tax benefit recognized in our consolidated condensed financial statements for share-based awards were as follows:
Periods Ended April 30,
 
Three Months
 
Six Months
($ In millions)
 
2016
 
2015
 
2016
 
2015
Selling, general and administrative expense
 
$
7.0

 
$
6.2

 
$
12.8

 
$
15.9

Cost of sales
 
0.7

 
0.6

 
1.2

 
1.4

Research and development expense
 
0.2

 
0.2

 
0.6

 
0.4

Total share-based compensation expense
 
$
7.9

 
$
7.0

 
$
14.6

 
$
17.7

Related income tax benefit
 
$
2.3

 
$
2.2

 
$
4.3

 
$
5.6

We capitalized share-based compensation expense as part of the cost of inventory in the amounts of $0.7 million and $1.2 million during the three and six months ended April 30, 2016, respectively; and $0.6 million and $1.4 million during the three and six months ended April 30, 2015, respectively.


33

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




Capital Resources and Liquidity
Second Quarter Highlights
Operating cash flow $97.8 million compared to $110.6 million in the fiscal second quarter of 2015
Expenditures for purchases of property, plant and equipment $41.2 million compared to $53.4 million in the prior year period
Six-Month Highlights
Operating cash flow $187.4 million compared to $190.5 million in the fiscal second quarter of 2015
Expenditures for purchases of property, plant and equipment $86.3 million compared to $118.4 million in the prior year period
No share repurchases under our share repurchase plan compared to $16.0 million in the prior year period
Comparative Statistics
($ in millions)
 
April 30, 2016
 
October 31, 2015
Cash and cash equivalents
 
$
44.5

 
$
16.4

Total assets
 
$
4,601.3

 
$
4,459.9

Working capital
 
$
592.9

 
$
272.6

Total debt
 
$
1,441.4

 
$
1,349.2

Stockholders’ equity
 
$
2,744.8

 
$
2,673.9

Ratio of debt to equity
 
0.53:1

 
0.50:1

Debt as a percentage of total capitalization
 
34
%
 
34
%
Operating cash flow - twelve months ended
 
$
387.9

 
$
391.0

Working Capital
The increase in working capital as of April 30, 2016 from the end of fiscal 2015 was primarily due to the decrease in short-term debt as the $200.0 million revolving lines of credit entered into on March 24, 2015 were repaid in our fiscal second quarter of 2016 using the funds from the term loan as part of the new 2016 Credit Agreement. The increase in working capital was also due to the decrease in accounts payable and the increase in accounts receivables and inventories.
The $13.9 million increase in inventories was primarily related to the acquisitions in CooperSurgical in the first half of 2016 and, in CooperVision, increased production to support product launches including clariti and MyDay, our single-use silicone hydrogel contact lenses. At April 30, 2016, our inventory months on hand (MOH) were 7.3 after adjusting for equipment rationalization costs related to the acquisition of Sauflon and facility start-up costs, compared to 7.5 at October 31, 2015. Our unadjusted inventory MOH were 7.0 and 6.2 at April 30, 2016, and October 31, 2015, respectively. Our days sales outstanding (DSO) were 54 days at April 30, 2016, compared to 57 days at October 31, 2015 and 56 days at April 30, 2015.
We have reviewed our needs in the United States for possible repatriation of undistributed earnings or cash of our foreign subsidiaries. Cooper presently intends to continue to indefinitely invest all earnings and cash outside of the United States of all foreign subsidiaries to fund foreign investments or meet foreign working capital and property, plant and equipment requirements.

34

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




Operating Cash Flow
Cash flow provided by operating activities in the fiscal first half of 2016 continued to be our major source of liquidity, at $187.4 million compared to $190.5 million in the prior year period. Current period results include $126.2 million of net income and non-cash items primarily made up of $101.4 million related to depreciation and amortization and $14.5 million related to share-based compensation. Results also include changes in operating assets and liabilities, which primarily reflect the increases in inventories and other assets of $14.6 million, the increases in trade and other receivables of $18.8 million, the increases in accounts payable and other liabilities of $0.6 million, and the decrease of $21.8 million relating to deferred taxes and taxes payable. The $3.1 million decrease in cash flow provided by operations in the fiscal first half of 2016 as compared to fiscal 2015 is primarily due to the decrease in operating capital.
For the fiscal first half of 2016, our primary source of cash flows provided by operating activities was cash collections from our customers for purchase of our products. Our primary uses of cash flows from operating activities were for personnel and material costs along with cash payments of $9.6 million for interest.
For the fiscal first half of 2015, our primary source of cash flows provided by operating activities was cash collections from our customers for purchase of our products. Our primary uses of cash flows from operating activities were for personnel and material costs along with cash payments of $6.8 million for interest.

Investing Cash Flow

Cash used in investing activities of $231.8 million in the fiscal first half of 2016 was driven by capital expenditures of $86.3 million, primarily to increase manufacturing capacity, and payments of $145.4 million primarily related to CooperSurgical acquisitions as discussed in Outlook above and in the notes to consolidated condensed financial statements.

Cash used in investing activities of $119.1 million in the fiscal first half of 2015 was driven by capital expenditures of $118.4 million, primarily to increase manufacturing capacity.

Financing Cash Flow

The changes in cash provided by financing activities primarily relate to borrowings and repayments of debt as well as the effects of share-based compensation awards. Cash provided by financing activities of $72.5 million in the fiscal first half of 2016 was driven by $93.4 million net borrowings of debt and $5.0 million of excess tax benefit relating to share-based compensation awards, partially offset by $12.5 million payment of debt acquisition costs, $11.5 million for taxes paid related to vested share-based compensation awards, dividend payments on common stock of $1.5 million and $0.4 million for distributions to noncontrolling interests.

Cash used in financing activities of $74.5 million in the fiscal first half of 2015 was driven by $39.3 million net repayment of debt, $16.0 million in payments for share repurchases in the fiscal first quarter of 2015 under our share repurchase plan, $8.6 million for the purchase of noncontrolling interests, net payment of $6.7 million for taxes paid related to vested share-based compensation awards, $2.4 million payment for contingent consideration, $1.4 million of dividend payments on common stock and $0.8 million for distributions to noncontrolling interests. Net repayment of debt in the period includes the payment of $51.2 million to settle all the outstanding loan notes issued for the Sauflon acquisition.

On March 1, 2016, we entered into a new syndicated revolving Credit and Term Loan Agreement (2016 Credit Agreement) with Keybank as administrative agent. For more information, please see Outlook above and the notes to consolidated condensed financial statements.

At April 30, 2016, we had about $1.0 billion available under the 2016 Credit Agreement. Current period debt outstanding includes the $830.0 million term loan entered into on March 1, 2016, $300.0 million of the $700.0 million term loan entered into on August 4, 2014, and $285.0 million of the $300.0 million term loan entered into on September 12, 2013. We are in compliance with our financial covenants including the Interest Coverage Ratio at 26.42 to 1.00 and the Total Leverage Ratio at 2.37 to 1.00. As defined, in both the Credit Agreement and term loans, the Interest Coverage Ratio is the ratio of Consolidated Proforma EBITDA to Consolidated Interest Expense with the requirement to be at least

35

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations




3.00 to 1.00 and the Total Leverage Ratio is the ratio of Consolidated Funded Indebtedness to Consolidated Proforma EBITDA with the requirement to be no higher than 3.75 to 1.00.
Estimates and Critical Accounting Policies
Management estimates and judgments are an integral part of financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). We believe that the critical accounting policies listed below address the more significant estimates required of management when preparing our consolidated financial statements in accordance with GAAP. We consider an accounting estimate critical if changes in the estimate may have a material impact on our financial condition or results of operations. We believe that the accounting estimates employed are appropriate and resulting balances are reasonable; however, actual results could differ from the original estimates, requiring adjustment to these balances in future periods. The accounting policies that reflect our more significant estimates, judgments and assumptions and which we believe are the most critical to aid in fully understanding and evaluating our reported financial results are:
Revenue recognition
Net realizable value of inventory
Valuation of goodwill
Business combinations
Income taxes
Share-based compensation
During the fiscal first half of 2016, there were no significant changes in our estimates and critical accounting policies. Please refer to Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended October 31, 2015, for a more complete discussion of our estimates and critical accounting policies.
We performed our annual impairment assessment of goodwill during the fiscal third quarter of 2015, and our analysis indicated that we had no impairment of goodwill. As described in Note 5 in this Quarterly Report on Form 10-Q and Note 1 in our Annual Report on Form 10-K for the fiscal year ended October 31, 2015, we will continue to monitor conditions and changes that could indicate that our recorded goodwill may be impaired.
Accounting Pronouncements Issued Not Yet Adopted

In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which is intended to improve the accounting for share-based payment transactions as part of the FASB’s simplification initiative. The ASU changes the following aspects of the accounting for share-based payment award transactions, including: accounting for income taxes; classification of excess tax benefits on the statement of cash flows; forfeitures; minimum statutory tax withholding requirements; and classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. We are currently evaluating the impact of ASU 2016-09, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2017.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-01 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. We are currently evaluating the impact of ASU 2016-02, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2019.

36

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations





In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes, which requires entities to present all deferred tax assets and liabilities as noncurrent. The amendments in the ASU are effective for the Company in our fiscal year and interim periods beginning on November 1, 2017. The Company does not expect the new guidance to have a material impact on the Company’s consolidated financial statements.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 requires revenue recognition to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 sets forth a new revenue recognition model that requires identifying the contract, identifying the performance obligations, determining the transaction price, allocating the transaction price to performance obligations and recognizing the revenue upon satisfaction of performance obligations. The amendments in the ASU can be applied either retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the update recognized at the date of the initial application along with additional disclosures. We are currently evaluating the impact of ASU 2014-09, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2018.

Accounting Pronouncements Recently Adopted

In April 2015, the FASB issued Accounting Standards Update (ASU) 2015-03, Interest - Imputation of Interest (Subtopic 835-30) Simplifying the Presentation of Debt Issuance Costs. The amendments in this update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for interim and annual reporting periods beginning after December 15, 2016. Early adoption is permitted. We elected to early adopt this guidance as a change in accounting principle on a retrospective basis in the fiscal first quarter ended January 31, 2016. As of January 31, 2016 and October 31, 2015, we have presented debt issuance costs related to our term loans, previously reported in other assets, as direct deductions from the carrying amount of the debt liability. We also presented the debt issuance costs related to our revolving credit facility as a deferred asset within other assets, as is permitted by ASU 2015-15, Imputation of Interest, which was issued in August 2015. Such adoption did not have a material impact to our consolidated financial position.

Trademarks

Aquaform®, Avaira®, Biofinity®, MyDay® and Proclear® are registered trademarks of The Cooper Companies, Inc., its affiliates and/or subsidiaries. PC Technology™, FIPS™ and A Quality of Life Company™ are trademarks of The Cooper Companies, Inc., its affiliates and/or subsidiaries. The clariti® mark is a registered trademark of The Cooper Companies, Inc., its affiliates and/or subsidiaries worldwide except in the United States where the use of clariti® is licensed.




37

THE COOPER COMPANIES, INC. AND SUBSIDIARIES


Item 3. Quantitative and Qualitative Disclosure About Market Risk
Most of our operations outside the United States have their local currency as their functional currency. We are exposed to risks caused by changes in foreign exchange, principally our British pound sterling, euro, Japanese yen, Danish krone, Swedish krona, Australian dollar and Canadian dollar-denominated debt and receivables denominated in currencies other than the United States dollar, and from operations in foreign currencies. We have taken steps to minimize our balance sheet exposure. Although we may enter into foreign exchange agreements with financial institutions to reduce our exposure to fluctuations in foreign currency values relative to our debt or receivables obligations, these hedging transactions do not eliminate that risk entirely. We are also exposed to risks associated with changes in interest rates, as the interest rates on our revolving lines of credit and term loans may vary with the Eurodollar rate. We may decrease this interest rate risk by hedging a portion of variable rate debt effectively converting it to fixed rate debt for varying periods. As of April 30, 2016, we have no outstanding interest rate swaps. For additional detail, see Item 1A. Risk Factors and Note 1 and Note 11 to the consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended October 31, 2015, and Note 11 in this Quarterly Report on Form 10-Q for the period ended April 30, 2016.

On March 1, 2016, we entered into a new syndicated Revolving Credit and Term Loan Agreement (2016 Credit Agreement) with Keybank as administrative agent. The new agreement provides for a multicurrency revolving credit facility in an aggregate principal amount of $1.0 billion and a term loan facility in the aggregate principal amount of $830.0 million. The 2016 Credit Agreement replaced our previous credit agreement and funds from the new term loan were used to repay the $200.0 million outstanding principal amount of the two uncommitted revolving lines of credit, entered into on March 24, 2015 and the outstanding amounts under the previous credit agreement. We also used funds from the new term loan to partially repay outstanding amounts under the term loans entered into on August 4, 2014 and September 12, 2013 and for general corporate purposes. At April 30, 2016, we had about $1.0 billion available under the revolving credit facility and $830.0 million outstanding under the term loan. For more information, please see the notes to consolidated condensed financial statements.
On August 4, 2014, we entered into a three-year, $700.0 million, senior unsecured term loan agreement that will mature on August 4, 2017. There is no amortization of the principal, and we may prepay the loan balances from time to time, in whole or in part, with premium or penalty. We repaid $400.0 million of the outstanding balance during the fiscal second quarter of 2016. At April 30, 2016, $300.0 million remained outstanding on this term loan.

On September 12, 2013, we entered into a five-year, $300.0 million, senior unsecured term loan agreement that will mature on September 12, 2018, and will be subject to amortization of principal of 5% per year payable quarterly beginning October 31, 2016, with the balance payable at maturity. We repaid $15.0 million of the outstanding balance during the fiscal second quarter of 2016. At April 30, 2016, $285.0 million remained outstanding on this term loan.


38

THE COOPER COMPANIES, INC. AND SUBSIDIARIES


Item 4. Controls and Procedures
The Company has established and currently maintains disclosure controls and procedures designed to ensure that material information required to be disclosed in its reports filed under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission and that any material information relating to the Company is recorded, processed, summarized and reported to its principal officers to allow timely decisions regarding required disclosures. In designing and evaluating the disclosure controls and procedures, management recognizes that controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving desired control objectives. In reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
In conjunction with the close of each fiscal quarter, the Company conducts a review and evaluation, under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. The Company’s Chief Executive Officer and Chief Financial Officer, based upon their evaluation as of April 30, 2016, the end of the fiscal quarter covered in this report, concluded that the Company’s disclosure controls and procedures were effective at the reasonable assurance level.
As of April 30, 2016, there has been no change in the Company’s internal control over financial reporting during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

39

THE COOPER COMPANIES, INC. AND SUBSIDIARIES



PART II—OTHER INFORMATION
Item 1. Legal Proceedings

Since March 2015, over 50 putative class action complaints were filed by contact lens consumers alleging that contact lens manufacturers, in conjunction with their respective Unilateral Pricing Policy (UPP), conspired to reach agreements between each other and certain distributors and retailers regarding the prices at which certain contact lenses could be sold to consumers. The plaintiffs are seeking damages against CooperVision, Inc., other contact lens manufacturers, distributors and retailers, in various courts around the United States. In June 2015, all of the class action cases were consolidated and transferred to the United States District Court for the Middle District of Florida. CooperVision and the other defendants jointly filed a motion to dismiss the complaints which currently is pending, and the actions currently are in discovery. CooperVision denies the allegations and intends to defend the actions vigorously. We are not in a position to assess whether any loss or adverse effect on our financial condition is probable or remote or to estimate the range of potential loss, if any.

Item 1A. Risk Factors
There have been no material changes in the Company’s risk factors from those disclosed in our Annual Report on Form 10-K for fiscal year ended October 31, 2015.

40

THE COOPER COMPANIES, INC. AND SUBSIDIARIES


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The Company's share repurchase activity during the three-month period ended April 30, 2016, was as follows:
Period
 
Total Number
of Shares
Purchased
 
Average
Price Paid
Per Share
 
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
 
Maximum Approximate
Dollar Value of Shares
that May Yet Be
Purchased Under
Publicly Announced
Plans or Programs
2/1/16 - 2/29/16
 

 
$

 

 
$
118,400,000

3/1/16 - 3/31/16
 

 
$

 

 
$
118,400,000

4/1/16 - 4/30/16
 

 
$

 

 
$
118,400,000

Total
 

 
$

 

 
 
The transactions described in the table above represent the repurchase of the Company’s common stock on the New York Stock Exchange as part of the share repurchase program approved by the Company’s Board of Directors in December 2011 (2012 Share Repurchase Program). The program as amended in December 2012 and December 2013 provides authorization for a total of $500.0 million. Purchases under the 2012 Share Repurchase Program may be made from time-to-time on the open market at prevailing market prices or in privately negotiated transactions and are subject to a review of the circumstances in place at the time and will be made from time to time as permitted by securities laws and other legal requirements. This program has no expiration date and may be discontinued at any time. At April 30, 2016, the remaining repurchase authorization under the 2012 Share Repurchase Program was approximately $118.4 million.

41

THE COOPER COMPANIES, INC. AND SUBSIDIARIES


Item 6. Exhibits
Exhibit
Number
Description
 
 
11*
Calculation of Earnings Per Share
 
 
31.1
Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
 
 
31.2
Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
 
 
32.1
Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350
 
 
32.2
Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350
 
 
101
The following materials from the Company's Quarterly Report on Form 10-Q for the period ended April 30, 2016, formatted in Extensible Business Reporting Language (XBRL): (i) Consolidated Statements of Income for the three and six months ended April 30, 2016 and 2015, (ii) Consolidated Statements of Comprehensive Income for the three and six months ended April 30, 2016 and 2015, (iii) Consolidated Condensed Balance Sheets at April 30, 2016 and October 31, 2015, (iv) Consolidated Condensed Statements of Cash Flows for the six months ended April 30, 2016 and 2015 and (v) related notes to consolidated condensed financial statements.
 
 
 
 
*
The information called for in this Exhibit is provided in Note 8. Earnings Per Share to the Consolidated Condensed Financial Statements in this report.

42

THE COOPER COMPANIES, INC. AND SUBSIDIARIES


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
The Cooper Companies, Inc.
 
(Registrant)
 
 
Date: June 3, 2016
/s/ Tina Maloney
 
Tina Maloney
 
Vice President and Corporate Controller
 
(Principal Accounting Officer)


43

THE COOPER COMPANIES, INC. AND SUBSIDIARIES


Index of Exhibits
Exhibit No.
  
 
Page No
 
 
 
 
11*
Calculation of Earnings Per Share
 
 
 
 
 
 
31.1
Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
 
 
 
 
 
31.2
Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
 
 
 
 
 
32.1
Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350
 
 
 
 
 
32.2
Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350
 
 
 
 
 
101
The following materials from the Company's Quarterly Report on Form 10-Q for the period ended April 30, 2016, formatted in Extensible Business Reporting Language (XBRL): (i) Consolidated Statements of Income for the three and six months ended April 30, 2016 and 2015, (ii) Consolidated Statements of Comprehensive Income for the three and six months ended April 30, 2016 and 2015, (iii) Consolidated Condensed Balance Sheets at April 30, 2016 and October 31, 2015, (iv) Consolidated Condensed Statements of Cash Flows for the six months ended April 30, 2016 and 2015 and (v) related notes to consolidated condensed financial statements.


 
 
*
The information called for in this Exhibit is provided in Note 8. Earnings Per Share to the Consolidated Condensed Financial Statements in this report.

44
EX-31.1 2 coo-ex311_20160430x10q.htm EXHIBIT 31.1 Exhibit

Exhibit 31.1

CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002

I, Robert S. Weiss, certify that:

1. I have reviewed this quarterly report on Form 10-Q of The Cooper Companies, Inc. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: June 3, 2016
 
 
 
/s/ Robert S. Weiss
 
 
Robert S. Weiss
 
 
President and
Chief Executive Officer
 

EX-31.2 3 coo-ex312_20160430x10q.htm EXHIBIT 31.2 Exhibit

Exhibit 31.2


CERTIFICATION PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
I, Gregory W. Matz, certify that:

1. I have reviewed this quarterly report on Form 10-Q of The Cooper Companies, Inc. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: June 3, 2016
 
 
 
/s/ Gregory W. Matz
 
 
Gregory W. Matz
 
 
Sr. Vice President, Chief Financial Officer and Chief Risk Officer
 

EX-32.1 4 coo-ex321_20160430x10q.htm EXHIBIT 32.1 Exhibit
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

 

I, Robert S. Weiss, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

the Quarterly Report on Form 10-Q of the Company for the quarterly period ended April 30, 2016, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: June 3, 2016
/s/ Robert S. Weiss
 
Robert S. Weiss
 
President and Chief Executive Officer


EX-32.2 5 coo-ex322_20160430x10q.htm EXHIBIT 32.2 Exhibit
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002


I, Gregory W. Matz, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

the Quarterly Report on Form 10-Q of the Company for the quarterly period ended April 30, 2016, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: June 3, 2016
/s/ Gregory W. Matz
 
Gregory W. Matz
 
Sr. Vice President, Chief Financial Officer and
Chief Risk Officer


EX-101.INS 6 coo-20160430.xml XBRL INSTANCE DOCUMENT 0000711404 2015-11-01 2016-04-30 0000711404 2016-04-30 0000711404 2014-11-01 2015-04-30 0000711404 2015-02-01 2015-04-30 0000711404 2016-02-01 2016-04-30 0000711404 2015-10-31 0000711404 2014-10-31 0000711404 2015-04-30 0000711404 coo:ThePipetteCompanyMember 2016-02-08 2016-02-08 0000711404 coo:GenesisGeneticsMember 2016-03-31 0000711404 coo:ResearchInstrumentsMember 2015-12-17 0000711404 coo:ThePipetteCompanyMember 2016-02-08 0000711404 coo:ThePipetteCompanyMember us-gaap:CustomerRelationshipsMember 2016-02-08 0000711404 coo:ResearchInstrumentsMember us-gaap:TradeNamesMember 2015-12-17 0000711404 coo:GenesisGeneticsMember us-gaap:CustomerRelationshipsMember 2016-03-31 0000711404 coo:GenesisGeneticsMember 2016-03-31 2016-03-31 0000711404 coo:GenesisGeneticsMember us-gaap:TradeNamesMember 2016-03-31 0000711404 coo:ResearchInstrumentsMember us-gaap:CustomerRelationshipsMember 2015-12-17 0000711404 coo:ResearchInstrumentsMember 2015-12-17 2015-12-17 0000711404 coo:ThePipetteCompanyMember us-gaap:TradeNamesMember 2016-02-08 0000711404 coo:ResearchInstrumentsMember us-gaap:TechnologyBasedIntangibleAssetsMember 2015-12-17 0000711404 coo:SauflonMember us-gaap:FacilityClosingMember 2015-11-01 2016-04-30 0000711404 coo:SauflonMember coo:ProductRationalizationMember 2016-04-30 0000711404 coo:SauflonMember coo:ProductRationalizationMember 2014-10-31 0000711404 coo:SauflonMember 2016-04-30 0000711404 coo:SauflonMember coo:ProductRationalizationMember 2015-11-01 2016-04-30 0000711404 coo:SauflonMember 2015-11-01 2016-04-30 0000711404 coo:SauflonMember us-gaap:FacilityClosingMember 2014-11-01 2015-10-31 0000711404 coo:SauflonMember us-gaap:EmployeeSeveranceMember 2014-11-01 2015-10-31 0000711404 coo:SauflonMember us-gaap:FacilityClosingMember 2014-10-31 0000711404 coo:SauflonMember coo:ProductRationalizationMember 2014-11-01 2015-10-31 0000711404 coo:SauflonMember us-gaap:EmployeeSeveranceMember 2015-10-31 0000711404 coo:SauflonMember us-gaap:EmployeeSeveranceMember 2015-11-01 2016-04-30 0000711404 coo:SauflonMember 2014-11-01 2015-10-31 0000711404 coo:SauflonMember us-gaap:EmployeeSeveranceMember 2014-10-31 0000711404 coo:SauflonMember 2014-10-31 0000711404 coo:SauflonMember us-gaap:FacilityClosingMember 2016-04-30 0000711404 coo:SauflonMember us-gaap:EmployeeSeveranceMember 2016-04-30 0000711404 coo:SauflonMember us-gaap:FacilityClosingMember 2015-10-31 0000711404 coo:SauflonMember coo:ProductRationalizationMember 2015-10-31 0000711404 coo:SauflonMember 2015-10-31 0000711404 coo:SauflonMember us-gaap:EmployeeSeveranceMember 2013-11-01 2014-10-31 0000711404 coo:SauflonMember us-gaap:FacilityClosingMember 2013-11-01 2014-10-31 0000711404 coo:SauflonMember 2013-11-01 2014-10-31 0000711404 coo:SauflonMember coo:ProductRationalizationMember 2013-11-01 2014-10-31 0000711404 coo:SauflonMember 2015-02-01 2015-04-30 0000711404 coo:SauflonMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:FacilityClosingMember 2015-11-01 2016-04-30 0000711404 coo:SauflonMember us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:EmployeeSeveranceMember 2015-11-01 2016-04-30 0000711404 coo:SauflonMember us-gaap:CostOfSalesMember us-gaap:EmployeeSeveranceMember 2016-02-01 2016-04-30 0000711404 coo:SauflonMember us-gaap:CostOfSalesMember coo:ProductRationalizationMember 2015-02-01 2015-04-30 0000711404 coo:SauflonMember us-gaap:CostOfSalesMember coo:ProductRationalizationMember 2014-11-01 2015-04-30 0000711404 coo:SauflonMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember 2015-11-01 2016-04-30 0000711404 coo:SauflonMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember 2015-02-01 2015-04-30 0000711404 coo:SauflonMember us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:EmployeeSeveranceMember 2015-02-01 2015-04-30 0000711404 coo:SauflonMember us-gaap:CostOfSalesMember coo:ProductRationalizationMember 2016-02-01 2016-04-30 0000711404 coo:SauflonMember us-gaap:CostOfSalesMember us-gaap:EmployeeSeveranceMember 2015-11-01 2016-04-30 0000711404 coo:SauflonMember us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:EmployeeSeveranceMember 2014-11-01 2015-04-30 0000711404 coo:SauflonMember us-gaap:CostOfSalesMember coo:ProductRationalizationMember 2015-11-01 2016-04-30 0000711404 coo:SauflonMember 2016-02-01 2016-04-30 0000711404 coo:SauflonMember 2014-11-01 2015-04-30 0000711404 coo:CoopersurgicalMember 2014-10-31 0000711404 coo:CoopervisionMember 2015-11-01 2016-04-30 0000711404 coo:CoopervisionMember 2014-11-01 2015-10-31 0000711404 coo:CoopersurgicalMember 2014-11-01 2015-10-31 0000711404 coo:CoopervisionMember 2014-10-31 0000711404 coo:CoopersurgicalMember 2015-11-01 2016-04-30 0000711404 coo:CoopersurgicalMember 2015-10-31 0000711404 2014-11-01 2015-10-31 0000711404 coo:CoopervisionMember 2016-04-30 0000711404 coo:CoopervisionMember 2015-10-31 0000711404 coo:CoopersurgicalMember 2016-04-30 0000711404 us-gaap:TrademarksMember 2016-04-30 0000711404 us-gaap:CustomerRelationshipsMember 2015-10-31 0000711404 us-gaap:CustomerRelationshipsMember 2016-04-30 0000711404 us-gaap:TechnologyBasedIntangibleAssetsMember 2015-10-31 0000711404 us-gaap:TechnologyBasedIntangibleAssetsMember 2016-04-30 0000711404 coo:LicenseAndDistributionRightsAndOtherMember 2016-04-30 0000711404 us-gaap:TrademarksMember 2015-10-31 0000711404 coo:LicenseAndDistributionRightsAndOtherMember 2015-10-31 0000711404 coo:TermLoan700MMember coo:FederalFundsRateMember 2014-08-04 2014-08-04 0000711404 coo:TermLoan300MMember 2016-02-01 2016-04-30 0000711404 coo:A2016CreditAgreementMember us-gaap:EurodollarMember 2016-03-01 2016-03-01 0000711404 coo:A2016CreditAgreementMember coo:FederalFundsRateMember 2016-03-01 2016-03-01 0000711404 us-gaap:LineOfCreditMember 2015-03-24 2015-03-24 0000711404 coo:TermLoan700MMember 2014-08-04 0000711404 coo:TermLoan300MMember 2013-09-12 0000711404 coo:TermLoan700MMember us-gaap:EurodollarMember 2014-08-04 2014-08-04 0000711404 us-gaap:MinimumMember 2016-03-01 2016-03-01 0000711404 coo:A2016CreditAgreementMember 2016-03-01 2016-03-01 0000711404 us-gaap:RevolvingCreditFacilityMember 2016-03-01 0000711404 coo:A2016CreditAgreementMember 2016-03-01 0000711404 us-gaap:LineOfCreditMember 2016-04-30 0000711404 coo:TermLoan700MMember 2014-08-04 2014-08-04 0000711404 coo:TermLoan300MMember coo:FederalFundsRateMember 2013-09-12 2013-09-12 0000711404 coo:TermLoan300MMember 2013-09-12 2013-09-12 0000711404 coo:A2016CreditAgreementMember 2016-04-30 0000711404 us-gaap:LineOfCreditMember 2016-03-01 2016-03-01 0000711404 us-gaap:MaximumMember 2016-03-01 2016-03-01 0000711404 coo:A2016CreditAgreementMember 2016-03-01 0000711404 us-gaap:LineOfCreditMember 2015-03-24 0000711404 coo:TermLoan700MMember 2016-02-01 2016-04-30 0000711404 us-gaap:LineOfCreditMember 2016-03-01 2016-03-01 0000711404 coo:TermLoan300MMember 2016-04-30 0000711404 coo:TermLoan700MMember 2016-04-30 0000711404 us-gaap:LineOfCreditMember us-gaap:EurodollarMember 2015-03-24 2015-03-24 0000711404 coo:TermLoan300MMember us-gaap:EurodollarMember 2013-09-12 2013-09-12 0000711404 2015-11-01 0000711404 us-gaap:RestrictedStockUnitsRSUMember 2015-02-01 2015-04-30 0000711404 us-gaap:RestrictedStockUnitsRSUMember 2014-11-01 2015-04-30 0000711404 us-gaap:EmployeeStockOptionMember 2014-11-01 2015-04-30 0000711404 us-gaap:RestrictedStockUnitsRSUMember 2016-02-01 2016-04-30 0000711404 us-gaap:EmployeeStockOptionMember 2015-02-01 2015-04-30 0000711404 us-gaap:EmployeeStockOptionMember 2015-11-01 2016-04-30 0000711404 us-gaap:EmployeeStockOptionMember 2016-02-01 2016-04-30 0000711404 us-gaap:RestrictedStockUnitsRSUMember 2015-11-01 2016-04-30 0000711404 us-gaap:ResearchAndDevelopmentExpenseMember 2015-02-01 2015-04-30 0000711404 us-gaap:CostOfSalesMember 2016-02-01 2016-04-30 0000711404 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2014-11-01 2015-04-30 0000711404 us-gaap:CostOfSalesMember 2015-02-01 2015-04-30 0000711404 us-gaap:ResearchAndDevelopmentExpenseMember 2016-02-01 2016-04-30 0000711404 us-gaap:ResearchAndDevelopmentExpenseMember 2015-11-01 2016-04-30 0000711404 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2015-02-01 2015-04-30 0000711404 us-gaap:CostOfSalesMember 2014-11-01 2015-04-30 0000711404 us-gaap:CostOfSalesMember 2015-11-01 2016-04-30 0000711404 us-gaap:ResearchAndDevelopmentExpenseMember 2014-11-01 2015-04-30 0000711404 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2015-11-01 2016-04-30 0000711404 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-02-01 2016-04-30 0000711404 coo:CapitalizedInInventoryMember 2015-02-01 2015-04-30 0000711404 coo:CapitalizedInInventoryMember 2015-11-01 2016-04-30 0000711404 coo:CapitalizedInInventoryMember 2016-02-01 2016-04-30 0000711404 coo:CapitalizedInInventoryMember 2014-11-01 2015-04-30 0000711404 2016-02-09 2016-02-09 0000711404 2014-11-01 2015-01-31 0000711404 2011-12-15 0000711404 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember 2015-10-31 0000711404 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember 2016-04-30 0000711404 2015-03-01 2016-04-30 0000711404 country:US 2015-10-31 0000711404 coo:RestOfWorldOtherEliminationsAndCorporateMember 2016-04-30 0000711404 us-gaap:EuropeMember 2015-10-31 0000711404 coo:RestOfWorldOtherEliminationsAndCorporateMember 2015-10-31 0000711404 country:US 2016-04-30 0000711404 us-gaap:EuropeMember 2016-04-30 0000711404 us-gaap:CorporateMember 2015-02-01 2015-04-30 0000711404 coo:CoopervisionMember 2014-11-01 2015-04-30 0000711404 coo:CoopersurgicalMember 2015-02-01 2015-04-30 0000711404 coo:CoopervisionMember coo:ToricSoftLensMember 2016-02-01 2016-04-30 0000711404 coo:CoopervisionMember coo:SingleUseSphereSoftLensMember 2014-11-01 2015-04-30 0000711404 coo:CoopersurgicalMember 2014-11-01 2015-04-30 0000711404 us-gaap:CorporateMember 2015-11-01 2016-04-30 0000711404 coo:CoopervisionMember coo:ToricSoftLensMember 2014-11-01 2015-04-30 0000711404 coo:CoopervisionMember 2016-02-01 2016-04-30 0000711404 coo:CoopervisionMember coo:NonSingleUseSphereAndOtherEyeCareProductsMember 2016-02-01 2016-04-30 0000711404 coo:CoopervisionMember coo:ToricSoftLensMember 2015-11-01 2016-04-30 0000711404 coo:CoopervisionMember coo:NonSingleUseSphereAndOtherEyeCareProductsMember 2014-11-01 2015-04-30 0000711404 coo:CoopervisionMember coo:MultifocalSoftLensMember 2015-02-01 2015-04-30 0000711404 coo:CoopervisionMember coo:SingleUseSphereSoftLensMember 2016-02-01 2016-04-30 0000711404 coo:CoopervisionMember coo:MultifocalSoftLensMember 2015-11-01 2016-04-30 0000711404 us-gaap:CorporateMember 2014-11-01 2015-04-30 0000711404 coo:CoopervisionMember coo:SingleUseSphereSoftLensMember 2015-02-01 2015-04-30 0000711404 coo:CoopersurgicalMember 2016-02-01 2016-04-30 0000711404 coo:CoopervisionMember coo:NonSingleUseSphereAndOtherEyeCareProductsMember 2015-02-01 2015-04-30 0000711404 coo:CoopervisionMember coo:NonSingleUseSphereAndOtherEyeCareProductsMember 2015-11-01 2016-04-30 0000711404 us-gaap:CorporateMember 2016-02-01 2016-04-30 0000711404 coo:CoopervisionMember 2015-02-01 2015-04-30 0000711404 coo:CoopervisionMember coo:MultifocalSoftLensMember 2016-02-01 2016-04-30 0000711404 coo:CoopervisionMember coo:ToricSoftLensMember 2015-02-01 2015-04-30 0000711404 coo:CoopervisionMember coo:SingleUseSphereSoftLensMember 2015-11-01 2016-04-30 0000711404 coo:CoopervisionMember coo:MultifocalSoftLensMember 2014-11-01 2015-04-30 0000711404 us-gaap:CorporateMember 2015-10-31 0000711404 us-gaap:CorporateMember 2016-04-30 0000711404 country:US 2015-02-01 2015-04-30 0000711404 coo:RestOfWorldOtherEliminationsAndCorporateMember 2015-02-01 2015-04-30 0000711404 country:US 2015-11-01 2016-04-30 0000711404 us-gaap:EuropeMember 2015-02-01 2015-04-30 0000711404 country:US 2016-02-01 2016-04-30 0000711404 us-gaap:EuropeMember 2014-11-01 2015-04-30 0000711404 us-gaap:EuropeMember 2016-02-01 2016-04-30 0000711404 coo:RestOfWorldOtherEliminationsAndCorporateMember 2014-11-01 2015-04-30 0000711404 coo:RestOfWorldOtherEliminationsAndCorporateMember 2015-11-01 2016-04-30 0000711404 country:US 2014-11-01 2015-04-30 0000711404 coo:RestOfWorldOtherEliminationsAndCorporateMember 2016-02-01 2016-04-30 0000711404 us-gaap:EuropeMember 2015-11-01 2016-04-30 0000711404 coo:KSystemsMember us-gaap:SubsequentEventMember 2016-05-04 2016-05-04 0000711404 coo:ReprogeneticsUKMember us-gaap:SubsequentEventMember 2016-05-31 2016-05-31 0000711404 coo:RecombineMember us-gaap:SubsequentEventMember 2016-05-25 2016-05-25 xbrli:pure iso4217:USD xbrli:shares coo:action iso4217:USD xbrli:shares 80754000 85505000 0.05 26.42 0.005 0.015 750000000 400000 4100000 3.75 3.00 57700000 57700000 -200000 200000 14900000 14700000 100000 100000 400000 1500000 2.37 false --10-31 Q2 2016 2016-04-30 10-Q 0000711404 48448341 Large Accelerated Filer COOPER COMPANIES INC 159.96 116912000 105759000 282918000 298825000 683633000 731776000 -100000 0 0 -13700000 -19800000 -19900000 -92400000 -171800000 -233300000 -106200000 -191600000 -191643000 -253153000 -253200000 1434705000 1442735000 7000000 17700000 7900000 14600000 5956000 7765000 12316000 25911000 14312000 30515000 123000 1000 123000 1000 537000 7000 537000 2000 4459864000 4459900000 674800000 3714600000 70500000 4601300000 4601253000 817600000 3678900000 104800000 841428000 915115000 1300000 800000 2015-12-17 2016-02-08 2016-03-31 2016-05-25 2016-05-04 2016-05-31 53600000 20200000 60000000 85000000 11500000 12000000 8000000 14100000 2100000 10000000 10300000 1900000 6200000 2200000 28600000 25200000 3400000 5600000 5200000 400000 7300000 3800000 -200000 25222000 17911000 16426000 44464000 -7311000 28038000 0.03 0.10 0.10 120000000 120000000 51558000 51738000 5156000 5174000 94406000 43112000 125984000 63940000 1105000 584000 751000 745000 95511000 43696000 126735000 64685000 166960000 335780000 185295000 372971000 0.005 0.01 0.005 0.01 0.0090 0.005 0.01 2016-10-31 2013-09-12 2014-08-04 2015-03-24 2018-09-12 2017-08-04 2016-03-24 2021-03-01 P5Y P3Y P90D 10000000 41731000 41256000 4510000 5969000 31016000 37568000 -200000 -500000 -400000 -800000 0 0 0 0 0.08 2500000 2500000 1500000 3000000 1600000 3300000 1100000 2100000 1200000 2500000 1800000 3700000 2300000 4600000 2000000 4100000 2300000 4600000 7500000 87389000 101434000 400000 900000 2016-01-22 1.25 2.52 1.53 2.59 1.23 2.48 1.52 2.57 -4185000 -53000 -0.086 -0.054 67373000 59038000 2200000 5600000 2300000 4300000 0 5005000 200000000 250200000 26600000 104500000 114700000 4400000 278000000 32300000 113300000 127000000 5400000 59600000 40900000 51500000 54100000 56100000 661300000 71700000 247000000 318900000 23700000 715000000 73300000 279800000 332000000 29900000 2220900000 359400000 1861500000 2197077000 2197100000 369500000 1827600000 2233300000 2233251000 451300000 1782000000 36100000 14700000 27600000 -40000000 -7300000 -32700000 -43100000 2600000 -45700000 0 16200000 17400000 -1200000 79300000 79200000 100000 267716000 544067000 298498000 560462000 67000000 66992000 134457000 82600000 82638000 133400000 133368000 5855000 11571000 8183000 7172000 -65358000 -61667000 700000 800000 500000 400000 411090000 411100000 437000000 437005000 4692000 4700000 8633000 7611000 7600000 12900000 12886000 324300000 332200000 419692000 419700000 433596000 433600000 80900000 85800000 14500000 15600000 1785960000 1856472000 4459864000 4601253000 568782000 322217000 0.0025 0.00125 2016-03-01 100000000.0 1000000000.0 1000000000 240400000 31700000 3800000 0 1105408000 1105400000 1411182000 1411200000 109000000 0 50 6395000 6705000 -74490000 72458000 -119117000 -231754000 190481000 187387000 60713000 121900000 121892000 74100000 74125000 125500000 125481000 424000 994000 330000 715000 700000 686000 -1016000 418000 400000 -1000000 -972000 70998000 71000000 14200000 67700000 -10900000 144106000 27400000 140900000 -24200000 89800000 89831000 17700000 83600000 -11500000 147226000 147200000 33100000 136400000 -22300000 38662000 45554000 34367000 -79251000 52273000 -61525000 -79400000 -61500000 0 0 -89400000 -61600000 0 0 0 30000 0 0 0 0 0 34374000 -79190000 52280000 -61511000 -7000 -14000 -7000 -14000 10000000 100000 -3900000 0 -100000 0 0 0 -3900000 0 0 47000 0 0 140694000 127229000 500000 300000 -45564000 -21424000 752000 145422000 15996000 0 8557000 0 9400000 0 9000000 400000 3800000 0 3700000 100000 0 12541000 1500000 1448000 1452000 816000 383000 50000000 19600000 59300000 118365000 86332000 0.10 0.10 1000000 1000000 0 0 0 0 0 0 80661000 96974000 483400000 1367300000 710000 0 -2406000 0 135514000 -23552000 -6662000 -11525000 61137000 122886000 74455000 126196000 1650730000 1696135000 967097000 967100000 65000000 494200000 407900000 964359000 964400000 71900000 500900000 391600000 100000 0 15000000 400000000 658229000 1250394000 16819000 32932000 16696000 31458000 2016-10-31 107400000 87700000 18500000 1200000 125000000 95000000 27000000 3000000 36100000 15300000 20300000 500000 5200000 200000 -4500000 13900000 300000 55600000 57700000 -2500000 400000 4200000 700000 15700000 14700000 500000 100000 100000 300000 14700000 700000 300000 20400000 0 19900000 500000 8900000 0 8600000 300000 5900000 0 5500000 400000 1779440000 1903469000 434676000 434700000 75100000 359600000 37900000 129500000 85100000 107100000 82600000 197400000 154700000 879847000 150900000 728900000 80400000 263600000 169300000 215600000 164700000 401300000 313800000 483800000 483793000 92600000 391200000 42500000 130600000 97600000 120500000 96500000 221400000 165900000 933433000 933400000 177800000 755600000 82900000 256300000 188400000 228000000 182200000 428200000 323000000 167583000 341118000 177659000 351263000 600000 600000 200000 6200000 1400000 1400000 400000 15900000 700000 700000 200000 7000000 1200000 1200000 600000 12800000 162.28 162.28 131.60 131.60 162.28 162.28 162.69 162.69 243803000 243800000 30200000 30191000 0 500000000 118400000 2667509000 2738076000 2673904000 2744781000 3290000 3290000 100000 0 0 360149000 360149000 16000000 3700000 29400000 996300000 1415000000 830000000 285000000 300000000 300000000 700000000 830000000 49163000 49139000 49100000 48853000 48900000 48800000 48838000 48463000 48330000 48300000 48400000 48428000 48400000 48365000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Restructuring and Integration Costs</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2014 Sauflon Integration Plan</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fiscal fourth quarter of 2014, in connection with the Sauflon acquisition, our CooperVision business unit initiated restructuring and integration activities to optimize operational synergies of the combined companies. These activities include workforce reductions, consolidation of duplicative facilities and product rationalization. We estimate that the total restructuring costs under this plan will be </font><font style="font-family:inherit;font-size:10pt;">$125.0 million</font><font style="font-family:inherit;font-size:10pt;">. These costs include approximately </font><font style="font-family:inherit;font-size:10pt;">$95.0 million</font><font style="font-family:inherit;font-size:10pt;"> associated with assets, including product rationalization and related equipment disposals and accelerated depreciation, about </font><font style="font-family:inherit;font-size:10pt;">$27.0 million</font><font style="font-family:inherit;font-size:10pt;"> associated with employee termination costs, and about </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> associated with facility lease termination costs. We are substantially complete with activities related to operating expenses, and we expect to incur costs related to the manufacturing activities through the end of fiscal 2016.&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> month periods ended </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, we recorded in cost of sales </font><font style="font-family:inherit;font-size:10pt;">$4.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$14.7 million</font><font style="font-family:inherit;font-size:10pt;"> of expense, respectively, arising from production-related asset disposals and accelerated depreciation on equipment, primarily related to our hydrogel lenses, based on our review of products, materials and manufacturing processes of Sauflon. We recorded in cost of sales, employee termination costs of </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> in the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> month periods ended </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. We recorded </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> of employee termination costs and </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> for lease termination costs in selling, general and administrative expense in the six months ended April 30, 2016. We also recorded in research and development expense </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> of employee termination costs in the six months ended April 30, 2016. In addition, CooperVision incurred </font><font style="font-family:inherit;font-size:10pt;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> of integration costs included in operating expenses in the three and six month periods ended April 30, 2016, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> month periods ended </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, we recorded in cost of sales </font><font style="font-family:inherit;font-size:10pt;">$5.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$13.9 million</font><font style="font-family:inherit;font-size:10pt;"> of expense, respectively, arising from production-related asset disposals and accelerated depreciation on equipment, primarily related to our hydrogel lenses, based on our review of products, materials and manufacturing processes of Sauflon. In the three month period ended April 30, 2015, we reduced the accrued employee termination costs in selling, general and administrative expense by </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;"> based on estimates of the expected costs and the results of voluntary terminations. We recorded in research and development expense </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> of employee termination costs in the three and six months ended April 30, 2015, respectively. In addition, CooperVision incurred </font><font style="font-family:inherit;font-size:10pt;">$8.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$14.1 million</font><font style="font-family:inherit;font-size:10pt;"> of integration costs in the three and six months ended April 30, 2015, respectively, recorded in selling, general and administrative expense.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of the cumulative total restructuring costs by major component recognized to date as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, is as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.07692307692307%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:42%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Employee-related</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Facilities-related</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Product Rationalization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts incurred in:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended October 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Year ended October 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Six months ended April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Cumulative amounts incurred as of April 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the restructuring activities by major component for the fiscal year ended October 31, 2015 and the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.07692307692307%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:42%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Employee-related</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Facilities-related</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Product Rationalization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">(Reductions) additions during fiscal 2015</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments during the fiscal year</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Non-cash adjustments (a) (b)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(57.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(57.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Additions during the six months ended April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments during the six months ended April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Non-cash adjustments (a) (b)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at April 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(a) Non-cash adjustments for employee-related and facilities-related costs represent currency translation adjustment.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(b) Non-cash adjustments for product rationalization represent equipment disposals, inventory write-offs and accelerated depreciation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Acquisitions</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> we completed the acquisition of Genesis Genetics Inc., a genetics laboratory specializing in preimplantation genetic screening and preimplantation genetic diagnosis used during the IVF process, headquartered in Plymouth, Michigan. The fair value of the consideration transferred for the acquisition was approximately </font><font style="font-family:inherit;font-size:10pt;">$60.0 million</font><font style="font-family:inherit;font-size:10pt;"> in cash, </font><font style="font-family:inherit;font-size:10pt;">$59.3 million</font><font style="font-family:inherit;font-size:10pt;"> net of cash acquired. Our preliminary allocation of the fair value of the purchase price includes </font><font style="font-family:inherit;font-size:10pt;">$28.6 million</font><font style="font-family:inherit;font-size:10pt;"> in identifiable intangible assets, consisting of </font><font style="font-family:inherit;font-size:10pt;">$25.2 million</font><font style="font-family:inherit;font-size:10pt;"> for customer relationships and </font><font style="font-family:inherit;font-size:10pt;">$3.4 million</font><font style="font-family:inherit;font-size:10pt;"> for trade names; </font><font style="font-family:inherit;font-size:10pt;">$27.6 million</font><font style="font-family:inherit;font-size:10pt;"> in goodwill; and </font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;"> in identifiable net assets.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">February&#160;8, 2016</font><font style="font-family:inherit;font-size:10pt;">, we completed the acquisition of The Pipette Company, a manufacturer and distributor of micro pipettes for the Assisted Reproductive Technology market headquartered in Adelaide, Australia. The fair value of the consideration transferred for the acquisition was approximately </font><font style="font-family:inherit;font-size:10pt;">$20.2 million</font><font style="font-family:inherit;font-size:10pt;"> in cash, </font><font style="font-family:inherit;font-size:10pt;">$19.6 million</font><font style="font-family:inherit;font-size:10pt;"> net of cash acquired. Our preliminary allocation of the fair value of the purchase price includes </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;"> in identifiable intangible assets, consisting of </font><font style="font-family:inherit;font-size:10pt;">$5.2 million</font><font style="font-family:inherit;font-size:10pt;"> for customer relationships and </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> for trade names; </font><font style="font-family:inherit;font-size:10pt;">$14.7 million</font><font style="font-family:inherit;font-size:10pt;"> in goodwill; and </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> in identifiable net liabilities.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">December&#160;17, 2015</font><font style="font-family:inherit;font-size:10pt;">, we completed the acquisition of Research Instruments Limited, a manufacturer and supplier of in vitro fertilization (IVF) medical devices and systems headquartered in Cornwall, United Kingdom. The fair value of the consideration transferred for the acquisition was approximately </font><font style="font-family:inherit;font-size:10pt;">$53.6 million</font><font style="font-family:inherit;font-size:10pt;"> in cash, </font><font style="font-family:inherit;font-size:10pt;">$50.0 million</font><font style="font-family:inherit;font-size:10pt;"> net of cash acquired. Our preliminary allocation of the fair value of the purchase price includes </font><font style="font-family:inherit;font-size:10pt;">$10.3 million</font><font style="font-family:inherit;font-size:10pt;"> in identifiable intangible assets, consisting of </font><font style="font-family:inherit;font-size:10pt;">$6.2 million</font><font style="font-family:inherit;font-size:10pt;"> for developed technology, </font><font style="font-family:inherit;font-size:10pt;">$2.2 million</font><font style="font-family:inherit;font-size:10pt;"> of trade names and </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;"> for customer relationships; </font><font style="font-family:inherit;font-size:10pt;">$36.1 million</font><font style="font-family:inherit;font-size:10pt;"> in goodwill; and </font><font style="font-family:inherit;font-size:10pt;">$7.3 million</font><font style="font-family:inherit;font-size:10pt;"> in identifiable net assets. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe these acquisitions strengthen CooperSurgical's fertility business through the addition of new or complementary products and services within IVF and our genetic testing platform.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The pro forma results of operations of these acquisitions have not been presented because the effects of the business combinations described above, individually and in the aggregate, were not material to our consolidated results of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Debt</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">April&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Overdraft and other credit facilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">240.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: unamortized debt issuance cost on term loans</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">243.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term loans</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,415.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">996.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: unamortized debt issuance cost on term loans</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,411.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,105.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revolving Credit and Term Loan Agreement on March 1, 2016 (2016 Credit Agreement)</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">March&#160;1, 2016</font><font style="font-family:inherit;font-size:10pt;">, we entered into a new Revolving Credit and Term Loan Agreement (2016 Credit Agreement), among the Company, CooperVision International Holding Company, LP, the lenders from time to time party thereto and KeyBank National Association, as administrative agent. The 2016 Credit Agreement provides for a multicurrency revolving credit facility in an aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;"> and a term loan facility in an aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">$830.0 million</font><font style="font-family:inherit;font-size:10pt;">, each of which, unless terminated earlier, mature on </font><font style="font-family:inherit;font-size:10pt;">March&#160;1, 2021</font><font style="font-family:inherit;font-size:10pt;">. In addition, we have the ability from time to time to request an increase to the size of the revolving credit facility or establish one or more new term loans under the term loan facility in an aggregate amount up to </font><font style="font-family:inherit;font-size:10pt;">$750.0 million</font><font style="font-family:inherit;font-size:10pt;">, subject to the discretionary participation of the lenders.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2016 Credit Agreement replaced our previous Credit Agreement that was entered into on January 12, 2011, and we terminated the Credit Agreement on March 1, 2016. In connection with the termination, all borrowings outstanding under the Credit Agreement were repaid and all letters of credit outstanding were transferred to the 2016 Credit Agreement. We did not incur any termination or prepayment penalties with respect to replacing the Credit Agreement. We used funds from the new term loan to repay the </font><font style="font-family:inherit;font-size:10pt;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;"> outstanding principal amount of the two uncommitted revolving lines of credit, entered into on </font><font style="font-family:inherit;font-size:10pt;">March&#160;24, 2015</font><font style="font-family:inherit;font-size:10pt;">, as well as to partially repay outstanding amounts under the term loans entered into on August 4, 2014, and September 12, 2013, and for general corporate purposes.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts outstanding under the 2016 Credit Agreement will bear interest, at our option, at either the base rate, which is a rate per annum equal to the greatest of (a)&#160;KeyBank&#8217;s prime rate, (b)&#160;</font><font style="font-family:inherit;font-size:10pt;">0.5%</font><font style="font-family:inherit;font-size:10pt;"> in excess of the federal funds effective rate and (c)&#160;</font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> in excess of the adjusted LIBO rate for a one month interest period on such day, or the adjusted LIBO rate or adjusted foreign currency rate, plus, in each case, an applicable rate of, initially, </font><font style="font-family:inherit;font-size:10pt;">0.5%</font><font style="font-family:inherit;font-size:10pt;"> in respect of base rate loans and </font><font style="font-family:inherit;font-size:10pt;">1.5%</font><font style="font-family:inherit;font-size:10pt;"> in respect of adjusted LIBO rate or adjusted foreign currency rate loans. Following a specified period after the closing date, the applicable rates will be determined quarterly by reference to a grid based upon our ratio of consolidated net indebtedness to consolidated pro forma EBITDA, as defined in the 2016 Credit Agreement. During the term of the revolving credit facility, we may borrow, repay and re-borrow amounts available under the revolving credit facility, subject to voluntary reduction of the revolving commitment.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We pay an annual commitment fee that ranges from </font><font style="font-family:inherit;font-size:10pt;">0.125%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">0.25%</font><font style="font-family:inherit;font-size:10pt;"> of the unused portion of the revolving credit facility depending on certain financial ratios. In addition to the annual commitment fee described above, we are also required to pay certain letter of credit and related fronting fees and other administrative fees pursuant to the terms of the 2016 Credit Agreement.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2016 Credit Agreement is not secured by any of the Company's, or any of its subsidiaries&#8217; (including CooperVision International Holding Company&#8217;s), assets. All obligations under this facility will be guaranteed by each of the Company&#8217;s existing and future direct and indirect domestic material subsidiaries, as defined in the 2016 Credit Agreement. CooperVision International Holding Company is responsible only for its own obligations, if any, and does not guarantee any of the Company&#8217;s obligations under the 2016 Credit Agreement.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The facility is not subject to amortization and is not subject to mandatory prepayments prior to maturity. We may prepay loan balances from time to time, in whole or in part, without premium or penalty (other than any related breakage costs). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2016 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require us to maintain a certain total leverage ratio and interest coverage ratio, each as defined in the 2016 Credit Agreement. The 2016 Credit Agreement also contains customary events of default, the occurrence of which would permit KeyBank as the administrative agent to declare the principal, accrued interest and other obligations under the agreement to be immediately due and payable.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the terms of the 2016 Credit Agreement and the term loans discussed below, we are also required to maintain specified financial ratios:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The ratio of Consolidated Proforma EBITDA to Consolidated Interest Expense (as defined, Interest Coverage Ratio) be at least </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3.00</font><font style="font-family:inherit;font-size:10pt;"> to 1.00 at all times.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The ratio of Consolidated Funded Indebtedness to Consolidated Proforma EBITDA (as defined, Total Leverage Ratio) be no higher than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3.75</font><font style="font-family:inherit;font-size:10pt;"> to 1.00. </font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, we were in compliance with the Interest Coverage Ratio at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">26.42</font><font style="font-family:inherit;font-size:10pt;"> to 1.00 and the Total Leverage Ratio at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2.37</font><font style="font-family:inherit;font-size:10pt;"> to 1.00.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;">$830.0 million</font><font style="font-family:inherit;font-size:10pt;"> outstanding under the term loan and about </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;"> available under the revolving credit agreement.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Uncommitted Revolving Lines of Credit on March 24, 2015</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">March&#160;24, 2015</font><font style="font-family:inherit;font-size:10pt;">, we entered into two uncommitted line of credit agreements with TD Bank, N.A. and Santander Bank, N.A. These lines of credit had a termination date of </font><font style="font-family:inherit;font-size:10pt;">March&#160;24, 2016</font><font style="font-family:inherit;font-size:10pt;">, and each provided revolving loan amounts to Cooper of up to </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;">, at the lender's option, with maturity dates of up to </font><font style="font-family:inherit;font-size:10pt;">ninety days</font><font style="font-family:inherit;font-size:10pt;"> from the loan origination date. Amounts outstanding under these agreements will bear interest at a rate equal to LIBOR for the period plus, </font><font style="font-family:inherit;font-size:10pt;">0.90%</font><font style="font-family:inherit;font-size:10pt;">, payable in arrears on the last day of the period, as defined in the agreements.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fiscal second quarter of 2016, in connection with the refinancing discussed above, we repaid the full outstanding principal amount of the two uncommitted revolving lines of credit. At </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> amounts outstanding under these agreements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$700.0 million Term Loan on August 4, 2014</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">August&#160;4, 2014</font><font style="font-family:inherit;font-size:10pt;">, we entered into a </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-year, </font><font style="font-family:inherit;font-size:10pt;">$700.0 million</font><font style="font-family:inherit;font-size:10pt;">, senior unsecured term loan agreement by and among the Company, the lenders party thereto and KeyBank National Association as administrative agent. This syndicated credit facility will mature and the balance is payable on </font><font style="font-family:inherit;font-size:10pt;">August&#160;4, 2017</font><font style="font-family:inherit;font-size:10pt;">. There is no amortization of principal and we may prepay loan balances from time to time, in whole or in part, without premium or penalty. In August 2014, we utilized this facility to fund the acquisition of Sauflon, as well as to provide working capital and for general corporate purposes. In fiscal second quarter of 2016, we repaid </font><font style="font-family:inherit;font-size:10pt;">$400.0 million</font><font style="font-family:inherit;font-size:10pt;"> of the outstanding balance using funds from the 2016 Credit Agreement.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts outstanding under this term loan agreement will bear interest, at the Company&#8217;s option, at either the base rate, which is a rate per annum equal to the greatest of (a)&#160;KeyBank&#8217;s prime rate, (b)&#160;</font><font style="font-family:inherit;font-size:10pt;">0.5%</font><font style="font-family:inherit;font-size:10pt;"> in excess of the federal funds effective rate and (c)&#160;</font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> in excess of the adjusted Eurodollar rate (currently referred to as LIBOR) for a one-month interest period on such day, or the adjusted Eurodollar rate, plus, in each case, an applicable margin. The applicable margins will be determined quarterly by reference to a grid based upon the Company&#8217;s Total Leverage Ratio, as defined in the term loan agreement and consistent with the 2016 Credit Agreement discussed above.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This term loan agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the agreement, and consistent with the 2016 Credit Agreement as discussed above. This term loan agreement also contains customary events of default, the occurrence of which would permit the Administrative Agent to declare the principal, accrued interest and other obligations of the Company under the agreement to be immediately due and payable. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 1, 2016, we entered into an Amendment and Restatement Agreement (Amended and Restated 2014 Term Loan) to amend and restate in its entirety the Term Loan Agreement, dated as of August 4, 2014, as amended by Amendment No. 1 dated as of August 21, 2015 (2014 Term Loan Agreement), by and among the Company, the lenders party thereto, and KeyBank National Association, as administrative agent. The Amended and Restated 2014 Term Loan modifies certain provisions of the 2014 Term Loan Agreement to, among other things, conform certain restrictive covenants and events of default to the restrictive covenants and events of default contained in our new 2016 Credit Agreement. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;"> outstanding under this term loan.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$300.0 million Term Loan on September 12, 2013</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">September&#160;12, 2013</font><font style="font-family:inherit;font-size:10pt;">, the Company entered into a </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year, </font><font style="font-family:inherit;font-size:10pt;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;">, senior unsecured term loan agreement by and among the Company; the lenders party thereto and KeyBank National Association, as administrative agent. This syndicated credit facility, as subsequently amended, will mature on </font><font style="font-family:inherit;font-size:10pt;">September&#160;12, 2018</font><font style="font-family:inherit;font-size:10pt;">, and will be subject to amortization of principal of </font><font style="font-family:inherit;font-size:10pt;">5%</font><font style="font-family:inherit;font-size:10pt;"> per annum payable quarterly beginning </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, with the balance payable at maturity. In fiscal second quarter of 2016, we repaid </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;"> of the outstanding balance using the funds from the 2016 Credit Agreement.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts outstanding under this term loan agreement will bear interest, at the Company's option, at either the base rate, which is a rate per annum equal to the greatest of (a) </font><font style="font-family:inherit;font-size:10pt;">KeyBank's prime rate</font><font style="font-family:inherit;font-size:10pt;">, (b) </font><font style="font-family:inherit;font-size:10pt;">0.5%</font><font style="font-family:inherit;font-size:10pt;"> in excess of the federal funds effective rate and (c) </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> in excess of the adjusted Eurodollar rate (currently referred to as LIBOR) for a one-month interest period on such day, or the adjusted Eurodollar rate, plus, in each case, an applicable margin. The applicable margins will be determined quarterly by reference to a grid based upon the Company's Total Leverage Ratio, as defined in the term loan agreement, and consistent with the 2016 Credit Agreement discussed above.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This term loan agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the agreement, consistent with the 2016 Credit Agreement discussed above. The agreement also contains customary events of default, the occurrence of which would permit the Administrative Agent to declare the principal, accrued interest and other obligations of the Company under the agreement to be immediately due and payable.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Sauflon acquisition, on June 30, 2014, we entered into an amendment to this term loan agreement, dated as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;12, 2013</font><font style="font-family:inherit;font-size:10pt;">, by and among (i) the Company, (ii) the lenders from time to time party thereto and (iii) KeyBank National Association, as administrative agent. This term loan amendment modifies certain provisions of the term loan agreement to, among other things, amend certain restrictive covenants and related definitions to allow for certain indebtedness, investments, guaranty obligations, acquisitions, intercompany loans, capital distributions and dispositions of assets made or to be made in connection with the acquisition.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 4, 2014, we entered into Amendment No. 2 to this term loan agreement, dated as of </font><font style="font-family:inherit;font-size:10pt;">September&#160;12, 2013</font><font style="font-family:inherit;font-size:10pt;">, as amended by Amendment No. 1 dated as of June 30, 2014, by and among the Company, the lenders party thereto and KeyBank National Association, as administrative agent. The term loan amendment modifies certain provisions of the term loan agreement to remove the call premium related to prepayments and/or refinancing of the term loan agreement, effective August 4, 2014.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 1, 2016, we entered into an Amendment and Restatement Agreement (Amended and Restated 2013 Term Loan) to amend and restate in its entirety the Term Loan Agreement, dated as of September 12, 2013, as amended by Amendment No. 1 dated as of June 30, 2014, Amendment No. 2 dated as of August 4, 2014 and Amendment No. 3 dated as of August 21, 2015 (2013 Term Loan Agreement), by and among the Company, the lenders party thereto, and KeyBank National Association, as administrative agent. The Amended and Restated 2013 Term Loan modifies certain provisions of the 2013 Term Loan Agreement to, among other things, conform certain restrictive covenants and events of default to the restrictive covenants and events of default contained in our new 2016 Credit Agreement.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;">$285.0 million</font><font style="font-family:inherit;font-size:10pt;"> outstanding under this term loan.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Share-Based Compensation Plans</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cooper has several share-based compensation plans that are described in the Company&#8217;s Annual Report on Form 10&#8209;K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">. The compensation expense and related income tax benefit recognized in our consolidated condensed financial statements for share-based awards were as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Periods Ended April 30,</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three&#160;Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total share-based compensation expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Related income tax benefit</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We capitalized share-based compensation expense as part of the cost of inventory in the amounts of </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> during the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively; and </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.4 million</font><font style="font-family:inherit;font-size:10pt;"> during the three and </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Earnings Per Share</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Periods Ended April 30,</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to Cooper stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Basic:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per common share attributable to Cooper stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.53</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.59</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.52</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Diluted:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of potential dilutive common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted weighted average common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per common share attributable to Cooper stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.52</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.23</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.57</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.48</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth stock options to purchase Cooper&#8217;s common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Periods Ended April 30,</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In thousands, except exercise prices)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numbers of stock option shares excluded</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Range of exercise prices</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$131.60-$162.69</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162.28</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$131.60-$162.69</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162.28</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numbers of restricted stock units excluded</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Fair Value Measurements</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets and liabilities are measured and reported at fair value per related accounting standards that define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset&#8217;s or liability&#8217;s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1: Quoted market prices in active markets for identical assets or liabilities.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3: Unobservable inputs reflecting the reporting entity&#8217;s own assumptions.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe that the balances of our revolving debt and term loans approximated their fair values at </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">October&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;"> and are categorized as Level 2 of the fair value hierarchy. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has derivative assets and liabilities that may include interest rate swaps, cross currency swaps and foreign currency forward contracts. The impact of the counterparty&#8217;s creditworthiness when in an asset position and Cooper&#8217;s creditworthiness when in a liability position has also been factored into the fair value measurement of the derivative instruments. Both the counterparty and Cooper are expected to continue to perform under the contractual terms of the instruments.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may use interest rate swaps to maintain our desired mix of fixed-rate and variable-rate debt. The swaps exchange fixed and variable rate payments without exchanging the notional principal amount of the debt. We generally have elected to use the income approach to value the derivatives using observable Level 2 market expectations at the measurement date and standard valuation techniques to convert future amounts to a single present amount assuming that participants are motivated but not compelled to transact. Level 2 inputs are limited to quoted prices for similar assets or liabilities in active markets, specifically Eurodollar futures contracts up to three years, and inputs other than quoted prices that are observable for the asset or liability - specifically LIBOR cash and swap rates and credit risk at commonly quoted intervals. Mid-market pricing may be used as a practical expedient for fair value measurements.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may use foreign exchange forward contracts to minimize, to the extent reasonable and practical, our exposure to the impact of foreign currency fluctuations. We have elected to use the income approach to value the derivatives using observable Level 2 market expectations at the measurement date and standard valuation techniques to convert future amounts to a single present amount assuming that participants are motivated but not compelled to transact. Level 2 inputs for the valuations are limited to quoted prices for similar assets or liabilities in active markets and inputs other than quoted prices that are observable for the asset or liability - specifically LIBOR cash rates, credit risk at commonly quoted intervals, foreign exchange spot rates and forward points. Mid-market pricing is used as a practical expedient for fair value measurements.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth our financial assets and liabilities that were measured at fair value on a recurring basis using Level 2 inputs during the fiscal first </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, within the fair value hierarchy at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, and fiscal year </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, within the fair value hierarchy at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">April&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Income Taxes</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our effective tax rate (ETR) (provision for income taxes divided by pretax income) for the fiscal first half of 2016 was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">5.4%</font><font style="font-family:inherit;font-size:10pt;">. Our year-to-date results reflect the projected fiscal year ETR, plus any discrete items. The ETR used to record the provision for income taxes for the fiscal first half of 2015 was </font><font style="font-family:inherit;font-size:10pt;">8.6%</font><font style="font-family:inherit;font-size:10pt;">. The decrease in the effective tax rate in the fiscal first half of 2016 was primarily due to a release of reserves associated with a prior year tax filing, a statutory tax rate reduction in the United Kingdom and the retroactive extension&#160;of the R&amp;D tax credit.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognize the benefit from a tax position only if it is more likely than not that the position would be sustained upon audit based solely on the technical merits of the tax position. At November&#160;1, 2015, Cooper had unrecognized tax benefits of which, if recognized, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$29.4 million</font><font style="font-family:inherit;font-size:10pt;"> would impact our ETR. For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">six</font><font style="font-family:inherit;font-size:10pt;">-month period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, there were no material changes to the total amount of unrecognized tax benefits.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest and penalties of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;"> have been reflected as a component of the total liability at November&#160;1, 2015. It is our policy to recognize the items of interest and penalties directly related to income taxes as additional income tax expense.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Included in the balance of unrecognized tax benefits at November&#160;1, 2015, is </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> related to tax positions for which it is reasonably possible that the total amounts could significantly change during the next twelve months. This amount represents a decrease in unrecognized tax benefits related to expiring statutes in various jurisdictions worldwide and relates primarily to transfer pricing matters.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, the tax years for which Cooper remains subject to United States Federal income tax assessment upon examination are 2014 through 2015. Cooper remains subject to income tax examinations in other significant tax jurisdictions including the United Kingdom, Japan, France and Australia for the tax years 2012 through 2015.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Intangible Assets</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CooperVision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CooperSurgical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,861.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">359.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,220.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (reductions) additions during the year ended October 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,827.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">369.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,197.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net additions during the six-month period ended April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at April 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,782.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">451.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,233.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We performed our annual impairment assessment in our fiscal third quarter of 2015, and our analysis indicated that we had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impairment of goodwill. As described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2015, we will continue to monitor conditions and changes which could indicate that our recorded goodwill may be impaired.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Intangible Assets</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of April 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of October 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross&#160;Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&amp;&#160;Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross&#160;Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&amp;&#160;Translation</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">247.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">License and distribution rights and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">715.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">661.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: accumulated amortization and translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other intangible assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">437.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We estimate that amortization expense for our existing other intangible assets at </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, will be </font><font style="font-family:inherit;font-size:10pt;">$59.6 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2016, </font><font style="font-family:inherit;font-size:10pt;">$56.1 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2017, </font><font style="font-family:inherit;font-size:10pt;">$54.1 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2018, </font><font style="font-family:inherit;font-size:10pt;">$51.5 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2019 and </font><font style="font-family:inherit;font-size:10pt;">$40.9 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal 2020.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Inventories</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">April&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">324.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">419.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are stated at the lower of cost or market. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Contingencies</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since March 2015, over </font><font style="font-family:inherit;font-size:10pt;">50</font><font style="font-family:inherit;font-size:10pt;"> putative class action complaints were filed by contact lens consumers alleging that contact lens manufacturers, in conjunction with their respective Unilateral Pricing Policy (UPP), conspired to reach agreements between each other and certain distributors and retailers regarding the prices at which certain contact lenses could be sold to consumers. The plaintiffs are seeking damages against CooperVision, Inc., other contact lens manufacturers, distributors and retailers, in various courts around the United States. In June 2015, all of the class action cases were consolidated and transferred to the United States District Court for the Middle District of Florida. CooperVision and the other defendants jointly filed a motion to dismiss the complaints which currently is pending, and the actions currently are in discovery. CooperVision denies the allegations and intends to defend the actions vigorously. We are not in a position to assess whether any loss or adverse effect on our financial condition is probable or remote or to estimate the range of potential loss, if any.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Pronouncements Issued Not Yet Adopted</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU 2016-09,</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, </font><font style="font-family:inherit;font-size:10pt;">which is intended to improve the accounting for share-based payment transactions as part of the FASB&#8217;s simplification initiative. The ASU changes the following aspects of the accounting for share-based payment award transactions, including: accounting for income taxes; classification of excess tax benefits on the statement of cash flows; forfeitures; minimum statutory tax withholding requirements; and classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. We are currently evaluating the impact of ASU 2016-09, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2017.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842). </font><font style="font-family:inherit;font-size:10pt;">ASU 2016-01 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. We are currently evaluating the impact of ASU 2016-02, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2019.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2015, the FASB issued ASU 2015-17, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Balance Sheet Classification of Deferred Taxes, </font><font style="font-family:inherit;font-size:10pt;">which requires entities to present all deferred tax assets and liabilities as noncurrent. The amendments in the ASU are effective for the Company in our fiscal year and interim periods beginning on November 1, 2017. The Company does not expect the new guidance to have a material impact on the Company&#8217;s consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;">. ASU 2014-09 requires revenue recognition to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 sets forth a new revenue recognition model that requires identifying the contract, identifying the performance obligations, determining the transaction price, allocating the transaction price to performance obligations and recognizing the revenue upon satisfaction of performance obligations. The amendments in the ASU can be applied either retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the update recognized at the date of the initial application along with additional disclosures. We are currently evaluating the impact of ASU 2014-09, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2018.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Pronouncements Recently Adopted</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the FASB issued Accounting Standards Update (ASU) 2015-03, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest - Imputation of Interest (Subtopic 835-30) Simplifying the Presentation of Debt Issuance Costs. </font><font style="font-family:inherit;font-size:10pt;">The amendments in this update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for interim and annual reporting periods beginning after December 15, 2016. Early adoption is permitted. We elected to early adopt this guidance as a change in accounting principle on a retrospective basis in the fiscal first quarter ended January 31, 2016. As of January 31, 2016 and October 31, 2015, we have presented debt issuance costs related to our term loans, previously reported in other assets, as direct deductions from the carrying amount of the debt liability. We also presented the debt issuance costs related to our revolving credit facility as a deferred asset within other assets, as is permitted by ASU 2015-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Imputation of Interest</font><font style="font-family:inherit;font-size:10pt;">, which was issued in August 2015. Such adoption did not have a material impact to our consolidated financial position.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">General</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Cooper Companies, Inc. (Cooper, we or the Company) is a global medical device company publicly traded on the NYSE Euronext (NYSE: COO). Cooper is dedicated to being A Quality of Life Company</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">TM</sup></font><font style="font-family:inherit;font-size:10pt;"> with a focus on delivering shareholder value. Cooper operates through our business units, CooperVision and CooperSurgical.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision develops, manufactures and markets a broad range of soft contact lenses for the worldwide vision correction market.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical develops, manufactures and markets medical devices and procedure solutions to improve health care delivery to women.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited consolidated condensed financial statements presented in this report contain all adjustments necessary to present fairly Cooper&#8217;s consolidated condensed financial position at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the consolidated results of its operations for the three and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> and its consolidated condensed cash flows for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">. Most of these adjustments are normal and recurring. However, certain adjustments associated with acquisitions are of a nonrecurring nature. Readers should not assume that the results reported here either indicate or guarantee future performance.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During interim periods, we follow the accounting policies described in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">. Please refer to this when reviewing this Quarterly Report on Form 10-Q.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management estimates and judgments are an integral part of financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). We believe that the critical accounting policies listed below address the more significant estimates required of Management when preparing our consolidated financial statements in accordance with GAAP. We consider an accounting estimate critical if changes in the estimate may have a material impact on our financial condition or results of operations. We believe that the accounting estimates employed are appropriate and resulting balances are reasonable; however, actual results could differ from the original estimates, requiring adjustment to these balances in future periods. The accounting policies that reflect our more significant estimates, judgments and assumptions and which we believe are the most critical to aid in fully understanding and evaluating our reported financial results are:</font></div><div style="line-height:120%;padding-left:0px;padding-top:12px;text-align:justify;"><font style="padding-top:12px;text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">Revenue recognition</font></div><div style="line-height:120%;padding-left:0px;padding-top:12px;text-align:justify;"><font style="padding-top:12px;text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">Net realizable value of inventory</font></div><div style="line-height:120%;padding-left:0px;padding-top:12px;text-align:justify;"><font style="padding-top:12px;text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">Valuation of goodwill</font></div><div style="line-height:120%;padding-left:0px;padding-top:12px;text-align:justify;"><font style="padding-top:12px;text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">Business combinations</font></div><div style="line-height:120%;padding-left:0px;padding-top:12px;text-align:justify;"><font style="padding-top:12px;text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">Income taxes</font></div><div style="line-height:120%;padding-left:0px;padding-top:12px;text-align:justify;"><font style="padding-top:12px;text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">Share-based compensation</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fiscal first half of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, there were no significant changes in our estimates and critical accounting policies. Please refer to Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item&#160;7 of our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">, for a more complete discussion of our estimates and critical accounting policies.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Pronouncements Issued Not Yet Adopted</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU 2016-09,</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, </font><font style="font-family:inherit;font-size:10pt;">which is intended to improve the accounting for share-based payment transactions as part of the FASB&#8217;s simplification initiative. The ASU changes the following aspects of the accounting for share-based payment award transactions, including: accounting for income taxes; classification of excess tax benefits on the statement of cash flows; forfeitures; minimum statutory tax withholding requirements; and classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. We are currently evaluating the impact of ASU 2016-09, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2017.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842). </font><font style="font-family:inherit;font-size:10pt;">ASU 2016-01 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. We are currently evaluating the impact of ASU 2016-02, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2019.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2015, the FASB issued ASU 2015-17, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Balance Sheet Classification of Deferred Taxes, </font><font style="font-family:inherit;font-size:10pt;">which requires entities to present all deferred tax assets and liabilities as noncurrent. The amendments in the ASU are effective for the Company in our fiscal year and interim periods beginning on November 1, 2017. The Company does not expect the new guidance to have a material impact on the Company&#8217;s consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;">. ASU 2014-09 requires revenue recognition to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 sets forth a new revenue recognition model that requires identifying the contract, identifying the performance obligations, determining the transaction price, allocating the transaction price to performance obligations and recognizing the revenue upon satisfaction of performance obligations. The amendments in the ASU can be applied either retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the update recognized at the date of the initial application along with additional disclosures. We are currently evaluating the impact of ASU 2014-09, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2018.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Pronouncements Recently Adopted</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the FASB issued Accounting Standards Update (ASU) 2015-03, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest - Imputation of Interest (Subtopic 835-30) Simplifying the Presentation of Debt Issuance Costs. </font><font style="font-family:inherit;font-size:10pt;">The amendments in this update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for interim and annual reporting periods beginning after December 15, 2016. Early adoption is permitted. We elected to early adopt this guidance as a change in accounting principle on a retrospective basis in the fiscal first quarter ended January 31, 2016. As of January 31, 2016 and October 31, 2015, we have presented debt issuance costs related to our term loans, previously reported in other assets, as direct deductions from the carrying amount of the debt liability. We also presented the debt issuance costs related to our revolving credit facility as a deferred asset within other assets, as is permitted by ASU 2015-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Imputation of Interest</font><font style="font-family:inherit;font-size:10pt;">, which was issued in August 2015. Such adoption did not have a material impact to our consolidated financial position.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Employee Benefits</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cooper&#8217;s Retirement Income Plan (Plan), a defined benefit plan, covers substantially all full-time United States employees. Our contributions are designed to fund normal cost on a current basis and to fund the estimated prior service cost of benefit improvements. The unit credit actuarial cost method is used to determine the annual cost. Cooper pays the entire cost of the Plan and funds such costs as they accrue. Virtually all of the assets of the Plan are comprised of equities and participation in equity and fixed income funds.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our results of operations for the three and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> reflect the following components of net periodic pension costs:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Periods Ended April 30,</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized net actuarial loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We contributed </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> to the Plan in the fiscal first half of 2016, and expect to contribute an additional </font><font style="font-family:inherit;font-size:10pt;">$7.5 million</font><font style="font-family:inherit;font-size:10pt;"> during fiscal 2016. We contributed </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> to the Plan in the fiscal first half of 2015. The expected rate of return on plan assets for determining net periodic pension cost is </font><font style="font-family:inherit;font-size:10pt;">8%</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">April&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,678.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,714.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">817.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,601.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,459.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Analysis of Changes in Accumulated Other Comprehensive Income (Loss):</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Currency Translation Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change in Value of&#160;</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivative Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Minimum Pension Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(106.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross change in value during the year ended October 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(79.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(89.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassification adjustments for loss realized in net income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax effect for the period</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance at October 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(171.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(191.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross change in value during the six-month period ended April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Reclassification adjustments for loss realized in net income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax effect for the period</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance at April 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(233.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(253.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth stock options to purchase Cooper&#8217;s common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Periods Ended April 30,</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In thousands, except exercise prices)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numbers of stock option shares excluded</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Range of exercise prices</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$131.60-$162.69</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162.28</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$131.60-$162.69</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162.28</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numbers of restricted stock units excluded</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">April&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Overdraft and other credit facilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">240.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: unamortized debt issuance cost on term loans</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">243.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">109.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term loans</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,415.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">996.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: unamortized debt issuance cost on term loans</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,411.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,105.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Periods Ended April 30,</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions, except per share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to Cooper stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Basic:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per common share attributable to Cooper stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.53</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.59</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.52</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Diluted:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of potential dilutive common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted weighted average common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per common share attributable to Cooper stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.52</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.23</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.57</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.48</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The compensation expense and related income tax benefit recognized in our consolidated condensed financial statements for share-based awards were as follows:</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Periods Ended April 30,</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three&#160;Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total share-based compensation expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Related income tax benefit</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">April&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-lived assets by country of domicile:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">494.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">391.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">407.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of world</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">964.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">967.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth our financial assets and liabilities that were measured at fair value on a recurring basis using Level 2 inputs during the fiscal first </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, within the fair value hierarchy at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, and fiscal year </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;">, within the fair value hierarchy at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">April&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Intangible Assets</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of April 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of October 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross&#160;Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&amp;&#160;Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross&#160;Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&amp;&#160;Translation</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Technology</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">279.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">247.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">License and distribution rights and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">715.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">661.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: accumulated amortization and translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other intangible assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">437.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CooperVision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CooperSurgical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,861.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">359.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,220.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (reductions) additions during the year ended October 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,827.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">369.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,197.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net additions during the six-month period ended April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at April 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,782.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">451.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,233.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">April&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">324.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">419.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our results of operations for the three and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015</font><font style="font-family:inherit;font-size:10pt;"> reflect the following components of net periodic pension costs:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Periods Ended April 30,</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recognized net actuarial loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of the cumulative total restructuring costs by major component recognized to date as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, is as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.07692307692307%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:42%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Employee-related</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Facilities-related</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Product Rationalization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts incurred in:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended October 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Year ended October 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Six months ended April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Cumulative amounts incurred as of April 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the restructuring activities by major component for the fiscal year ended October 31, 2015 and the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.07692307692307%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:42%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Employee-related</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Facilities-related</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Product Rationalization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">(Reductions) additions during fiscal 2015</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments during the fiscal year</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Non-cash adjustments (a) (b)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(57.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(57.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Additions during the six months ended April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments during the six months ended April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Non-cash adjustments (a) (b)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at April 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(a) Non-cash adjustments for employee-related and facilities-related costs represent currency translation adjustment.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(b) Non-cash adjustments for product rationalization represent equipment disposals, inventory write-offs and accelerated depreciation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Geographic information:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Periods Ended April 30,</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales to external customers by country of domicile:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">154.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">323.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of world</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">182.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">483.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">933.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">879.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment information:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Periods Ended April 30,</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision net sales by category:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Toric lens</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Multifocal lens</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Single-use sphere lens</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">188.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non single-use sphere and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">256.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">263.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total CooperVision net sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">391.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">359.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">755.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">728.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical net sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total net sales</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">483.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">933.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">879.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income (loss):</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">136.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total operating income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense, net<br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">133.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Business Segment Information</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cooper uses operating income, as presented in our financial reports, as the primary measure of segment profitability. We do not allocate costs from corporate functions to segment operating income. Items below operating income are not considered when measuring the profitability of a segment. We use the same accounting policies to generate segment results as we do for our consolidated results.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets are those used in continuing operations except cash and cash equivalents, which we include as corporate assets. Long-lived assets are property, plant and equipment.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment information:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Periods Ended April 30,</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision net sales by category:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Toric lens</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">215.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Multifocal lens</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Single-use sphere lens</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">188.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non single-use sphere and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">256.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">263.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total CooperVision net sales</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">391.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">359.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">755.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">728.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical net sales</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total net sales</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">483.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">933.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">879.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income (loss):</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">136.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total operating income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (income) expense, net<br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">133.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">April&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperVision</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,678.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,714.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CooperSurgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">817.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,601.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,459.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Geographic information:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Periods Ended April 30,</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales to external customers by country of domicile:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">154.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">323.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of world</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">182.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">483.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">933.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">879.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">April&#160;30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-lived assets by country of domicile:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">494.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">391.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">407.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of world</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">964.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">967.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Stockholders&#8217; Equity</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Analysis of Changes in Accumulated Other Comprehensive Income (Loss):</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Currency Translation Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change in Value of&#160;</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivative Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Minimum Pension Liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(106.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross change in value during the year ended October 31, 2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(79.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(89.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassification adjustments for loss realized in net income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax effect for the period</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance at October 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(171.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(191.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross change in value during the six-month period ended April 30, 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Reclassification adjustments for loss realized in net income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax effect for the period</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Balance at April 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(233.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(253.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Share Repurchases</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2011, our Board of Directors authorized the 2012 Share Repurchase Program and subsequently amended the total repurchase authorization to </font><font style="font-family:inherit;font-size:10pt;">$500.0 million</font><font style="font-family:inherit;font-size:10pt;"> of the Company&#8217;s common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Share Repurchase Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements. We did not repurchase shares in the fiscal first half of 2016. In the fiscal first quarter of 2015, we repurchased </font><font style="font-family:inherit;font-size:10pt;">100 thousand</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company&#8217;s common stock for </font><font style="font-family:inherit;font-size:10pt;">$16.0 million</font><font style="font-family:inherit;font-size:10pt;">, at an average purchase price of </font><font style="font-family:inherit;font-size:10pt;">$159.96</font><font style="font-family:inherit;font-size:10pt;"> per share. At </font><font style="font-family:inherit;font-size:10pt;">April&#160;30, 2016</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">$118.4 million</font><font style="font-family:inherit;font-size:10pt;"> remains authorized for repurchase under the program.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Dividends</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We paid a semiannual dividend of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;"> or </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3 cents</font><font style="font-family:inherit;font-size:10pt;"> per share on February&#160;9, 2016, to stockholders of record on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January&#160;22, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Subsequent Event</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subsequent to our fiscal second quarter of 2016, on </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, CooperSurgical acquired Reprogenetics UK, a genetics laboratory specializing in service offerings of preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) used during the IVF process, for approximately </font><font style="font-family:inherit;font-size:10pt;">$12.0 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subsequent to our fiscal second quarter of 2016, on </font><font style="font-family:inherit;font-size:10pt;">May&#160;25, 2016</font><font style="font-family:inherit;font-size:10pt;">, CooperSurgical acquired the commercial assets of Recombine Inc., a clinical genetic testing company specializing in carrier screening for approximately </font><font style="font-family:inherit;font-size:10pt;">$85.0 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subsequent to our fiscal second quarter of 2016, on </font><font style="font-family:inherit;font-size:10pt;">May&#160;4, 2016</font><font style="font-family:inherit;font-size:10pt;">, CooperSurgical acquired Kivex Biotec A/S (K-Systems), a manufacturer and distributor of equipment for IVF clinics, for approximately </font><font style="font-family:inherit;font-size:10pt;">$11.5 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> EX-101.SCH 7 coo-20160430.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2103100 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - Acquisitions (Details) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Business Segment Information link:presentationLink link:calculationLink link:definitionLink 2416403 - Disclosure - Business Segment Information (Schedule of Identifiable Assets By Segment Information) (Details) link:presentationLink link:calculationLink link:definitionLink 2416405 - Disclosure - Business Segment Information (Schedule of Long-Lived Assets By Country Of Domicile) (Details) link:presentationLink link:calculationLink link:definitionLink 2416404 - Disclosure - Business Segment Information (Schedule of Net Sales To External Customers By Country Of Domicile) (Details) link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Business Segment Information (Schedule of Segment Information) (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Business Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - Consolidated Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Condensed Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1002001 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Statements of Income link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2415401 - Disclosure - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Debt (Schedule of Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Earnings Per Share (Schedule of Earnings Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Earnings Per Share (Schedule of Stock Options to Purchase Common Stock Not Included in Diluted Net Income Per Share Calculation) (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Employee Benefits link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Employee Benefits (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Employee Benefits (Schedule of Components of Net Periodic Pension Costs) (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Employee Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Fair Value Measurements (Schedule Of Financial Assets And Liabilities Measured At Fair Value On A Recurring Basis Using Level 2 Inputs) (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - General (Policies) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2408401 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Intangible Assets (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Intangible Assets (Schedule of Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Intangible Assets (Schedule of Other Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Inventories (Schedule of Inventories) (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Restructuring and Integration Costs link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Restructuring and Integration Costs (Details) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Restructuring and Integration Costs (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Restructuring and Integration Costs (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Share-Based Compensation Plans link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Share-Based Compensation Plans (Schedule Of Compensation Expense And Related Income Tax Benefit For Share-Based Awards) (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Share-Based Compensation Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Stockholders' Equity Analysis of Changes in Accumulated Other Comprehensive Income (Loss) (Tables) link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - Stockholders' Equity (Dividends) (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Stockholders' Equity (Schedule of Changes in Accumulated Other Comprehensive Income (Loss))(Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Stockholders' Equity (Share Repurchases) (Details) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 2417401 - Disclosure - Subsequent Event (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 coo-20160430_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 coo-20160430_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 coo-20160430_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Equity [Abstract] Share Repurchase Program, maximum amount authorized Stock Repurchase Program, Authorized Amount Number of common stock repurchased, shares Treasury Stock, Shares, Acquired Cost of common stock repurchased Treasury Stock, Value, Acquired, Cost Method Average purchase price per share Accelerated Share Repurchases, Final Price Paid Per Share Share Repurchase Program, remaining authorized amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Statement, Geographical [Axis] Geographical [Axis] Segment, Geographical [Domain] Geographical [Domain] United States [Member] UNITED STATES Europe [Member] Europe [Member] Rest Of World [Member] Rest Of World Other Eliminations And Corporate [Member] Rest Of World, Other Eliminations And Corporate [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total long-lived assets Property, Plant and Equipment, Net General Discussion of Pension and Other Postretirement Benefits [Abstract] Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Expected return on plan assets Defined Benefit Plan, Expected Return on Plan Assets Amortization of prior service cost Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Recognized net actuarial loss Defined Benefit Plan, Actuarial Gain (Loss) Net periodic pension cost Defined Benefit Plan, Net Periodic Benefit Cost Statement, Operating Activities Segment [Axis] Operating Activities [Axis] Segment, Operating Activities [Domain] Operating Activities [Domain] Toric Lens [Member] Toric Soft Lens [Member] Toric Soft Lens [Member]. Multifocal Lens [Member] Multifocal Soft Lens [Member] Multifocal Soft Lens [Member] Single-Use Sphere Lens [Member] Single Use Sphere Soft Lens [Member] Single-Use Sphere Soft Lens [Member] Non Single-Use Sphere And Other Eye Care Products And Other [Member] Non Single Use Sphere And Other Eye Care Products [Member] Non Single-Use Sphere And Other Eye Care Products [Member] Business Segments [Axis] Segments [Axis] Segment [Domain] Segments [Domain] CooperVision [Member] Coopervision [Member] CooperVision [Member] CooperSurgical [Member] Coopersurgical [Member] CooperSurgical [Member] Corporate Segment [Member] Corporate Segment [Member] Net sales Revenue, Net Operating income (loss) Operating Income (Loss) Interest expense Interest Expense Other (income) expense, net Nonoperating Income (Expense) Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Inventory Disclosure [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Work-in-process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Inventories, net Inventory, Net Document And Entity Information [Abstract] Document and Entity Information [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Share-based Compensation [Abstract] Share-Based Compensation Plans Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Restructuring and Related Activities [Abstract] Schedule of Restructuring Costs Restructuring and Related Costs [Table Text Block] Debt Disclosure [Abstract] Schedule of Debt Schedule of Debt [Table Text Block] Foreign Currency Translation Adjustment [Roll Forward] Cumulative Translation Adjustment Summary [Roll Forward] Foreign Currency Translation Adjustment, Beginning Balance Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Foreign Currency Translation Adjustment, Gross change in value for the period Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax Foreign Currency Translation Adjustment, Reclassification adjustments for loss realized in net income Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax Foreign Currency Translation Adjustment, Tax effect for the period Other Comprehensive Income (Loss), Foreign Currency Translation Gain (Loss) Arising During Period, Tax Foreign Currency Translation Adjustment, Ending Balance Change in Value of Derivative Instruments [Roll Forward] Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax [Roll Forward] Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax [Roll Forward] Change in Value of Derivative Instruments, Beginning Balance Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Change in Value of Derivative Instruments, Gross change in value for the period Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Change in Value of Derivative Instruments, Reclassification adjustments for loss realized in net income Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax Change in value of derivative instruments, Tax effect for the period Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax Change in Value of Derivative Instruments, Ending Balance Minimum Pension Liability [Roll Forward] Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans [Roll Forward] Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans [Roll Forward] Minimum Pension Liability, Beginning Balance Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax Minimum Pension Liability, Gross change in value for the period Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Unamortized Gain (Loss) Arising During Period, before Tax Minimum Pension Liability, Reclassification adjustments for loss realized in net income Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), Net of Tax Minimum Pension Liability, Tax effect for the period Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Tax Minimum Pension Liability, Ending Balance Accumulated Other Comprehensive Income (Loss) [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Total, Beginning balance Accumulated Other Comprehensive Income (Loss), Net of Tax Gross change in value for the period Other Comprehensive Income (Loss), before Reclassifications, before Tax Reclassification adjustments for loss realized in net income Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Tax effect for the period Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Total, Ending balance Schedule of Components of Net Periodic Pension Costs Schedule of Net Benefit Costs [Table Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] Balance, beginning Goodwill Net additions during the six-month period ended April 30, 2016 Goodwill, Period Increase (Decrease) Translation Goodwill, Foreign Currency Translation Gain (Loss) Balance, ending [Table] Schedule of Restructuring and Related Costs [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Sauflon [Member] Sauflon [Member] Sauflon [Member] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Product Rationalization [Member] Product Rationalization [Member] Product Rationalization [Member] Employee Severance [Member] Employee Severance [Member] Facility Closing [Member] Facility Closing [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of sales [Member] Cost of Sales [Member] Selling, general and administrative expense [Member] Selling, General and Administrative Expenses [Member] Research and development expense [Member] Research and Development Expense [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring and related cost, expected cost Restructuring and Related Cost, Expected Cost Restructuring and related activities, completion date Restructuring and Related Activities, Completion Date Additions during the period Restructuring Charges Integration costs Business Combination, Integration Related Costs Company's contribution to the pension plan Defined Benefit Plan, Contributions by Employer Defined benefit plan, estimated future employer contributions in current fiscal year Defined Benefit Plans, Estimated Future Employer Contributions in Current Fiscal Year Expected rate of return on plan assets for determining net periodic pension cost Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets Short-term: Short-term Debt [Abstract] Overdraft and other credit facilities Line of Credit, Current Current portion of long-term debt Long-term Debt, Current Maturities Less: unamortized debt issuance cost on term loans Short Term Unamortized Debt Issuance Expense Short Term Unamortized Debt Issuance Expense Short-term debt Short-term Debt Long-term: Long-term Debt, Unclassified [Abstract] Credit agreements Long-term Line of Credit, Noncurrent Term loans Unsecured Long-term Debt, Noncurrent Other Other Long-term Debt, Noncurrent Less: unamortized debt issuance cost on term loans Long Term Unamortized Debt Issuance Expense Long Term Unamortized Debt Issuance Expense Long-term debt Long-term Debt, Excluding Current Maturities Schedule of Segment Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Identifiable Assets by Segment Reconciliation of Assets from Segment to Consolidated [Table Text Block] Schedule of Net Sales to External Customers by Country of Domicile Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Schedule of Long-Lived Assets by Country of Domicile Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block] Components of Income Tax Expense (Benefit), Continuing Operations [Abstract] Income Taxes Income Tax Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Defined Benefit Plan, Fair Value of Plan Assets by Measurement [Axis] Fair Value, Hierarchy [Axis] Fair Value Plan Asset Measurement [Domain] Fair Value Hierarchy [Domain] Significant Observable Inputs (Level 2) [Member] Fair Value, Inputs, Level 2 [Member] Schedule of Trading Securities and Other Trading Assets, Major Types of Trading Securities and Assets [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Trading Securities and Assets [Domain] Major Types of Debt and Equity Securities [Domain] Foreign Exchange Contracts [Member] Foreign Exchange Contract [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair value financial assets Assets, Fair Value Disclosure Fair value of financial liabilities Derivative Liability Organization, Consolidation and Presentation of Financial Statements [Abstract] General Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Schedule of Goodwill Schedule of Goodwill [Table Text Block] Schedule of Other Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Statement of Financial Position [Abstract] Trade accounts receivable, allowance for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock, par value Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares, issued Common Stock, Shares, Issued Treasury stock, shares Treasury Stock, Shares Intangible Assets Intangible Assets Disclosure [Text Block] Debt Debt Disclosure [Text Block] Restructuring and Integration Costs Business Acquisition, Integration, Restructuring and Other Related Costs [Text Block] Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Customer Relationships [Member] Customer Relationships [Member] Trade Names [Member] Trade Names [Member] Technology-Based Intangible Assets [Member] Technology-Based Intangible Assets [Member] Genesis Genetics [Member] Genesis Genetics [Member] Genesis Genetics [Member] The Pipette Company [Member] The Pipette Company [Member] The Pipette Company [Member] Research Instruments [Member] Research Instruments [Member] Research Instruments [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Business acquisition, effective date of acquisition Business Acquisition, Effective Date of Acquisition Total purchase consideration Business Combination, Consideration Transferred Payments to Acquire Businesses, Net of Cash Acquired Payments to Acquire Businesses, Net of Cash Acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Goodwill, Acquired During Period Goodwill, Acquired During Period Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Schedule of Inventories Schedule of Inventory, Current [Table Text Block] ASSETS Assets [Abstract] Assets, Current [Abstract] Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Trade accounts receivable, net of allowance for doubtful accounts of $7,765 at April 30, 2016 and $5,956 at October 31, 2015 Accounts Receivable, Net, Current Inventories Deferred tax assets Deferred Tax Assets, Net of Valuation Allowance, Current Prepaid expense and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property, plant and equipment, at cost Property, Plant and Equipment, Gross Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, plant and equipment, net Goodwill Other intangibles, net Intangible Assets, Net (Excluding Goodwill) Deferred tax assets Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Other assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Short-term debt Accounts payable Accounts Payable, Current Employee compensation and benefits Employee-related Liabilities, Current Other current liabilities Other Liabilities, Current Total current liabilities Liabilities, Current Long-term debt Deferred tax liabilities Deferred Tax Liabilities, Net, Noncurrent Accrued pension liability and other Accrued pension liability and other This represents the noncurrent liability recognized in the balance sheet that is associated with the defined benefit pension plans. (The current liability will be separate, but it will normally be small, if there is even any at all). It also represents aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet due to materiality considerations. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). Total liabilities Liabilities Commitments and contingencies Commitments and Contingencies Stockholders’ equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Preferred stock, 10 cents par value, shares authorized: 1,000; zero shares issued or outstanding Preferred Stock, Value, Issued Common stock, 10 cents par value, shares authorized: 120,000; issued 51,738 at April 30, 2016 and 51,558 at October 31, 2015 Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Retained earnings Retained Earnings (Accumulated Deficit) Treasury stock at cost: 3,290 shares at April 30, 2016 and October 31, 2015 Treasury Stock, Value Total Cooper stockholders' equity Stockholders' Equity Attributable to Parent Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Stockholders’ equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and stockholders' equity Liabilities and Equity Total net sales to external customers Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Depreciation and amortization Depreciation, Depletion and Amortization Decrease in operating capital Increase (Decrease) in Operating Capital Other non-cash items Other Noncash Income (Expense) Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Acquisitions of businesses, net of cash acquired, and other Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds from long-term debt Proceeds from Issuance of Long-term Debt Repayments of long-term debt Repayments of Long-term Debt Net (repayments of) proceeds from short-term debt Proceeds from (Repayments of) Short-term Debt Repurchase of common stock Payments for Repurchase of Common Stock Net payments related to share-based compensation awards Proceeds from (Repurchase of) Equity Excess tax benefit from share-based compensation awards Excess Tax Benefit from Share-based Compensation, Financing Activities Purchase of shares from noncontrolling interests Payments for Repurchase of Redeemable Noncontrolling Interest Dividends on common stock Payments of Ordinary Dividends, Common Stock Debt acquisition costs Payments of Debt Issuance Costs Distributions to noncontrolling interests Payments of Ordinary Dividends, Noncontrolling Interest Payment of contingent consideration Proceeds from (Repayments of) Other Debt Proceeds from construction allowance Proceeds from (Payments for) Other Financing Activities Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Net increase (decrease) in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period Business Segment Information Segment Reporting Disclosure [Text Block] Acquisitions Business Combination Disclosure [Text Block] Effective tax rate (ETR) Effective Income Tax Rate Reconciliation, Percent Unrecognized tax benefits that would impact ETR Unrecognized Tax Benefits that Would Impact Effective Tax Rate Interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Unrecognized tax benefits related to tax positions Decrease in Unrecognized Tax Benefits is Reasonably Possible Statement of Comprehensive Income [Abstract] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Change in value of derivative instruments, net of tax provision of $30 in 2015 Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax Change in minimum pension liability, net of tax Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Less: comprehensive income attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive loss attributable to Cooper stockholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Change in value of derivative instruments, tax Earnings Per Share [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Stock Options [Member] Employee Stock Option [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Numbers of stock option shares excluded Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Range of exercise prices, lower limit Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Range of exercise prices, upper limit Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Reprogenetics UK [Member] Reprogenetics UK [Member] Reprogenetics UK [Member] Recombine [Member] Recombine [Member] Recombine [Member] K-Systems [Member] K-Systems [Member] K-Systems [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Capitalized in inventory [Member] Capitalized In Inventory [Member] Capitalized In Inventory [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based compensation expense Share-based Compensation Total share-based compensation expense Allocated Share-based Compensation Expense Related income tax benefit Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Employee Benefits Pension and Other Postretirement Benefits Disclosure [Text Block] Accounting Pronouncements Issued Not Yet Adopted and Accounting Pronouncements Recently Adopted New Accounting Pronouncements, Policy [Policy Text Block] Inventories Inventory Disclosure [Text Block] Line of Credit Facility [Table] Line of Credit Facility [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] 2016 Credit Agreement [Member] 2016 Credit Agreement [Member] 2016 Credit Agreement [Member] Line of Credit [Member] Line of Credit [Member] Term Loan $700M [Member] Term Loan $700M [Member] Term Loan $700M [Member] Term Loan $300M [Member] Term Loan $300M [Member] Term Loan $300M [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility [Member] Revolving Credit Facility [Member] Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Federal Funds Rate [Member] Federal Funds Rate [Member] Federal Funds Rate [Member] Eurodollar [Member] Eurodollar [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Line of credit facility, initiation date Line of Credit Facility, Initiation Date Aggregate commitment amount of credit facility Line of Credit Facility, Maximum Borrowing Capacity Debt instrument, maturity date Debt Instrument, Maturity Date Line of credit facility, potential additional borrowing capacity Line of Credit Facility, Additional Borrowing Capacity Line of Credit Facility, Additional Borrowing Capacity Extinguishment of debt, amount Extinguishment of Debt, Amount Debt instrument, issuance date Debt Instrument, Issuance Date Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Line of credit facility interest rate margin on base rate loans percentage Line Of Credit Facility Interest Rate Margin On Base Rate Loans Percentage Line Of Credit Facility Interest Rate Margin On Base Rate Loans Percentage Line of credit facility interest rate margin on foreign currency loans percentage Line Of Credit Facility Interest Rate Margin On Foreign Currency Loans Percentage Line Of Credit Facility Interest Rate Margin On Foreign Currency Loans Percentage Commitment fee percentage Line of Credit Facility, Commitment Fee Percentage Required minimum Interest coverage ratio Required Minimum Interest Coverage Ratio Required minimum interest coverage ratio. Required maximum total leverage ratio Required Maximum Total Leverage Ratio Required maximum total leverage ratio. Interest coverage ratio Interest Coverage Ratio Interest Coverage Ratio Total leverage ratio Total Leverage Ratio Total Leverage Ratio Amount available under the credit agreement Line of Credit Facility, Remaining Borrowing Capacity Debt term Debt Instrument, Term Repayments of Debt Repayments of Debt Amortization of term loan principal Amortization Of Term Loan Principal Term loan subject to amortization of principal of 5% per annum payable quarterly beginning Oct 31, 2016, with balance payable at maturity Debt instrument, date of first required payment Debt Instrument, Date of First Required Payment Total Identifiable assets Goodwill, Impairment Loss Goodwill, Impairment Loss Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] 2016 Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Five Schedule of Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Stock Options to Purchase Common Stock Not Included in Diluted Net Income Per Share Calculation Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Commitments and Contingencies Disclosure [Abstract] Number of putative class action complaints filed (over) Loss Contingency, New Claims Filed, Number Net income attributable to Cooper stockholders Net Income (Loss) Attributable to Parent Basic: Earnings Per Share, Basic [Abstract] Weighted average common shares Weighted Average Number of Shares Outstanding, Basic Basic earnings per common share attributable to Cooper stockholders Earnings Per Share, Basic Diluted: Earnings Per Share, Diluted [Abstract] Effect of potential dilutive common shares Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Diluted weighted average common shares Weighted Average Number of Shares Outstanding, Diluted Diluted earnings per common share attributable to Cooper stockholders Earnings Per Share, Diluted Earnings Per Share Earnings Per Share [Text Block] Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis Using Level 2 Inputs Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Cumulative amounts incurred as of April 30, 2016 Restructuring and Related Cost, Cost Incurred to Date Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Balance, beginning Restructuring Reserve Additions (reductions) during the period Payments during the period Payments for Restructuring Non-cash adjustments Restructuring Reserve, Amounts Settled Without Cash and Translation Adjustments Restructuring Reserve, Amounts Settled Without Cash and Translation Adjustments Balance, ending Dividends on common stock Cash dividend, per share Common Stock, Dividends, Per Share, Cash Paid Dividends payable, date of record Dividends Payable, Date of Record Contingencies Contingencies Disclosure [Text Block] Schedule of Compensation Expense and Related Income Tax Benefit for Share-Based Awards Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Subsequent Event Subsequent Events [Text Block] Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Finite-Lived Intangible Assets [Table] Trademarks [Member] Trademarks [Member] License and distribution right and other [Member] License And Distribution Rights And Other [Member] License and Distribution Rights and Other [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Accumulated Amortization & Translation Finite-Lived Intangible Assets, Accumulated Amortization Other intangible assets, net Income Statement [Abstract] Cost of sales Cost of Goods and Services Sold Gross profit Gross Profit Selling, general and administrative expense Selling, General and Administrative Expense Research and development expense Research and Development Expense Amortization of intangibles Amortization of Intangible Assets Operating income Provision for income taxes Income Tax Expense (Benefit) Net income Less: net income attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Net income attributable to Cooper stockholders Earnings per share attributable to Cooper stockholders - basic Earnings per share attributable to Cooper stockholders - diluted Number of shares used to compute earnings per share: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic Diluted EX-101.PRE 11 coo-20160430_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.4.0.3
Document and Entity Information
6 Months Ended
Apr. 30, 2016
shares
Document And Entity Information [Abstract]  
Document Type 10-Q
Amendment Flag false
Document Period End Date Apr. 30, 2016
Document Fiscal Year Focus 2016
Document Fiscal Period Focus Q2
Entity Registrant Name COOPER COMPANIES INC
Entity Central Index Key 0000711404
Current Fiscal Year End Date --10-31
Entity Filer Category Large Accelerated Filer
Entity Common Stock, Shares Outstanding 48,448,341
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Apr. 30, 2016
Apr. 30, 2015
Income Statement [Abstract]        
Net sales $ 483,793 $ 434,676 $ 933,433 $ 879,847
Cost of sales 185,295 166,960 372,971 335,780
Gross profit 298,498 267,716 560,462 544,067
Selling, general and administrative expense 177,659 167,583 351,263 341,118
Research and development expense 16,696 16,819 31,458 32,932
Amortization of intangibles 14,312 12,316 30,515 25,911
Operating income 89,831 70,998 147,226 144,106
Interest expense 7,611 4,692 12,886 8,633
Other (income) expense, net (418) (686) 972 1,016
Income before income taxes 82,638 66,992 133,368 134,457
Provision for income taxes 8,183 5,855 7,172 11,571
Net income 74,455 61,137 126,196 122,886
Less: net income attributable to noncontrolling interests 330 424 715 994
Net income attributable to Cooper stockholders $ 74,125 $ 60,713 $ 125,481 $ 121,892
Earnings per share attributable to Cooper stockholders - basic $ 1.53 $ 1.25 $ 2.59 $ 2.52
Earnings per share attributable to Cooper stockholders - diluted $ 1.52 $ 1.23 $ 2.57 $ 2.48
Number of shares used to compute earnings per share:        
Basic 48,428 48,463 48,365 48,330
Diluted 48,853 49,163 48,838 49,139
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Apr. 30, 2016
Apr. 30, 2015
Statement of Comprehensive Income [Abstract]        
Net income $ 74,455 $ 61,137 $ 126,196 $ 122,886
Other comprehensive income (loss):        
Foreign currency translation adjustment 52,273 34,367 (61,525) (79,251)
Change in value of derivative instruments, net of tax provision of $30 in 2015 0 0 0 47
Change in minimum pension liability, net of tax 7 7 14 14
Other comprehensive income (loss) 52,280 34,374 (61,511) (79,190)
Comprehensive income 126,735 95,511 64,685 43,696
Less: comprehensive income attributable to noncontrolling interests 751 1,105 745 584
Comprehensive loss attributable to Cooper stockholders $ 125,984 $ 94,406 $ 63,940 $ 43,112
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Apr. 30, 2016
Apr. 30, 2015
Oct. 31, 2015
Statement of Comprehensive Income [Abstract]          
Change in value of derivative instruments, tax $ 0 $ 0 $ 0 $ 30 $ 0
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2016
Oct. 31, 2015
Assets, Current [Abstract]    
Cash and cash equivalents $ 44,464 $ 16,426
Trade accounts receivable, net of allowance for doubtful accounts of $7,765 at April 30, 2016 and $5,956 at October 31, 2015 298,825 282,918
Inventories 433,596 419,692
Deferred tax assets 41,256 41,731
Prepaid expense and other current assets 96,974 80,661
Total current assets 915,115 841,428
Property, plant and equipment, at cost 1,696,135 1,650,730
Less: accumulated depreciation and amortization 731,776 683,633
Property, plant and equipment, net 964,359 967,097
Goodwill 2,233,251 2,197,077
Other intangibles, net 437,005 411,090
Deferred tax assets 5,969 4,510
Other assets 45,554 38,662
Total assets 4,601,253 4,459,864
Current liabilities:    
Short-term debt 30,191 243,803
Accounts payable 105,759 116,912
Employee compensation and benefits 59,038 67,373
Other current liabilities 127,229 140,694
Total current liabilities 322,217 568,782
Long-term debt 1,411,182 1,105,408
Deferred tax liabilities 37,568 31,016
Accrued pension liability and other 85,505 80,754
Total liabilities $ 1,856,472 $ 1,785,960
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, 10 cents par value, shares authorized: 1,000; zero shares issued or outstanding $ 0 $ 0
Common stock, 10 cents par value, shares authorized: 120,000; issued 51,738 at April 30, 2016 and 51,558 at October 31, 2015 5,174 5,156
Additional paid-in capital 1,442,735 1,434,705
Accumulated other comprehensive loss (253,153) (191,643)
Retained earnings 1,903,469 1,779,440
Treasury stock at cost: 3,290 shares at April 30, 2016 and October 31, 2015 (360,149) (360,149)
Total Cooper stockholders' equity 2,738,076 2,667,509
Noncontrolling interests 6,705 6,395
Stockholders’ equity 2,744,781 2,673,904
Total liabilities and stockholders' equity $ 4,601,253 $ 4,459,864
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Condensed Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Apr. 30, 2016
Oct. 31, 2015
Statement of Financial Position [Abstract]    
Trade accounts receivable, allowance for doubtful accounts $ 7,765 $ 5,956
Preferred stock, par value $ 0.10 $ 0.10
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.10 $ 0.10
Common stock, shares authorized 120,000,000 120,000,000
Common stock, shares, issued 51,738,000 51,558,000
Treasury stock, shares 3,290,000 3,290,000
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Cash flows from operating activities:    
Net income $ 126,196 $ 122,886
Depreciation and amortization 101,434 87,389
Decrease in operating capital (61,667) (65,358)
Other non-cash items 21,424 45,564
Net cash provided by operating activities 187,387 190,481
Cash flows from investing activities:    
Purchases of property, plant and equipment (86,332) (118,365)
Acquisitions of businesses, net of cash acquired, and other (145,422) (752)
Net cash used in investing activities (231,754) (119,117)
Cash flows from financing activities:    
Proceeds from long-term debt 1,367,300 483,400
Repayments of long-term debt (1,250,394) (658,229)
Net (repayments of) proceeds from short-term debt (23,552) 135,514
Repurchase of common stock 0 (15,996)
Net payments related to share-based compensation awards (11,525) (6,662)
Excess tax benefit from share-based compensation awards 5,005 0
Purchase of shares from noncontrolling interests 0 (8,557)
Dividends on common stock (1,452) (1,448)
Debt acquisition costs (12,541) 0
Distributions to noncontrolling interests (383) (816)
Payment of contingent consideration 0 (2,406)
Proceeds from construction allowance 0 710
Net cash provided by (used in) financing activities 72,458 (74,490)
Effect of exchange rate changes on cash and cash equivalents (53) (4,185)
Net increase (decrease) in cash and cash equivalents 28,038 (7,311)
Cash and cash equivalents - beginning of period 16,426 25,222
Cash and cash equivalents - end of period $ 44,464 $ 17,911
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.4.0.3
General
6 Months Ended
Apr. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
General
General
The Cooper Companies, Inc. (Cooper, we or the Company) is a global medical device company publicly traded on the NYSE Euronext (NYSE: COO). Cooper is dedicated to being A Quality of Life CompanyTM with a focus on delivering shareholder value. Cooper operates through our business units, CooperVision and CooperSurgical.
CooperVision develops, manufactures and markets a broad range of soft contact lenses for the worldwide vision correction market.
CooperSurgical develops, manufactures and markets medical devices and procedure solutions to improve health care delivery to women.
The unaudited consolidated condensed financial statements presented in this report contain all adjustments necessary to present fairly Cooper’s consolidated condensed financial position at April 30, 2016 and October 31, 2015, the consolidated results of its operations for the three and six months ended April 30, 2016 and 2015 and its consolidated condensed cash flows for the six months ended April 30, 2016 and 2015. Most of these adjustments are normal and recurring. However, certain adjustments associated with acquisitions are of a nonrecurring nature. Readers should not assume that the results reported here either indicate or guarantee future performance.
During interim periods, we follow the accounting policies described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2015. Please refer to this when reviewing this Quarterly Report on Form 10-Q.
Management estimates and judgments are an integral part of financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). We believe that the critical accounting policies listed below address the more significant estimates required of Management when preparing our consolidated financial statements in accordance with GAAP. We consider an accounting estimate critical if changes in the estimate may have a material impact on our financial condition or results of operations. We believe that the accounting estimates employed are appropriate and resulting balances are reasonable; however, actual results could differ from the original estimates, requiring adjustment to these balances in future periods. The accounting policies that reflect our more significant estimates, judgments and assumptions and which we believe are the most critical to aid in fully understanding and evaluating our reported financial results are:
Revenue recognition
Net realizable value of inventory
Valuation of goodwill
Business combinations
Income taxes
Share-based compensation
During the fiscal first half of 2016, there were no significant changes in our estimates and critical accounting policies. Please refer to Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended October 31, 2015, for a more complete discussion of our estimates and critical accounting policies.
Accounting Pronouncements Issued Not Yet Adopted

In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which is intended to improve the accounting for share-based payment transactions as part of the FASB’s simplification initiative. The ASU changes the following aspects of the accounting for share-based payment award transactions, including: accounting for income taxes; classification of excess tax benefits on the statement of cash flows; forfeitures; minimum statutory tax withholding requirements; and classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. We are currently evaluating the impact of ASU 2016-09, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2017.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-01 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. We are currently evaluating the impact of ASU 2016-02, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2019.

In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes, which requires entities to present all deferred tax assets and liabilities as noncurrent. The amendments in the ASU are effective for the Company in our fiscal year and interim periods beginning on November 1, 2017. The Company does not expect the new guidance to have a material impact on the Company’s consolidated financial statements.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 requires revenue recognition to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 sets forth a new revenue recognition model that requires identifying the contract, identifying the performance obligations, determining the transaction price, allocating the transaction price to performance obligations and recognizing the revenue upon satisfaction of performance obligations. The amendments in the ASU can be applied either retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the update recognized at the date of the initial application along with additional disclosures. We are currently evaluating the impact of ASU 2014-09, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2018.
Accounting Pronouncements Recently Adopted

In April 2015, the FASB issued Accounting Standards Update (ASU) 2015-03, Interest - Imputation of Interest (Subtopic 835-30) Simplifying the Presentation of Debt Issuance Costs. The amendments in this update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for interim and annual reporting periods beginning after December 15, 2016. Early adoption is permitted. We elected to early adopt this guidance as a change in accounting principle on a retrospective basis in the fiscal first quarter ended January 31, 2016. As of January 31, 2016 and October 31, 2015, we have presented debt issuance costs related to our term loans, previously reported in other assets, as direct deductions from the carrying amount of the debt liability. We also presented the debt issuance costs related to our revolving credit facility as a deferred asset within other assets, as is permitted by ASU 2015-15, Imputation of Interest, which was issued in August 2015. Such adoption did not have a material impact to our consolidated financial position.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.4.0.3
Acquisitions
6 Months Ended
Apr. 30, 2016
Business Combinations [Abstract]  
Acquisitions
Acquisitions

On March 31, 2016 we completed the acquisition of Genesis Genetics Inc., a genetics laboratory specializing in preimplantation genetic screening and preimplantation genetic diagnosis used during the IVF process, headquartered in Plymouth, Michigan. The fair value of the consideration transferred for the acquisition was approximately $60.0 million in cash, $59.3 million net of cash acquired. Our preliminary allocation of the fair value of the purchase price includes $28.6 million in identifiable intangible assets, consisting of $25.2 million for customer relationships and $3.4 million for trade names; $27.6 million in goodwill; and $3.8 million in identifiable net assets.

On February 8, 2016, we completed the acquisition of The Pipette Company, a manufacturer and distributor of micro pipettes for the Assisted Reproductive Technology market headquartered in Adelaide, Australia. The fair value of the consideration transferred for the acquisition was approximately $20.2 million in cash, $19.6 million net of cash acquired. Our preliminary allocation of the fair value of the purchase price includes $5.6 million in identifiable intangible assets, consisting of $5.2 million for customer relationships and $0.4 million for trade names; $14.7 million in goodwill; and $0.2 million in identifiable net liabilities.
On December 17, 2015, we completed the acquisition of Research Instruments Limited, a manufacturer and supplier of in vitro fertilization (IVF) medical devices and systems headquartered in Cornwall, United Kingdom. The fair value of the consideration transferred for the acquisition was approximately $53.6 million in cash, $50.0 million net of cash acquired. Our preliminary allocation of the fair value of the purchase price includes $10.3 million in identifiable intangible assets, consisting of $6.2 million for developed technology, $2.2 million of trade names and $1.9 million for customer relationships; $36.1 million in goodwill; and $7.3 million in identifiable net assets.

We believe these acquisitions strengthen CooperSurgical's fertility business through the addition of new or complementary products and services within IVF and our genetic testing platform.

The pro forma results of operations of these acquisitions have not been presented because the effects of the business combinations described above, individually and in the aggregate, were not material to our consolidated results of operations.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.4.0.3
Restructuring and Integration Costs
6 Months Ended
Apr. 30, 2016
Restructuring and Related Activities [Abstract]  
Restructuring and Integration Costs
Restructuring and Integration Costs

2014 Sauflon Integration Plan
During the fiscal fourth quarter of 2014, in connection with the Sauflon acquisition, our CooperVision business unit initiated restructuring and integration activities to optimize operational synergies of the combined companies. These activities include workforce reductions, consolidation of duplicative facilities and product rationalization. We estimate that the total restructuring costs under this plan will be $125.0 million. These costs include approximately $95.0 million associated with assets, including product rationalization and related equipment disposals and accelerated depreciation, about $27.0 million associated with employee termination costs, and about $3.0 million associated with facility lease termination costs. We are substantially complete with activities related to operating expenses, and we expect to incur costs related to the manufacturing activities through the end of fiscal 2016.    

In the three and six month periods ended April 30, 2016, we recorded in cost of sales $4.2 million and $14.7 million of expense, respectively, arising from production-related asset disposals and accelerated depreciation on equipment, primarily related to our hydrogel lenses, based on our review of products, materials and manufacturing processes of Sauflon. We recorded in cost of sales, employee termination costs of $0.7 million and $0.5 million in the three and six month periods ended April 30, 2016, respectively. We recorded $0.1 million of employee termination costs and $0.3 million for lease termination costs in selling, general and administrative expense in the six months ended April 30, 2016. We also recorded in research and development expense $0.1 million of employee termination costs in the six months ended April 30, 2016. In addition, CooperVision incurred $2.1 million and $10.0 million of integration costs included in operating expenses in the three and six month periods ended April 30, 2016, respectively.

In the three and six month periods ended April 30, 2015, we recorded in cost of sales $5.2 million and $13.9 million of expense, respectively, arising from production-related asset disposals and accelerated depreciation on equipment, primarily related to our hydrogel lenses, based on our review of products, materials and manufacturing processes of Sauflon. In the three month period ended April 30, 2015, we reduced the accrued employee termination costs in selling, general and administrative expense by $4.5 million based on estimates of the expected costs and the results of voluntary terminations. We recorded in research and development expense $0.2 million and $0.3 million of employee termination costs in the three and six months ended April 30, 2015, respectively. In addition, CooperVision incurred $8.0 million and $14.1 million of integration costs in the three and six months ended April 30, 2015, respectively, recorded in selling, general and administrative expense.

A summary of the cumulative total restructuring costs by major component recognized to date as of April 30, 2016, is as follows:
(In millions)
Employee-related
 
Facilities-related
 
Product Rationalization
 
Total
Amounts incurred in:
 
 
 
 
 
 
 
Year ended October 31, 2014
$
20.3

 
$
0.5

 
$
15.3

 
$
36.1

Year ended October 31, 2015
(2.5
)
 
0.4

 
57.7

 
55.6

Six months ended April 30, 2016
0.7

 
0.3

 
14.7

 
15.7

Cumulative amounts incurred as of April 30, 2016
$
18.5

 
$
1.2

 
$
87.7

 
$
107.4



The following table summarizes the restructuring activities by major component for the fiscal year ended October 31, 2015 and the six months ended April 30, 2016:
(In millions)
Employee-related
 
Facilities-related
 
Product Rationalization
 
Total
 
 
 
 
 
 
 
 
Balance at October 31, 2014
$
19.9

 
$
0.5

 
$

 
$
20.4

(Reductions) additions during fiscal 2015
(2.5
)
 
0.4

 
57.7

 
55.6

Payments during the fiscal year
(9.0
)
 
(0.4
)
 

 
(9.4
)
Non-cash adjustments (a) (b)
0.2

 
(0.2
)
 
(57.7
)
 
(57.7
)
Balance at October 31, 2015
8.6

 
0.3

 

 
8.9

Additions during the six months ended April 30, 2016
0.7

 
0.3

 
14.7

 
15.7

Payments during the six months ended April 30, 2016
(3.7
)
 
(0.1
)
 

 
(3.8
)
Non-cash adjustments (a) (b)
(0.1
)
 
(0.1
)
 
(14.7
)
 
(14.9
)
Balance at April 30, 2016
$
5.5

 
$
0.4

 
$

 
$
5.9

(a) Non-cash adjustments for employee-related and facilities-related costs represent currency translation adjustment.
(b) Non-cash adjustments for product rationalization represent equipment disposals, inventory write-offs and accelerated depreciation.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.4.0.3
Inventories
6 Months Ended
Apr. 30, 2016
Inventory Disclosure [Abstract]  
Inventories
Inventories
(In millions)
April 30, 2016
 
October 31, 2015
Raw materials
$
85.8

 
$
80.9

Work-in-process
15.6

 
14.5

Finished goods
332.2

 
324.3

 
$
433.6

 
$
419.7


Inventories are stated at the lower of cost or market. Cost is computed using standard cost that approximates actual cost, on a first-in, first-out basis.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.4.0.3
Intangible Assets
6 Months Ended
Apr. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets
Intangible Assets

Goodwill
(In millions)
CooperVision
 
CooperSurgical
 
Total
Balance at October 31, 2014
$
1,861.5

 
$
359.4

 
$
2,220.9

Net (reductions) additions during the year ended October 31, 2015
(1.2
)
 
17.4

 
16.2

Translation
(32.7
)
 
(7.3
)
 
(40.0
)
Balance at October 31, 2015
1,827.6

 
369.5

 
2,197.1

Net additions during the six-month period ended April 30, 2016
0.1

 
79.2

 
79.3

Translation
(45.7
)
 
2.6

 
(43.1
)
Balance at April 30, 2016
$
1,782.0

 
$
451.3

 
$
2,233.3



We performed our annual impairment assessment in our fiscal third quarter of 2015, and our analysis indicated that we had no impairment of goodwill. As described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2015, we will continue to monitor conditions and changes which could indicate that our recorded goodwill may be impaired.

Other Intangible Assets
 
As of April 30, 2016
 
As of October 31, 2015
(In millions)
Gross Carrying
Amount
 
Accumulated
Amortization
& Translation
 
Gross Carrying
Amount
 
Accumulated
Amortization
& Translation
Trademarks
$
29.9

 
$
5.4

 
$
23.7

 
$
4.4

Technology
332.0

 
127.0

 
318.9

 
114.7

Customer relationships
279.8

 
113.3

 
247.0

 
104.5

License and distribution rights and other
73.3

 
32.3

 
71.7

 
26.6

 
715.0

 
$
278.0

 
661.3

 
$
250.2

Less: accumulated amortization and translation
278.0

 
 
 
250.2

 
 
Other intangible assets, net
$
437.0

 
 
 
$
411.1

 
 

We estimate that amortization expense for our existing other intangible assets at April 30, 2016, will be $59.6 million in fiscal 2016, $56.1 million in fiscal 2017, $54.1 million in fiscal 2018, $51.5 million in fiscal 2019 and $40.9 million in fiscal 2020.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.4.0.3
Debt
6 Months Ended
Apr. 30, 2016
Debt Disclosure [Abstract]  
Debt
Debt
(In millions)
April 30, 2016
 
October 31, 2015
Short-term:
 
 
 
Overdraft and other credit facilities
$
31.7

 
$
240.4

Current portion of long-term debt

 
3.8

Less: unamortized debt issuance cost on term loans
(1.5
)
 
(0.4
)
 
$
30.2

 
$
243.8

Long-term:
 
 
 
Credit agreements
$

 
$
109.0

Term loans
1,415.0

 
996.3

Other
0.3

 
0.5

Less: unamortized debt issuance cost on term loans
(4.1
)
 
(0.4
)
 
$
1,411.2

 
$
1,105.4



Revolving Credit and Term Loan Agreement on March 1, 2016 (2016 Credit Agreement)
On March 1, 2016, we entered into a new Revolving Credit and Term Loan Agreement (2016 Credit Agreement), among the Company, CooperVision International Holding Company, LP, the lenders from time to time party thereto and KeyBank National Association, as administrative agent. The 2016 Credit Agreement provides for a multicurrency revolving credit facility in an aggregate principal amount of $1.0 billion and a term loan facility in an aggregate principal amount of $830.0 million, each of which, unless terminated earlier, mature on March 1, 2021. In addition, we have the ability from time to time to request an increase to the size of the revolving credit facility or establish one or more new term loans under the term loan facility in an aggregate amount up to $750.0 million, subject to the discretionary participation of the lenders.
The 2016 Credit Agreement replaced our previous Credit Agreement that was entered into on January 12, 2011, and we terminated the Credit Agreement on March 1, 2016. In connection with the termination, all borrowings outstanding under the Credit Agreement were repaid and all letters of credit outstanding were transferred to the 2016 Credit Agreement. We did not incur any termination or prepayment penalties with respect to replacing the Credit Agreement. We used funds from the new term loan to repay the $200.0 million outstanding principal amount of the two uncommitted revolving lines of credit, entered into on March 24, 2015, as well as to partially repay outstanding amounts under the term loans entered into on August 4, 2014, and September 12, 2013, and for general corporate purposes.

Amounts outstanding under the 2016 Credit Agreement will bear interest, at our option, at either the base rate, which is a rate per annum equal to the greatest of (a) KeyBank’s prime rate, (b) 0.5% in excess of the federal funds effective rate and (c) 1% in excess of the adjusted LIBO rate for a one month interest period on such day, or the adjusted LIBO rate or adjusted foreign currency rate, plus, in each case, an applicable rate of, initially, 0.5% in respect of base rate loans and 1.5% in respect of adjusted LIBO rate or adjusted foreign currency rate loans. Following a specified period after the closing date, the applicable rates will be determined quarterly by reference to a grid based upon our ratio of consolidated net indebtedness to consolidated pro forma EBITDA, as defined in the 2016 Credit Agreement. During the term of the revolving credit facility, we may borrow, repay and re-borrow amounts available under the revolving credit facility, subject to voluntary reduction of the revolving commitment.

We pay an annual commitment fee that ranges from 0.125% to 0.25% of the unused portion of the revolving credit facility depending on certain financial ratios. In addition to the annual commitment fee described above, we are also required to pay certain letter of credit and related fronting fees and other administrative fees pursuant to the terms of the 2016 Credit Agreement.

The 2016 Credit Agreement is not secured by any of the Company's, or any of its subsidiaries’ (including CooperVision International Holding Company’s), assets. All obligations under this facility will be guaranteed by each of the Company’s existing and future direct and indirect domestic material subsidiaries, as defined in the 2016 Credit Agreement. CooperVision International Holding Company is responsible only for its own obligations, if any, and does not guarantee any of the Company’s obligations under the 2016 Credit Agreement.

The facility is not subject to amortization and is not subject to mandatory prepayments prior to maturity. We may prepay loan balances from time to time, in whole or in part, without premium or penalty (other than any related breakage costs).

The 2016 Credit Agreement contains customary restrictive covenants, as well as financial covenants that require us to maintain a certain total leverage ratio and interest coverage ratio, each as defined in the 2016 Credit Agreement. The 2016 Credit Agreement also contains customary events of default, the occurrence of which would permit KeyBank as the administrative agent to declare the principal, accrued interest and other obligations under the agreement to be immediately due and payable.
Pursuant to the terms of the 2016 Credit Agreement and the term loans discussed below, we are also required to maintain specified financial ratios:
The ratio of Consolidated Proforma EBITDA to Consolidated Interest Expense (as defined, Interest Coverage Ratio) be at least 3.00 to 1.00 at all times.
The ratio of Consolidated Funded Indebtedness to Consolidated Proforma EBITDA (as defined, Total Leverage Ratio) be no higher than 3.75 to 1.00.
At April 30, 2016, we were in compliance with the Interest Coverage Ratio at 26.42 to 1.00 and the Total Leverage Ratio at 2.37 to 1.00.
At April 30, 2016, we had $830.0 million outstanding under the term loan and about $1.0 billion available under the revolving credit agreement.
Uncommitted Revolving Lines of Credit on March 24, 2015
On March 24, 2015, we entered into two uncommitted line of credit agreements with TD Bank, N.A. and Santander Bank, N.A. These lines of credit had a termination date of March 24, 2016, and each provided revolving loan amounts to Cooper of up to $100.0 million, at the lender's option, with maturity dates of up to ninety days from the loan origination date. Amounts outstanding under these agreements will bear interest at a rate equal to LIBOR for the period plus, 0.90%, payable in arrears on the last day of the period, as defined in the agreements.
In the fiscal second quarter of 2016, in connection with the refinancing discussed above, we repaid the full outstanding principal amount of the two uncommitted revolving lines of credit. At April 30, 2016, there were no amounts outstanding under these agreements.

$700.0 million Term Loan on August 4, 2014

On August 4, 2014, we entered into a three-year, $700.0 million, senior unsecured term loan agreement by and among the Company, the lenders party thereto and KeyBank National Association as administrative agent. This syndicated credit facility will mature and the balance is payable on August 4, 2017. There is no amortization of principal and we may prepay loan balances from time to time, in whole or in part, without premium or penalty. In August 2014, we utilized this facility to fund the acquisition of Sauflon, as well as to provide working capital and for general corporate purposes. In fiscal second quarter of 2016, we repaid $400.0 million of the outstanding balance using funds from the 2016 Credit Agreement.

Amounts outstanding under this term loan agreement will bear interest, at the Company’s option, at either the base rate, which is a rate per annum equal to the greatest of (a) KeyBank’s prime rate, (b) 0.5% in excess of the federal funds effective rate and (c) 1% in excess of the adjusted Eurodollar rate (currently referred to as LIBOR) for a one-month interest period on such day, or the adjusted Eurodollar rate, plus, in each case, an applicable margin. The applicable margins will be determined quarterly by reference to a grid based upon the Company’s Total Leverage Ratio, as defined in the term loan agreement and consistent with the 2016 Credit Agreement discussed above.

This term loan agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the agreement, and consistent with the 2016 Credit Agreement as discussed above. This term loan agreement also contains customary events of default, the occurrence of which would permit the Administrative Agent to declare the principal, accrued interest and other obligations of the Company under the agreement to be immediately due and payable.

On March 1, 2016, we entered into an Amendment and Restatement Agreement (Amended and Restated 2014 Term Loan) to amend and restate in its entirety the Term Loan Agreement, dated as of August 4, 2014, as amended by Amendment No. 1 dated as of August 21, 2015 (2014 Term Loan Agreement), by and among the Company, the lenders party thereto, and KeyBank National Association, as administrative agent. The Amended and Restated 2014 Term Loan modifies certain provisions of the 2014 Term Loan Agreement to, among other things, conform certain restrictive covenants and events of default to the restrictive covenants and events of default contained in our new 2016 Credit Agreement.

At April 30, 2016, we had $300.0 million outstanding under this term loan.

$300.0 million Term Loan on September 12, 2013

On September 12, 2013, the Company entered into a five-year, $300.0 million, senior unsecured term loan agreement by and among the Company; the lenders party thereto and KeyBank National Association, as administrative agent. This syndicated credit facility, as subsequently amended, will mature on September 12, 2018, and will be subject to amortization of principal of 5% per annum payable quarterly beginning October 31, 2016, with the balance payable at maturity. In fiscal second quarter of 2016, we repaid $15.0 million of the outstanding balance using the funds from the 2016 Credit Agreement.

Amounts outstanding under this term loan agreement will bear interest, at the Company's option, at either the base rate, which is a rate per annum equal to the greatest of (a) KeyBank's prime rate, (b) 0.5% in excess of the federal funds effective rate and (c) 1% in excess of the adjusted Eurodollar rate (currently referred to as LIBOR) for a one-month interest period on such day, or the adjusted Eurodollar rate, plus, in each case, an applicable margin. The applicable margins will be determined quarterly by reference to a grid based upon the Company's Total Leverage Ratio, as defined in the term loan agreement, and consistent with the 2016 Credit Agreement discussed above.

This term loan agreement contains customary restrictive covenants, as well as financial covenants that require the Company to maintain a certain Total Leverage Ratio and Interest Coverage Ratio, each as defined in the agreement, consistent with the 2016 Credit Agreement discussed above. The agreement also contains customary events of default, the occurrence of which would permit the Administrative Agent to declare the principal, accrued interest and other obligations of the Company under the agreement to be immediately due and payable.

In connection with the Sauflon acquisition, on June 30, 2014, we entered into an amendment to this term loan agreement, dated as of September 12, 2013, by and among (i) the Company, (ii) the lenders from time to time party thereto and (iii) KeyBank National Association, as administrative agent. This term loan amendment modifies certain provisions of the term loan agreement to, among other things, amend certain restrictive covenants and related definitions to allow for certain indebtedness, investments, guaranty obligations, acquisitions, intercompany loans, capital distributions and dispositions of assets made or to be made in connection with the acquisition.

On August 4, 2014, we entered into Amendment No. 2 to this term loan agreement, dated as of September 12, 2013, as amended by Amendment No. 1 dated as of June 30, 2014, by and among the Company, the lenders party thereto and KeyBank National Association, as administrative agent. The term loan amendment modifies certain provisions of the term loan agreement to remove the call premium related to prepayments and/or refinancing of the term loan agreement, effective August 4, 2014.

On March 1, 2016, we entered into an Amendment and Restatement Agreement (Amended and Restated 2013 Term Loan) to amend and restate in its entirety the Term Loan Agreement, dated as of September 12, 2013, as amended by Amendment No. 1 dated as of June 30, 2014, Amendment No. 2 dated as of August 4, 2014 and Amendment No. 3 dated as of August 21, 2015 (2013 Term Loan Agreement), by and among the Company, the lenders party thereto, and KeyBank National Association, as administrative agent. The Amended and Restated 2013 Term Loan modifies certain provisions of the 2013 Term Loan Agreement to, among other things, conform certain restrictive covenants and events of default to the restrictive covenants and events of default contained in our new 2016 Credit Agreement.

At April 30, 2016, we had $285.0 million outstanding under this term loan.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.4.0.3
Income Taxes
6 Months Ended
Apr. 30, 2016
Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]  
Income Taxes
Income Taxes
Our effective tax rate (ETR) (provision for income taxes divided by pretax income) for the fiscal first half of 2016 was 5.4%. Our year-to-date results reflect the projected fiscal year ETR, plus any discrete items. The ETR used to record the provision for income taxes for the fiscal first half of 2015 was 8.6%. The decrease in the effective tax rate in the fiscal first half of 2016 was primarily due to a release of reserves associated with a prior year tax filing, a statutory tax rate reduction in the United Kingdom and the retroactive extension of the R&D tax credit.
We recognize the benefit from a tax position only if it is more likely than not that the position would be sustained upon audit based solely on the technical merits of the tax position. At November 1, 2015, Cooper had unrecognized tax benefits of which, if recognized, $29.4 million would impact our ETR. For the six-month period ended April 30, 2016, there were no material changes to the total amount of unrecognized tax benefits.
Interest and penalties of $3.7 million have been reflected as a component of the total liability at November 1, 2015. It is our policy to recognize the items of interest and penalties directly related to income taxes as additional income tax expense.
Included in the balance of unrecognized tax benefits at November 1, 2015, is $10.0 million related to tax positions for which it is reasonably possible that the total amounts could significantly change during the next twelve months. This amount represents a decrease in unrecognized tax benefits related to expiring statutes in various jurisdictions worldwide and relates primarily to transfer pricing matters.
At April 30, 2016, the tax years for which Cooper remains subject to United States Federal income tax assessment upon examination are 2014 through 2015. Cooper remains subject to income tax examinations in other significant tax jurisdictions including the United Kingdom, Japan, France and Australia for the tax years 2012 through 2015.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.4.0.3
Earnings Per Share
6 Months Ended
Apr. 30, 2016
Earnings Per Share [Abstract]  
Earnings Per Share
Earnings Per Share
Periods Ended April 30,
Three Months
 
Six Months
(In millions, except per share amounts)
2016
 
2015
 
2016
 
2015
Net income attributable to Cooper stockholders
$
74.1

 
$
60.7

 
$
125.5

 
$
121.9

Basic:

 

 

 

Weighted average common shares
48.4

 
48.5

 
48.4

 
48.3

Basic earnings per common share attributable to Cooper stockholders
$
1.53

 
$
1.25

 
$
2.59

 
$
2.52

Diluted:

 

 
 
 
 
Weighted average common shares
48.4

 
48.5

 
48.4

 
48.3

Effect of potential dilutive common shares
0.5

 
0.7

 
0.4

 
0.8

Diluted weighted average common shares
48.9

 
49.2

 
48.8

 
49.1

Diluted earnings per common share attributable to Cooper stockholders
$
1.52

 
$
1.23

 
$
2.57

 
$
2.48


The following table sets forth stock options to purchase Cooper’s common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:
Periods Ended April 30,
Three Months
 
Six Months
(In thousands, except exercise prices)
2016
 
2015
 
2016
 
2015
Numbers of stock option shares excluded
537

 
123

 
537

 
123

Range of exercise prices
$131.60-$162.69

 
$
162.28

 
$131.60-$162.69

 
$
162.28

Numbers of restricted stock units excluded
7

 
1

 
2

 
1

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.4.0.3
Share-Based Compensation Plans
6 Months Ended
Apr. 30, 2016
Share-based Compensation [Abstract]  
Share-Based Compensation Plans
Share-Based Compensation Plans
Cooper has several share-based compensation plans that are described in the Company’s Annual Report on Form 10‑K for the fiscal year ended October 31, 2015. The compensation expense and related income tax benefit recognized in our consolidated condensed financial statements for share-based awards were as follows:
Periods Ended April 30,
Three Months
 
Six Months
(In millions)
2016
 
2015
 
2016
 
2015
Selling, general and administrative expense
$
7.0

 
$
6.2

 
$
12.8

 
$
15.9

Cost of sales
0.7

 
0.6

 
1.2

 
1.4

Research and development expense
0.2

 
0.2

 
0.6

 
0.4

Total share-based compensation expense
$
7.9

 
$
7.0

 
$
14.6

 
$
17.7

Related income tax benefit
$
2.3

 
$
2.2

 
$
4.3

 
$
5.6


We capitalized share-based compensation expense as part of the cost of inventory in the amounts of $0.7 million and $1.2 million during the three and six months ended April 30, 2016, respectively; and $0.6 million and $1.4 million during the three and six months ended April 30, 2015, respectively.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stockholders' Equity
6 Months Ended
Apr. 30, 2016
Equity [Abstract]  
Stockholders' Equity
Stockholders’ Equity
Analysis of Changes in Accumulated Other Comprehensive Income (Loss):
(In millions)
Foreign Currency Translation Adjustment
 
Change in Value of 
Derivative Instruments
 
Minimum Pension Liability
 
Total
Balance at October 31, 2014
$
(92.4
)
 
$
(0.1
)
 
$
(13.7
)
 
$
(106.2
)
Gross change in value during the year ended October 31, 2015
(79.4
)
 

 
(10.0
)
 
(89.4
)
Reclassification adjustments for loss realized in net income

 
0.1

 

 
0.1

Tax effect for the period

 

 
3.9

 
3.9

Balance at October 31, 2015
$
(171.8
)
 
$

 
$
(19.8
)
 
$
(191.6
)
Gross change in value during the six-month period ended April 30, 2016
(61.5
)
 

 
(0.1
)
 
(61.6
)
Reclassification adjustments for loss realized in net income

 

 

 

Tax effect for the period

 

 

 

Balance at April 30, 2016
$
(233.3
)
 
$

 
$
(19.9
)
 
$
(253.2
)

Share Repurchases
In December 2011, our Board of Directors authorized the 2012 Share Repurchase Program and subsequently amended the total repurchase authorization to $500.0 million of the Company’s common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Share Repurchase Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements. We did not repurchase shares in the fiscal first half of 2016. In the fiscal first quarter of 2015, we repurchased 100 thousand shares of the Company’s common stock for $16.0 million, at an average purchase price of $159.96 per share. At April 30, 2016, approximately $118.4 million remains authorized for repurchase under the program.
Dividends
We paid a semiannual dividend of approximately $1.5 million or 3 cents per share on February 9, 2016, to stockholders of record on January 22, 2016.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.4.0.3
Fair Value Measurements
6 Months Ended
Apr. 30, 2016
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements
At April 30, 2016 and October 31, 2015, the carrying value of cash and cash equivalents, accounts receivable, prepaid expense and other current assets, lines of credit, accounts payable and other current liabilities approximate fair value due to the short-term nature of such instruments and the ability to obtain financing on similar terms.
Assets and liabilities are measured and reported at fair value per related accounting standards that define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value. An asset’s or liability’s level is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are valued and disclosed in one of the following three levels of the valuation hierarchy:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.
We believe that the balances of our revolving debt and term loans approximated their fair values at April 30, 2016 and October 31, 2015 and are categorized as Level 2 of the fair value hierarchy.
The Company has derivative assets and liabilities that may include interest rate swaps, cross currency swaps and foreign currency forward contracts. The impact of the counterparty’s creditworthiness when in an asset position and Cooper’s creditworthiness when in a liability position has also been factored into the fair value measurement of the derivative instruments. Both the counterparty and Cooper are expected to continue to perform under the contractual terms of the instruments.
We may use interest rate swaps to maintain our desired mix of fixed-rate and variable-rate debt. The swaps exchange fixed and variable rate payments without exchanging the notional principal amount of the debt. We generally have elected to use the income approach to value the derivatives using observable Level 2 market expectations at the measurement date and standard valuation techniques to convert future amounts to a single present amount assuming that participants are motivated but not compelled to transact. Level 2 inputs are limited to quoted prices for similar assets or liabilities in active markets, specifically Eurodollar futures contracts up to three years, and inputs other than quoted prices that are observable for the asset or liability - specifically LIBOR cash and swap rates and credit risk at commonly quoted intervals. Mid-market pricing may be used as a practical expedient for fair value measurements.
We may use foreign exchange forward contracts to minimize, to the extent reasonable and practical, our exposure to the impact of foreign currency fluctuations. We have elected to use the income approach to value the derivatives using observable Level 2 market expectations at the measurement date and standard valuation techniques to convert future amounts to a single present amount assuming that participants are motivated but not compelled to transact. Level 2 inputs for the valuations are limited to quoted prices for similar assets or liabilities in active markets and inputs other than quoted prices that are observable for the asset or liability - specifically LIBOR cash rates, credit risk at commonly quoted intervals, foreign exchange spot rates and forward points. Mid-market pricing is used as a practical expedient for fair value measurements.
The following table sets forth our financial assets and liabilities that were measured at fair value on a recurring basis using Level 2 inputs during the fiscal first six months of 2016, within the fair value hierarchy at April 30, 2016, and fiscal year 2015, within the fair value hierarchy at October 31, 2015:
(In millions)
April 30, 2016
 
October 31, 2015
Assets:
 
 
 
Foreign exchange contracts
$
0.8

 
$
1.3

Liabilities:

 

Foreign exchange contracts
$
0.9

 
$
0.4

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.4.0.3
Employee Benefits
6 Months Ended
Apr. 30, 2016
General Discussion of Pension and Other Postretirement Benefits [Abstract]  
Employee Benefits
Employee Benefits
Cooper’s Retirement Income Plan (Plan), a defined benefit plan, covers substantially all full-time United States employees. Our contributions are designed to fund normal cost on a current basis and to fund the estimated prior service cost of benefit improvements. The unit credit actuarial cost method is used to determine the annual cost. Cooper pays the entire cost of the Plan and funds such costs as they accrue. Virtually all of the assets of the Plan are comprised of equities and participation in equity and fixed income funds.
Our results of operations for the three and six months ended April 30, 2016 and 2015 reflect the following components of net periodic pension costs:
Periods Ended April 30,
Three Months
 
Six Months
(In millions)
2016
 
2015
 
2016
 
2015
Service cost
$
2.3

 
$
2.0

 
$
4.6

 
$
4.1

Interest cost
1.2

 
1.1

 
2.5

 
2.1

Expected return on plan assets
(1.6
)
 
(1.5
)
 
(3.3
)
 
(3.0
)
Amortization of prior service cost

 

 

 

Recognized net actuarial loss
0.4

 
0.2

 
0.8

 
0.5

Net periodic pension cost
$
2.3

 
$
1.8

 
$
4.6

 
$
3.7


We contributed $2.5 million to the Plan in the fiscal first half of 2016, and expect to contribute an additional $7.5 million during fiscal 2016. We contributed $2.5 million to the Plan in the fiscal first half of 2015. The expected rate of return on plan assets for determining net periodic pension cost is 8%.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.4.0.3
Contingencies
6 Months Ended
Apr. 30, 2016
Commitments and Contingencies Disclosure [Abstract]  
Contingencies
Contingencies

Since March 2015, over 50 putative class action complaints were filed by contact lens consumers alleging that contact lens manufacturers, in conjunction with their respective Unilateral Pricing Policy (UPP), conspired to reach agreements between each other and certain distributors and retailers regarding the prices at which certain contact lenses could be sold to consumers. The plaintiffs are seeking damages against CooperVision, Inc., other contact lens manufacturers, distributors and retailers, in various courts around the United States. In June 2015, all of the class action cases were consolidated and transferred to the United States District Court for the Middle District of Florida. CooperVision and the other defendants jointly filed a motion to dismiss the complaints which currently is pending, and the actions currently are in discovery. CooperVision denies the allegations and intends to defend the actions vigorously. We are not in a position to assess whether any loss or adverse effect on our financial condition is probable or remote or to estimate the range of potential loss, if any.
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.4.0.3
Business Segment Information
6 Months Ended
Apr. 30, 2016
Segment Reporting [Abstract]  
Business Segment Information
Business Segment Information
Cooper uses operating income, as presented in our financial reports, as the primary measure of segment profitability. We do not allocate costs from corporate functions to segment operating income. Items below operating income are not considered when measuring the profitability of a segment. We use the same accounting policies to generate segment results as we do for our consolidated results.
Identifiable assets are those used in continuing operations except cash and cash equivalents, which we include as corporate assets. Long-lived assets are property, plant and equipment.
Segment information:
Periods Ended April 30,
Three Months
 
Six Months
(In millions)
2016
 
2015
 
2016
 
2015
CooperVision net sales by category:
 
 
 
 
 
 
 
Toric lens
$
120.5

 
$
107.1

 
$
228.0

 
$
215.6

Multifocal lens
42.5

 
37.9

 
82.9

 
80.4

Single-use sphere lens
97.6

 
85.1

 
188.4

 
169.3

Non single-use sphere and other
130.6

 
129.5

 
256.3

 
263.6

Total CooperVision net sales
391.2

 
359.6

 
755.6

 
728.9

CooperSurgical net sales
92.6

 
75.1

 
177.8

 
150.9

Total net sales
$
483.8

 
$
434.7

 
$
933.4

 
$
879.8

Operating income (loss):
 
 
 
 
 
 
 
CooperVision
$
83.6

 
$
67.7

 
$
136.4

 
$
140.9

CooperSurgical
17.7

 
14.2

 
33.1

 
27.4

Corporate
(11.5
)
 
(10.9
)
 
(22.3
)
 
(24.2
)
Total operating income
89.8

 
71.0

 
147.2

 
144.1

Interest expense
7.6

 
4.7

 
12.9

 
8.6

Other (income) expense, net
(0.4
)
 
(0.7
)
 
1.0

 
1.0

Income before income taxes
$
82.6

 
$
67.0

 
$
133.4

 
$
134.5


(In millions)
April 30, 2016
 
October 31, 2015
Identifiable assets:
 
 
 
CooperVision
$
3,678.9

 
$
3,714.6

CooperSurgical
817.6

 
674.8

Corporate
104.8

 
70.5

Total
$
4,601.3

 
$
4,459.9


Geographic information:
Periods Ended April 30,
Three Months
 
Six Months
(In millions)
2016
 
2015
 
2016
 
2015
Net sales to external customers by country of domicile:
 
 
 
 
 
 
 
United States
$
221.4

 
$
197.4

 
$
428.2

 
$
401.3

Europe
165.9

 
154.7

 
323.0

 
313.8

Rest of world
96.5

 
82.6

 
182.2

 
164.7

Total
$
483.8

 
$
434.7

 
$
933.4

 
$
879.8


(In millions)
April 30, 2016
 
October 31, 2015
Long-lived assets by country of domicile:
 
 
 
United States
$
500.9

 
$
494.2

Europe
391.6

 
407.9

Rest of world
71.9

 
65.0

Total
$
964.4

 
$
967.1

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.4.0.3
Subsequent Event
6 Months Ended
Apr. 30, 2016
Subsequent Events [Abstract]  
Subsequent Event
Subsequent Event

Subsequent to our fiscal second quarter of 2016, on May 31, 2016, CooperSurgical acquired Reprogenetics UK, a genetics laboratory specializing in service offerings of preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) used during the IVF process, for approximately $12.0 million.

Subsequent to our fiscal second quarter of 2016, on May 25, 2016, CooperSurgical acquired the commercial assets of Recombine Inc., a clinical genetic testing company specializing in carrier screening for approximately $85.0 million.

Subsequent to our fiscal second quarter of 2016, on May 4, 2016, CooperSurgical acquired Kivex Biotec A/S (K-Systems), a manufacturer and distributor of equipment for IVF clinics, for approximately $11.5 million.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.4.0.3
General (Policies)
6 Months Ended
Apr. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Accounting Pronouncements Issued Not Yet Adopted and Accounting Pronouncements Recently Adopted
Accounting Pronouncements Issued Not Yet Adopted

In March 2016, the FASB issued ASU 2016-09, Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which is intended to improve the accounting for share-based payment transactions as part of the FASB’s simplification initiative. The ASU changes the following aspects of the accounting for share-based payment award transactions, including: accounting for income taxes; classification of excess tax benefits on the statement of cash flows; forfeitures; minimum statutory tax withholding requirements; and classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. We are currently evaluating the impact of ASU 2016-09, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2017.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-01 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. We are currently evaluating the impact of ASU 2016-02, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2019.

In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes, which requires entities to present all deferred tax assets and liabilities as noncurrent. The amendments in the ASU are effective for the Company in our fiscal year and interim periods beginning on November 1, 2017. The Company does not expect the new guidance to have a material impact on the Company’s consolidated financial statements.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 requires revenue recognition to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 sets forth a new revenue recognition model that requires identifying the contract, identifying the performance obligations, determining the transaction price, allocating the transaction price to performance obligations and recognizing the revenue upon satisfaction of performance obligations. The amendments in the ASU can be applied either retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the update recognized at the date of the initial application along with additional disclosures. We are currently evaluating the impact of ASU 2014-09, which is effective for the Company in our fiscal year and interim periods beginning on November 1, 2018.
Accounting Pronouncements Recently Adopted

In April 2015, the FASB issued Accounting Standards Update (ASU) 2015-03, Interest - Imputation of Interest (Subtopic 835-30) Simplifying the Presentation of Debt Issuance Costs. The amendments in this update require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for interim and annual reporting periods beginning after December 15, 2016. Early adoption is permitted. We elected to early adopt this guidance as a change in accounting principle on a retrospective basis in the fiscal first quarter ended January 31, 2016. As of January 31, 2016 and October 31, 2015, we have presented debt issuance costs related to our term loans, previously reported in other assets, as direct deductions from the carrying amount of the debt liability. We also presented the debt issuance costs related to our revolving credit facility as a deferred asset within other assets, as is permitted by ASU 2015-15, Imputation of Interest, which was issued in August 2015. Such adoption did not have a material impact to our consolidated financial position.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.4.0.3
Restructuring and Integration Costs (Tables)
6 Months Ended
Apr. 30, 2016
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Costs
A summary of the cumulative total restructuring costs by major component recognized to date as of April 30, 2016, is as follows:
(In millions)
Employee-related
 
Facilities-related
 
Product Rationalization
 
Total
Amounts incurred in:
 
 
 
 
 
 
 
Year ended October 31, 2014
$
20.3

 
$
0.5

 
$
15.3

 
$
36.1

Year ended October 31, 2015
(2.5
)
 
0.4

 
57.7

 
55.6

Six months ended April 30, 2016
0.7

 
0.3

 
14.7

 
15.7

Cumulative amounts incurred as of April 30, 2016
$
18.5

 
$
1.2

 
$
87.7

 
$
107.4



The following table summarizes the restructuring activities by major component for the fiscal year ended October 31, 2015 and the six months ended April 30, 2016:
(In millions)
Employee-related
 
Facilities-related
 
Product Rationalization
 
Total
 
 
 
 
 
 
 
 
Balance at October 31, 2014
$
19.9

 
$
0.5

 
$

 
$
20.4

(Reductions) additions during fiscal 2015
(2.5
)
 
0.4

 
57.7

 
55.6

Payments during the fiscal year
(9.0
)
 
(0.4
)
 

 
(9.4
)
Non-cash adjustments (a) (b)
0.2

 
(0.2
)
 
(57.7
)
 
(57.7
)
Balance at October 31, 2015
8.6

 
0.3

 

 
8.9

Additions during the six months ended April 30, 2016
0.7

 
0.3

 
14.7

 
15.7

Payments during the six months ended April 30, 2016
(3.7
)
 
(0.1
)
 

 
(3.8
)
Non-cash adjustments (a) (b)
(0.1
)
 
(0.1
)
 
(14.7
)
 
(14.9
)
Balance at April 30, 2016
$
5.5

 
$
0.4

 
$

 
$
5.9

(a) Non-cash adjustments for employee-related and facilities-related costs represent currency translation adjustment.
(b) Non-cash adjustments for product rationalization represent equipment disposals, inventory write-offs and accelerated depreciation.
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.4.0.3
Inventories (Tables)
6 Months Ended
Apr. 30, 2016
Inventory Disclosure [Abstract]  
Schedule of Inventories
(In millions)
April 30, 2016
 
October 31, 2015
Raw materials
$
85.8

 
$
80.9

Work-in-process
15.6

 
14.5

Finished goods
332.2

 
324.3

 
$
433.6

 
$
419.7

XML 37 R26.htm IDEA: XBRL DOCUMENT v3.4.0.3
Intangible Assets (Tables)
6 Months Ended
Apr. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Goodwill
(In millions)
CooperVision
 
CooperSurgical
 
Total
Balance at October 31, 2014
$
1,861.5

 
$
359.4

 
$
2,220.9

Net (reductions) additions during the year ended October 31, 2015
(1.2
)
 
17.4

 
16.2

Translation
(32.7
)
 
(7.3
)
 
(40.0
)
Balance at October 31, 2015
1,827.6

 
369.5

 
2,197.1

Net additions during the six-month period ended April 30, 2016
0.1

 
79.2

 
79.3

Translation
(45.7
)
 
2.6

 
(43.1
)
Balance at April 30, 2016
$
1,782.0

 
$
451.3

 
$
2,233.3

Schedule of Other Intangible Assets
Other Intangible Assets
 
As of April 30, 2016
 
As of October 31, 2015
(In millions)
Gross Carrying
Amount
 
Accumulated
Amortization
& Translation
 
Gross Carrying
Amount
 
Accumulated
Amortization
& Translation
Trademarks
$
29.9

 
$
5.4

 
$
23.7

 
$
4.4

Technology
332.0

 
127.0

 
318.9

 
114.7

Customer relationships
279.8

 
113.3

 
247.0

 
104.5

License and distribution rights and other
73.3

 
32.3

 
71.7

 
26.6

 
715.0

 
$
278.0

 
661.3

 
$
250.2

Less: accumulated amortization and translation
278.0

 
 
 
250.2

 
 
Other intangible assets, net
$
437.0

 
 
 
$
411.1

 
 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.4.0.3
Debt (Tables)
6 Months Ended
Apr. 30, 2016
Debt Disclosure [Abstract]  
Schedule of Debt
(In millions)
April 30, 2016
 
October 31, 2015
Short-term:
 
 
 
Overdraft and other credit facilities
$
31.7

 
$
240.4

Current portion of long-term debt

 
3.8

Less: unamortized debt issuance cost on term loans
(1.5
)
 
(0.4
)
 
$
30.2

 
$
243.8

Long-term:
 
 
 
Credit agreements
$

 
$
109.0

Term loans
1,415.0

 
996.3

Other
0.3

 
0.5

Less: unamortized debt issuance cost on term loans
(4.1
)
 
(0.4
)
 
$
1,411.2

 
$
1,105.4

XML 39 R28.htm IDEA: XBRL DOCUMENT v3.4.0.3
Earnings Per Share (Tables)
6 Months Ended
Apr. 30, 2016
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
Periods Ended April 30,
Three Months
 
Six Months
(In millions, except per share amounts)
2016
 
2015
 
2016
 
2015
Net income attributable to Cooper stockholders
$
74.1

 
$
60.7

 
$
125.5

 
$
121.9

Basic:

 

 

 

Weighted average common shares
48.4

 
48.5

 
48.4

 
48.3

Basic earnings per common share attributable to Cooper stockholders
$
1.53

 
$
1.25

 
$
2.59

 
$
2.52

Diluted:

 

 
 
 
 
Weighted average common shares
48.4

 
48.5

 
48.4

 
48.3

Effect of potential dilutive common shares
0.5

 
0.7

 
0.4

 
0.8

Diluted weighted average common shares
48.9

 
49.2

 
48.8

 
49.1

Diluted earnings per common share attributable to Cooper stockholders
$
1.52

 
$
1.23

 
$
2.57

 
$
2.48

Schedule of Stock Options to Purchase Common Stock Not Included in Diluted Net Income Per Share Calculation
The following table sets forth stock options to purchase Cooper’s common stock and restricted stock units that were not included in the diluted earnings per share calculation because their effect would have been antidilutive for the periods presented:
Periods Ended April 30,
Three Months
 
Six Months
(In thousands, except exercise prices)
2016
 
2015
 
2016
 
2015
Numbers of stock option shares excluded
537

 
123

 
537

 
123

Range of exercise prices
$131.60-$162.69

 
$
162.28

 
$131.60-$162.69

 
$
162.28

Numbers of restricted stock units excluded
7

 
1

 
2

 
1

XML 40 R29.htm IDEA: XBRL DOCUMENT v3.4.0.3
Share-Based Compensation Plans (Tables)
6 Months Ended
Apr. 30, 2016
Share-based Compensation [Abstract]  
Schedule of Compensation Expense and Related Income Tax Benefit for Share-Based Awards
The compensation expense and related income tax benefit recognized in our consolidated condensed financial statements for share-based awards were as follows:
Periods Ended April 30,
Three Months
 
Six Months
(In millions)
2016
 
2015
 
2016
 
2015
Selling, general and administrative expense
$
7.0

 
$
6.2

 
$
12.8

 
$
15.9

Cost of sales
0.7

 
0.6

 
1.2

 
1.4

Research and development expense
0.2

 
0.2

 
0.6

 
0.4

Total share-based compensation expense
$
7.9

 
$
7.0

 
$
14.6

 
$
17.7

Related income tax benefit
$
2.3

 
$
2.2

 
$
4.3

 
$
5.6

XML 41 R30.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stockholders' Equity Analysis of Changes in Accumulated Other Comprehensive Income (Loss) (Tables)
6 Months Ended
Apr. 30, 2016
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
Analysis of Changes in Accumulated Other Comprehensive Income (Loss):
(In millions)
Foreign Currency Translation Adjustment
 
Change in Value of 
Derivative Instruments
 
Minimum Pension Liability
 
Total
Balance at October 31, 2014
$
(92.4
)
 
$
(0.1
)
 
$
(13.7
)
 
$
(106.2
)
Gross change in value during the year ended October 31, 2015
(79.4
)
 

 
(10.0
)
 
(89.4
)
Reclassification adjustments for loss realized in net income

 
0.1

 

 
0.1

Tax effect for the period

 

 
3.9

 
3.9

Balance at October 31, 2015
$
(171.8
)
 
$

 
$
(19.8
)
 
$
(191.6
)
Gross change in value during the six-month period ended April 30, 2016
(61.5
)
 

 
(0.1
)
 
(61.6
)
Reclassification adjustments for loss realized in net income

 

 

 

Tax effect for the period

 

 

 

Balance at April 30, 2016
$
(233.3
)
 
$

 
$
(19.9
)
 
$
(253.2
)
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.4.0.3
Fair Value Measurements (Tables)
6 Months Ended
Apr. 30, 2016
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis Using Level 2 Inputs
The following table sets forth our financial assets and liabilities that were measured at fair value on a recurring basis using Level 2 inputs during the fiscal first six months of 2016, within the fair value hierarchy at April 30, 2016, and fiscal year 2015, within the fair value hierarchy at October 31, 2015:
(In millions)
April 30, 2016
 
October 31, 2015
Assets:
 
 
 
Foreign exchange contracts
$
0.8

 
$
1.3

Liabilities:

 

Foreign exchange contracts
$
0.9

 
$
0.4

XML 43 R32.htm IDEA: XBRL DOCUMENT v3.4.0.3
Employee Benefits (Tables)
6 Months Ended
Apr. 30, 2016
General Discussion of Pension and Other Postretirement Benefits [Abstract]  
Schedule of Components of Net Periodic Pension Costs
Our results of operations for the three and six months ended April 30, 2016 and 2015 reflect the following components of net periodic pension costs:
Periods Ended April 30,
Three Months
 
Six Months
(In millions)
2016
 
2015
 
2016
 
2015
Service cost
$
2.3

 
$
2.0

 
$
4.6

 
$
4.1

Interest cost
1.2

 
1.1

 
2.5

 
2.1

Expected return on plan assets
(1.6
)
 
(1.5
)
 
(3.3
)
 
(3.0
)
Amortization of prior service cost

 

 

 

Recognized net actuarial loss
0.4

 
0.2

 
0.8

 
0.5

Net periodic pension cost
$
2.3

 
$
1.8

 
$
4.6

 
$
3.7

XML 44 R33.htm IDEA: XBRL DOCUMENT v3.4.0.3
Business Segment Information (Tables)
6 Months Ended
Apr. 30, 2016
Segment Reporting [Abstract]  
Schedule of Segment Information
Segment information:
Periods Ended April 30,
Three Months
 
Six Months
(In millions)
2016
 
2015
 
2016
 
2015
CooperVision net sales by category:
 
 
 
 
 
 
 
Toric lens
$
120.5

 
$
107.1

 
$
228.0

 
$
215.6

Multifocal lens
42.5

 
37.9

 
82.9

 
80.4

Single-use sphere lens
97.6

 
85.1

 
188.4

 
169.3

Non single-use sphere and other
130.6

 
129.5

 
256.3

 
263.6

Total CooperVision net sales
391.2

 
359.6

 
755.6

 
728.9

CooperSurgical net sales
92.6

 
75.1

 
177.8

 
150.9

Total net sales
$
483.8

 
$
434.7

 
$
933.4

 
$
879.8

Operating income (loss):
 
 
 
 
 
 
 
CooperVision
$
83.6

 
$
67.7

 
$
136.4

 
$
140.9

CooperSurgical
17.7

 
14.2

 
33.1

 
27.4

Corporate
(11.5
)
 
(10.9
)
 
(22.3
)
 
(24.2
)
Total operating income
89.8

 
71.0

 
147.2

 
144.1

Interest expense
7.6

 
4.7

 
12.9

 
8.6

Other (income) expense, net
(0.4
)
 
(0.7
)
 
1.0

 
1.0

Income before income taxes
$
82.6

 
$
67.0

 
$
133.4

 
$
134.5

Schedule of Identifiable Assets by Segment
(In millions)
April 30, 2016
 
October 31, 2015
Identifiable assets:
 
 
 
CooperVision
$
3,678.9

 
$
3,714.6

CooperSurgical
817.6

 
674.8

Corporate
104.8

 
70.5

Total
$
4,601.3

 
$
4,459.9

Schedule of Net Sales to External Customers by Country of Domicile
Geographic information:
Periods Ended April 30,
Three Months
 
Six Months
(In millions)
2016
 
2015
 
2016
 
2015
Net sales to external customers by country of domicile:
 
 
 
 
 
 
 
United States
$
221.4

 
$
197.4

 
$
428.2

 
$
401.3

Europe
165.9

 
154.7

 
323.0

 
313.8

Rest of world
96.5

 
82.6

 
182.2

 
164.7

Total
$
483.8

 
$
434.7

 
$
933.4

 
$
879.8

Schedule of Long-Lived Assets by Country of Domicile
(In millions)
April 30, 2016
 
October 31, 2015
Long-lived assets by country of domicile:
 
 
 
United States
$
500.9

 
$
494.2

Europe
391.6

 
407.9

Rest of world
71.9

 
65.0

Total
$
964.4

 
$
967.1

XML 45 R34.htm IDEA: XBRL DOCUMENT v3.4.0.3
Acquisitions (Details) - USD ($)
$ in Millions
Mar. 31, 2016
Feb. 08, 2016
Dec. 17, 2015
Genesis Genetics [Member]      
Business Acquisition [Line Items]      
Business acquisition, effective date of acquisition Mar. 31, 2016    
Total purchase consideration $ 60.0    
Payments to Acquire Businesses, Net of Cash Acquired 59.3    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill 28.6    
Goodwill, Acquired During Period 27.6    
The Pipette Company [Member]      
Business Acquisition [Line Items]      
Business acquisition, effective date of acquisition   Feb. 08, 2016  
Total purchase consideration   $ 20.2  
Payments to Acquire Businesses, Net of Cash Acquired   19.6  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill   5.6  
Goodwill, Acquired During Period   14.7  
Research Instruments [Member]      
Business Acquisition [Line Items]      
Business acquisition, effective date of acquisition     Dec. 17, 2015
Total purchase consideration     $ 53.6
Payments to Acquire Businesses, Net of Cash Acquired     50.0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill     10.3
Goodwill, Acquired During Period     36.1
Customer Relationships [Member] | Genesis Genetics [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill 25.2    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net 3.8    
Customer Relationships [Member] | The Pipette Company [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill   5.2  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net   (0.2)  
Customer Relationships [Member] | Research Instruments [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill     1.9
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net     7.3
Trade Names [Member] | Genesis Genetics [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill $ 3.4    
Trade Names [Member] | The Pipette Company [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill   $ 0.4  
Trade Names [Member] | Research Instruments [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill     2.2
Technology-Based Intangible Assets [Member] | Research Instruments [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill     $ 6.2
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.4.0.3
Restructuring and Integration Costs (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Apr. 30, 2016
Apr. 30, 2015
Oct. 31, 2015
Oct. 31, 2014
Restructuring Cost and Reserve [Line Items]            
Restructuring and related activities, completion date     Oct. 31, 2016      
Sauflon [Member]            
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, expected cost $ 125.0   $ 125.0      
Additions during the period     15.7   $ 55.6 $ 36.1
Integration costs 2.1 $ 8.0 10.0 $ 14.1    
Sauflon [Member] | Product Rationalization [Member]            
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, expected cost 95.0   95.0      
Additions during the period     14.7   57.7 15.3
Sauflon [Member] | Product Rationalization [Member] | Cost of sales [Member]            
Restructuring Cost and Reserve [Line Items]            
Additions during the period 4.2 5.2 14.7 13.9    
Sauflon [Member] | Employee Severance [Member]            
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, expected cost 27.0   27.0      
Additions during the period     0.7   (2.5) 20.3
Sauflon [Member] | Employee Severance [Member] | Cost of sales [Member]            
Restructuring Cost and Reserve [Line Items]            
Additions during the period 0.7   0.5      
Sauflon [Member] | Employee Severance [Member] | Selling, general and administrative expense [Member]            
Restructuring Cost and Reserve [Line Items]            
Additions during the period   (4.5) 0.1      
Sauflon [Member] | Employee Severance [Member] | Research and development expense [Member]            
Restructuring Cost and Reserve [Line Items]            
Additions during the period   $ 0.2 0.1 $ 0.3    
Sauflon [Member] | Facility Closing [Member]            
Restructuring Cost and Reserve [Line Items]            
Restructuring and related cost, expected cost $ 3.0   3.0      
Additions during the period     0.3   $ 0.4 $ 0.5
Sauflon [Member] | Facility Closing [Member] | Selling, general and administrative expense [Member]            
Restructuring Cost and Reserve [Line Items]            
Additions during the period     $ 0.3      
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.4.0.3
Restructuring and Integration Costs (Details) - Sauflon [Member] - USD ($)
$ in Millions
6 Months Ended 12 Months Ended
Apr. 30, 2016
Oct. 31, 2015
Oct. 31, 2014
Restructuring Cost and Reserve [Line Items]      
Cumulative amounts incurred as of April 30, 2016 $ 107.4    
Restructuring Reserve [Roll Forward]      
Balance, beginning 8.9 $ 20.4  
Additions (reductions) during the period 15.7 55.6 $ 36.1
Payments during the period (3.8) (9.4)  
Non-cash adjustments (14.9) (57.7)  
Balance, ending 5.9 8.9 20.4
Employee Severance [Member]      
Restructuring Cost and Reserve [Line Items]      
Cumulative amounts incurred as of April 30, 2016 18.5    
Restructuring Reserve [Roll Forward]      
Balance, beginning 8.6 19.9  
Additions (reductions) during the period 0.7 (2.5) 20.3
Payments during the period (3.7) (9.0)  
Non-cash adjustments (0.1) 0.2  
Balance, ending 5.5 8.6 19.9
Facility Closing [Member]      
Restructuring Cost and Reserve [Line Items]      
Cumulative amounts incurred as of April 30, 2016 1.2    
Restructuring Reserve [Roll Forward]      
Balance, beginning 0.3 0.5  
Additions (reductions) during the period 0.3 0.4 0.5
Payments during the period (0.1) (0.4)  
Non-cash adjustments (0.1) (0.2)  
Balance, ending 0.4 0.3 0.5
Product Rationalization [Member]      
Restructuring Cost and Reserve [Line Items]      
Cumulative amounts incurred as of April 30, 2016 87.7    
Restructuring Reserve [Roll Forward]      
Balance, beginning 0.0 0.0  
Additions (reductions) during the period 14.7 57.7 15.3
Payments during the period 0.0 0.0  
Non-cash adjustments (14.7) (57.7)  
Balance, ending $ 0.0 $ 0.0 $ 0.0
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.4.0.3
Inventories (Schedule of Inventories) (Details) - USD ($)
$ in Thousands
Apr. 30, 2016
Oct. 31, 2015
Inventory Disclosure [Abstract]    
Raw materials $ 85,800 $ 80,900
Work-in-process 15,600 14,500
Finished goods 332,200 324,300
Inventories, net $ 433,596 $ 419,692
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.4.0.3
Intangible Assets (Schedule of Goodwill) (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Apr. 30, 2016
Oct. 31, 2015
Goodwill [Roll Forward]    
Balance, beginning $ 2,197,077 $ 2,220,900
Net additions during the six-month period ended April 30, 2016 79,300 16,200
Translation (43,100) (40,000)
Balance, ending 2,233,251 2,197,077
CooperVision [Member]    
Goodwill [Roll Forward]    
Balance, beginning 1,827,600 1,861,500
Net additions during the six-month period ended April 30, 2016 100 (1,200)
Translation (45,700) (32,700)
Balance, ending 1,782,000 1,827,600
CooperSurgical [Member]    
Goodwill [Roll Forward]    
Balance, beginning 369,500 359,400
Net additions during the six-month period ended April 30, 2016 79,200 17,400
Translation 2,600 (7,300)
Balance, ending $ 451,300 $ 369,500
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.4.0.3
Intangible Assets (Schedule of Other Intangible Assets) (Details) - USD ($)
$ in Thousands
Apr. 30, 2016
Oct. 31, 2015
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 715,000 $ 661,300
Accumulated Amortization & Translation 278,000 250,200
Other intangible assets, net 437,005 411,090
Trademarks [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 29,900 23,700
Accumulated Amortization & Translation 5,400 4,400
Technology-Based Intangible Assets [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 332,000 318,900
Accumulated Amortization & Translation 127,000 114,700
Customer Relationships [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 279,800 247,000
Accumulated Amortization & Translation 113,300 104,500
License and distribution right and other [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 73,300 71,700
Accumulated Amortization & Translation $ 32,300 $ 26,600
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.4.0.3
Intangible Assets (Narrative) (Details)
6 Months Ended
Apr. 30, 2016
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill, Impairment Loss $ 0
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]  
2016 59,600,000
2017 56,100,000
2018 54,100,000
2019 51,500,000
2020 $ 40,900,000
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.4.0.3
Debt (Schedule of Debt) (Details) - USD ($)
$ in Thousands
Apr. 30, 2016
Oct. 31, 2015
Short-term:    
Overdraft and other credit facilities $ 31,700 $ 240,400
Current portion of long-term debt 0 3,800
Less: unamortized debt issuance cost on term loans (1,500) (400)
Short-term debt 30,191 243,803
Long-term:    
Credit agreements 0 109,000
Term loans 1,415,000 996,300
Other 300 500
Less: unamortized debt issuance cost on term loans (4,100) (400)
Long-term debt $ 1,411,182 $ 1,105,408
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.4.0.3
Debt (Narrative) (Details)
3 Months Ended 6 Months Ended
Mar. 01, 2016
USD ($)
Mar. 24, 2015
USD ($)
Aug. 04, 2014
USD ($)
Sep. 12, 2013
USD ($)
Apr. 30, 2016
USD ($)
Apr. 30, 2016
USD ($)
Oct. 31, 2015
USD ($)
Line of Credit Facility [Line Items]              
Term loans         $ 1,415,000,000 $ 1,415,000,000 $ 996,300,000
Required minimum Interest coverage ratio           3.00  
Required maximum total leverage ratio           3.75  
Interest coverage ratio         26.42 26.42  
Total leverage ratio         2.37 2.37  
Amount available under the credit agreement         $ 1,000,000,000 $ 1,000,000,000  
Short-term debt         30,191,000 30,191,000 $ 243,803,000
Minimum [Member]              
Line of Credit Facility [Line Items]              
Commitment fee percentage 0.125%            
Maximum [Member]              
Line of Credit Facility [Line Items]              
Commitment fee percentage 0.25%            
Line of Credit [Member]              
Line of Credit Facility [Line Items]              
Aggregate commitment amount of credit facility   $ 100,000,000.0          
Debt instrument, maturity date   Mar. 24, 2016          
Extinguishment of debt, amount $ 200,000,000            
Debt instrument, issuance date   Mar. 24, 2015          
Debt term   90 days          
Short-term debt         0 0  
Line of Credit [Member] | Eurodollar [Member]              
Line of Credit Facility [Line Items]              
Debt instrument, basis spread on variable rate   0.90%          
Revolving Credit Facility [Member]              
Line of Credit Facility [Line Items]              
Aggregate commitment amount of credit facility 1,000,000,000.0            
2016 Credit Agreement [Member]              
Line of Credit Facility [Line Items]              
Line of credit facility, potential additional borrowing capacity $ 750,000,000            
2016 Credit Agreement [Member]              
Line of Credit Facility [Line Items]              
Line of credit facility, initiation date Mar. 01, 2016            
Term loans $ 830,000,000       830,000,000 830,000,000  
Line of credit facility interest rate margin on base rate loans percentage 0.50%            
Line of credit facility interest rate margin on foreign currency loans percentage 1.50%            
2016 Credit Agreement [Member] | Federal Funds Rate [Member]              
Line of Credit Facility [Line Items]              
Debt instrument, basis spread on variable rate 0.50%            
2016 Credit Agreement [Member] | Eurodollar [Member]              
Line of Credit Facility [Line Items]              
Debt instrument, basis spread on variable rate 1.00%            
Line of Credit [Member]              
Line of Credit Facility [Line Items]              
Debt instrument, maturity date Mar. 01, 2021            
Term Loan $700M [Member]              
Line of Credit Facility [Line Items]              
Term loans     $ 700,000,000   300,000,000 300,000,000  
Debt instrument, maturity date     Aug. 04, 2017        
Debt instrument, issuance date     Aug. 04, 2014        
Debt term     3 years        
Repayments of Debt         400,000,000    
Term Loan $700M [Member] | Federal Funds Rate [Member]              
Line of Credit Facility [Line Items]              
Debt instrument, basis spread on variable rate     0.50%        
Term Loan $700M [Member] | Eurodollar [Member]              
Line of Credit Facility [Line Items]              
Debt instrument, basis spread on variable rate     1.00%        
Term Loan $300M [Member]              
Line of Credit Facility [Line Items]              
Term loans       $ 300,000,000 285,000,000 $ 285,000,000  
Debt instrument, maturity date       Sep. 12, 2018      
Debt instrument, issuance date       Sep. 12, 2013      
Debt term       5 years      
Repayments of Debt         $ 15,000,000    
Amortization of term loan principal       5.00%      
Debt instrument, date of first required payment       Oct. 31, 2016      
Term Loan $300M [Member] | Federal Funds Rate [Member]              
Line of Credit Facility [Line Items]              
Debt instrument, basis spread on variable rate       0.50%      
Term Loan $300M [Member] | Eurodollar [Member]              
Line of Credit Facility [Line Items]              
Debt instrument, basis spread on variable rate       1.00%      
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.4.0.3
Income Taxes (Narrative) (Details) - USD ($)
$ in Millions
6 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Nov. 01, 2015
Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]      
Effective tax rate (ETR) 5.40% 8.60%  
Unrecognized tax benefits that would impact ETR     $ 29.4
Interest and penalties     3.7
Unrecognized tax benefits related to tax positions     $ 10.0
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.4.0.3
Earnings Per Share (Schedule of Earnings Per Share) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Apr. 30, 2016
Apr. 30, 2015
Earnings Per Share [Abstract]        
Net income attributable to Cooper stockholders $ 74,125 $ 60,713 $ 125,481 $ 121,892
Basic:        
Weighted average common shares 48,428 48,463 48,365 48,330
Basic earnings per common share attributable to Cooper stockholders $ 1.53 $ 1.25 $ 2.59 $ 2.52
Diluted:        
Effect of potential dilutive common shares 500 700 400 800
Diluted weighted average common shares 48,853 49,163 48,838 49,139
Diluted earnings per common share attributable to Cooper stockholders $ 1.52 $ 1.23 $ 2.57 $ 2.48
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.4.0.3
Earnings Per Share (Schedule of Stock Options to Purchase Common Stock Not Included in Diluted Net Income Per Share Calculation) (Details) - $ / shares
shares in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Apr. 30, 2016
Apr. 30, 2015
Stock Options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Numbers of stock option shares excluded 537 123 537 123
Range of exercise prices, lower limit $ 131.60 $ 162.28 $ 131.60 $ 162.28
Range of exercise prices, upper limit $ 162.69 $ 162.28 $ 162.69 $ 162.28
Restricted Stock Units (RSUs) [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Numbers of stock option shares excluded 7 1 2 1
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.4.0.3
Share-Based Compensation Plans (Schedule Of Compensation Expense And Related Income Tax Benefit For Share-Based Awards) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Apr. 30, 2016
Apr. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total share-based compensation expense $ 7.9 $ 7.0 $ 14.6 $ 17.7
Related income tax benefit 2.3 2.2 4.3 5.6
Selling, general and administrative expense [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense 7.0 6.2 12.8 15.9
Cost of sales [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense 0.7 0.6 1.2 1.4
Research and development expense [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense 0.2 0.2 0.6 0.4
Capitalized in inventory [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense $ 0.7 $ 0.6 $ 1.2 $ 1.4
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stockholders' Equity (Schedule of Changes in Accumulated Other Comprehensive Income (Loss))(Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Apr. 30, 2016
Apr. 30, 2015
Oct. 31, 2015
Foreign Currency Translation Adjustment [Roll Forward]          
Foreign Currency Translation Adjustment, Beginning Balance     $ (171,800) $ (92,400) $ (92,400)
Foreign Currency Translation Adjustment, Gross change in value for the period     (61,500)   (79,400)
Foreign Currency Translation Adjustment, Reclassification adjustments for loss realized in net income     0   0
Foreign Currency Translation Adjustment, Tax effect for the period     0   0
Foreign Currency Translation Adjustment, Ending Balance $ (233,300)   (233,300)   (171,800)
Change in Value of Derivative Instruments [Roll Forward]          
Change in Value of Derivative Instruments, Beginning Balance     0 (100) (100)
Change in Value of Derivative Instruments, Gross change in value for the period     0   0
Change in Value of Derivative Instruments, Reclassification adjustments for loss realized in net income     0   100
Change in value of derivative instruments, Tax effect for the period 0 $ 0 0 (30) 0
Change in Value of Derivative Instruments, Ending Balance 0   0   0
Minimum Pension Liability [Roll Forward]          
Minimum Pension Liability, Beginning Balance     (19,800) (13,700) (13,700)
Minimum Pension Liability, Gross change in value for the period     (100)   (10,000)
Minimum Pension Liability, Reclassification adjustments for loss realized in net income     0   0
Minimum Pension Liability, Tax effect for the period     0   3,900
Minimum Pension Liability, Ending Balance (19,900)   (19,900)   (19,800)
Accumulated Other Comprehensive Income (Loss) [Roll Forward]          
Total, Beginning balance     (191,643) $ (106,200) (106,200)
Gross change in value for the period     (61,600)   (89,400)
Reclassification adjustments for loss realized in net income     0   100
Tax effect for the period     0   3,900
Total, Ending balance $ (253,153)   $ (253,153)   $ (191,643)
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stockholders' Equity (Share Repurchases) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Apr. 30, 2016
Jan. 31, 2015
Apr. 30, 2016
Dec. 15, 2011
Equity [Abstract]        
Share Repurchase Program, maximum amount authorized       $ 500.0
Number of common stock repurchased, shares 0 100 0  
Cost of common stock repurchased   $ 16.0    
Average purchase price per share   $ 159.96    
Share Repurchase Program, remaining authorized amount $ 118.4   $ 118.4  
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stockholders' Equity (Dividends) (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Feb. 09, 2016
Apr. 30, 2016
Apr. 30, 2015
Subsequent Event [Line Items]      
Dividends on common stock $ 1,500 $ 1,452 $ 1,448
Cash dividend, per share $ 0.03    
Dividends payable, date of record   Jan. 22, 2016  
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.4.0.3
Fair Value Measurements (Schedule Of Financial Assets And Liabilities Measured At Fair Value On A Recurring Basis Using Level 2 Inputs) (Details) - Significant Observable Inputs (Level 2) [Member] - Foreign Exchange Contracts [Member] - USD ($)
$ in Millions
Apr. 30, 2016
Oct. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair value financial assets $ 0.8 $ 1.3
Fair value of financial liabilities $ 0.9 $ 0.4
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.4.0.3
Employee Benefits (Schedule of Components of Net Periodic Pension Costs) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Apr. 30, 2016
Apr. 30, 2015
General Discussion of Pension and Other Postretirement Benefits [Abstract]        
Service cost $ 2,300 $ 2,000 $ 4,600 $ 4,100
Interest cost 1,200 1,100 2,500 2,100
Expected return on plan assets (1,600) (1,500) (3,300) (3,000)
Amortization of prior service cost 0 0 0 0
Recognized net actuarial loss 400 200 800 500
Net periodic pension cost $ 2,300 $ 1,800 $ 4,600 $ 3,700
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.4.0.3
Employee Benefits (Narrative) (Details) - USD ($)
$ in Millions
6 Months Ended
Apr. 30, 2016
Apr. 30, 2015
General Discussion of Pension and Other Postretirement Benefits [Abstract]    
Company's contribution to the pension plan $ 2.5 $ 2.5
Defined benefit plan, estimated future employer contributions in current fiscal year $ 7.5  
Expected rate of return on plan assets for determining net periodic pension cost 8.00%  
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.4.0.3
Contingencies (Details)
14 Months Ended
Apr. 30, 2016
action
Commitments and Contingencies Disclosure [Abstract]  
Number of putative class action complaints filed (over) 50
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.4.0.3
Business Segment Information (Schedule of Segment Information) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Apr. 30, 2016
Apr. 30, 2015
Segment Reporting Information [Line Items]        
Net sales $ 483,793 $ 434,676 $ 933,433 $ 879,847
Operating income (loss) 89,831 70,998 147,226 144,106
Interest expense 7,611 4,692 12,886 8,633
Other (income) expense, net (418) (686) 972 1,016
Income before income taxes 82,638 66,992 133,368 134,457
CooperVision [Member]        
Segment Reporting Information [Line Items]        
Net sales 391,200 359,600 755,600 728,900
Operating income (loss) 83,600 67,700 136,400 140,900
CooperSurgical [Member]        
Segment Reporting Information [Line Items]        
Net sales 92,600 75,100 177,800 150,900
Operating income (loss) 17,700 14,200 33,100 27,400
Corporate Segment [Member]        
Segment Reporting Information [Line Items]        
Operating income (loss) (11,500) (10,900) (22,300) (24,200)
Toric Lens [Member] | CooperVision [Member]        
Segment Reporting Information [Line Items]        
Net sales 120,500 107,100 228,000 215,600
Multifocal Lens [Member] | CooperVision [Member]        
Segment Reporting Information [Line Items]        
Net sales 42,500 37,900 82,900 80,400
Single-Use Sphere Lens [Member] | CooperVision [Member]        
Segment Reporting Information [Line Items]        
Net sales 97,600 85,100 188,400 169,300
Non Single-Use Sphere And Other Eye Care Products And Other [Member] | CooperVision [Member]        
Segment Reporting Information [Line Items]        
Net sales $ 130,600 $ 129,500 $ 256,300 $ 263,600
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.4.0.3
Business Segment Information (Schedule of Identifiable Assets By Segment Information) (Details) - USD ($)
$ in Thousands
Apr. 30, 2016
Oct. 31, 2015
Segment Reporting Information [Line Items]    
Total Identifiable assets $ 4,601,253 $ 4,459,864
CooperVision [Member]    
Segment Reporting Information [Line Items]    
Total Identifiable assets 3,678,900 3,714,600
CooperSurgical [Member]    
Segment Reporting Information [Line Items]    
Total Identifiable assets 817,600 674,800
Corporate Segment [Member]    
Segment Reporting Information [Line Items]    
Total Identifiable assets $ 104,800 $ 70,500
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.4.0.3
Business Segment Information (Schedule of Net Sales To External Customers By Country Of Domicile) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Apr. 30, 2016
Apr. 30, 2015
Segment Reporting Information [Line Items]        
Total net sales to external customers $ 483,793 $ 434,676 $ 933,433 $ 879,847
United States [Member]        
Segment Reporting Information [Line Items]        
Total net sales to external customers 221,400 197,400 428,200 401,300
Europe [Member]        
Segment Reporting Information [Line Items]        
Total net sales to external customers 165,900 154,700 323,000 313,800
Rest Of World [Member]        
Segment Reporting Information [Line Items]        
Total net sales to external customers $ 96,500 $ 82,600 $ 182,200 $ 164,700
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.4.0.3
Business Segment Information (Schedule of Long-Lived Assets By Country Of Domicile) (Details) - USD ($)
$ in Thousands
Apr. 30, 2016
Oct. 31, 2015
Segment Reporting Information [Line Items]    
Total long-lived assets $ 964,359 $ 967,097
United States [Member]    
Segment Reporting Information [Line Items]    
Total long-lived assets 500,900 494,200
Europe [Member]    
Segment Reporting Information [Line Items]    
Total long-lived assets 391,600 407,900
Rest Of World [Member]    
Segment Reporting Information [Line Items]    
Total long-lived assets $ 71,900 $ 65,000
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.4.0.3
Subsequent Event (Details) - Subsequent Event [Member] - USD ($)
$ in Millions
May. 31, 2016
May. 25, 2016
May. 04, 2016
Reprogenetics UK [Member]      
Subsequent Event [Line Items]      
Business acquisition, effective date of acquisition May 31, 2016    
Total purchase consideration $ 12.0    
Recombine [Member]      
Subsequent Event [Line Items]      
Business acquisition, effective date of acquisition   May 25, 2016  
Total purchase consideration   $ 85.0  
K-Systems [Member]      
Subsequent Event [Line Items]      
Business acquisition, effective date of acquisition     May 04, 2016
Total purchase consideration     $ 11.5
EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 72 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 74 FilingSummary.xml IDEA: XBRL DOCUMENT 3.4.0.3 html 186 229 1 false 45 0 false 5 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.coopercos.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Consolidated Statements of Income Sheet http://www.coopercos.com/role/ConsolidatedStatementsOfIncome Consolidated Statements of Income Statements 2 false false R3.htm 1002000 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.coopercos.com/role/ConsolidatedStatementsOfComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 1002001 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical) Sheet http://www.coopercos.com/role/ConsolidatedStatementsOfComprehensiveIncomeParenthetical Consolidated Statements of Comprehensive Income (Parenthetical) Statements 4 false false R5.htm 1003000 - Statement - Consolidated Condensed Balance Sheets Sheet http://www.coopercos.com/role/ConsolidatedCondensedBalanceSheets Consolidated Condensed Balance Sheets Statements 5 false false R6.htm 1003501 - Statement - Consolidated Condensed Balance Sheets (Parenthetical) Sheet http://www.coopercos.com/role/ConsolidatedCondensedBalanceSheetsParenthetical Consolidated Condensed Balance Sheets (Parenthetical) Statements 6 false false R7.htm 1004000 - Statement - Consolidated Condensed Statements of Cash Flows Sheet http://www.coopercos.com/role/ConsolidatedCondensedStatementsOfCashFlows Consolidated Condensed Statements of Cash Flows Statements 7 false false R8.htm 2101100 - Disclosure - General Sheet http://www.coopercos.com/role/General General Notes 8 false false R9.htm 2103100 - Disclosure - Acquisitions Sheet http://www.coopercos.com/role/Acquisitions Acquisitions Notes 9 false false R10.htm 2104100 - Disclosure - Restructuring and Integration Costs Sheet http://www.coopercos.com/role/RestructuringAndIntegrationCosts Restructuring and Integration Costs Notes 10 false false R11.htm 2105100 - Disclosure - Inventories Sheet http://www.coopercos.com/role/Inventories Inventories Notes 11 false false R12.htm 2106100 - Disclosure - Intangible Assets Sheet http://www.coopercos.com/role/IntangibleAssets Intangible Assets Notes 12 false false R13.htm 2107100 - Disclosure - Debt Sheet http://www.coopercos.com/role/Debt Debt Notes 13 false false R14.htm 2108100 - Disclosure - Income Taxes Sheet http://www.coopercos.com/role/IncomeTaxes Income Taxes Notes 14 false false R15.htm 2109100 - Disclosure - Earnings Per Share Sheet http://www.coopercos.com/role/EarningsPerShare Earnings Per Share Notes 15 false false R16.htm 2110100 - Disclosure - Share-Based Compensation Plans Sheet http://www.coopercos.com/role/ShareBasedCompensationPlans Share-Based Compensation Plans Notes 16 false false R17.htm 2111100 - Disclosure - Stockholders' Equity Sheet http://www.coopercos.com/role/StockholdersEquity Stockholders' Equity Notes 17 false false R18.htm 2113100 - Disclosure - Fair Value Measurements Sheet http://www.coopercos.com/role/FairValueMeasurements Fair Value Measurements Notes 18 false false R19.htm 2114100 - Disclosure - Employee Benefits Sheet http://www.coopercos.com/role/EmployeeBenefits Employee Benefits Notes 19 false false R20.htm 2115100 - Disclosure - Contingencies Sheet http://www.coopercos.com/role/Contingencies Contingencies Notes 20 false false R21.htm 2116100 - Disclosure - Business Segment Information Sheet http://www.coopercos.com/role/BusinessSegmentInformation Business Segment Information Notes 21 false false R22.htm 2117100 - Disclosure - Subsequent Event Sheet http://www.coopercos.com/role/SubsequentEvent Subsequent Event Notes 22 false false R23.htm 2201201 - Disclosure - General (Policies) Sheet http://www.coopercos.com/role/GeneralPolicies General (Policies) Policies 23 false false R24.htm 2304301 - Disclosure - Restructuring and Integration Costs (Tables) Sheet http://www.coopercos.com/role/RestructuringAndIntegrationCostsTables Restructuring and Integration Costs (Tables) Tables http://www.coopercos.com/role/RestructuringAndIntegrationCosts 24 false false R25.htm 2305301 - Disclosure - Inventories (Tables) Sheet http://www.coopercos.com/role/InventoriesTables Inventories (Tables) Tables http://www.coopercos.com/role/Inventories 25 false false R26.htm 2306301 - Disclosure - Intangible Assets (Tables) Sheet http://www.coopercos.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.coopercos.com/role/IntangibleAssets 26 false false R27.htm 2307301 - Disclosure - Debt (Tables) Sheet http://www.coopercos.com/role/DebtTables Debt (Tables) Tables http://www.coopercos.com/role/Debt 27 false false R28.htm 2309301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.coopercos.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.coopercos.com/role/EarningsPerShare 28 false false R29.htm 2310301 - Disclosure - Share-Based Compensation Plans (Tables) Sheet http://www.coopercos.com/role/ShareBasedCompensationPlansTables Share-Based Compensation Plans (Tables) Tables http://www.coopercos.com/role/ShareBasedCompensationPlans 29 false false R30.htm 2311301 - Disclosure - Stockholders' Equity Analysis of Changes in Accumulated Other Comprehensive Income (Loss) (Tables) Sheet http://www.coopercos.com/role/StockholdersEquityAnalysisOfChangesInAccumulatedOtherComprehensiveIncomeLossTables Stockholders' Equity Analysis of Changes in Accumulated Other Comprehensive Income (Loss) (Tables) Tables 30 false false R31.htm 2313301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.coopercos.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.coopercos.com/role/FairValueMeasurements 31 false false R32.htm 2314301 - Disclosure - Employee Benefits (Tables) Sheet http://www.coopercos.com/role/EmployeeBenefitsTables Employee Benefits (Tables) Tables http://www.coopercos.com/role/EmployeeBenefits 32 false false R33.htm 2316301 - Disclosure - Business Segment Information (Tables) Sheet http://www.coopercos.com/role/BusinessSegmentInformationTables Business Segment Information (Tables) Tables http://www.coopercos.com/role/BusinessSegmentInformation 33 false false R34.htm 2403401 - Disclosure - Acquisitions (Details) Sheet http://www.coopercos.com/role/AcquisitionsDetails Acquisitions (Details) Details http://www.coopercos.com/role/Acquisitions 34 false false R35.htm 2404402 - Disclosure - Restructuring and Integration Costs (Narrative) (Details) Sheet http://www.coopercos.com/role/RestructuringAndIntegrationCostsNarrativeDetails Restructuring and Integration Costs (Narrative) (Details) Details http://www.coopercos.com/role/RestructuringAndIntegrationCostsTables 35 false false R36.htm 2404403 - Disclosure - Restructuring and Integration Costs (Details) Sheet http://www.coopercos.com/role/RestructuringAndIntegrationCostsDetails Restructuring and Integration Costs (Details) Details http://www.coopercos.com/role/RestructuringAndIntegrationCostsTables 36 false false R37.htm 2405402 - Disclosure - Inventories (Schedule of Inventories) (Details) Sheet http://www.coopercos.com/role/InventoriesScheduleOfInventoriesDetails Inventories (Schedule of Inventories) (Details) Details http://www.coopercos.com/role/InventoriesTables 37 false false R38.htm 2406402 - Disclosure - Intangible Assets (Schedule of Goodwill) (Details) Sheet http://www.coopercos.com/role/IntangibleAssetsScheduleOfGoodwillDetails Intangible Assets (Schedule of Goodwill) (Details) Details http://www.coopercos.com/role/IntangibleAssetsTables 38 false false R39.htm 2406403 - Disclosure - Intangible Assets (Schedule of Other Intangible Assets) (Details) Sheet http://www.coopercos.com/role/IntangibleAssetsScheduleOfOtherIntangibleAssetsDetails Intangible Assets (Schedule of Other Intangible Assets) (Details) Details http://www.coopercos.com/role/IntangibleAssetsTables 39 false false R40.htm 2406404 - Disclosure - Intangible Assets (Narrative) (Details) Sheet http://www.coopercos.com/role/IntangibleAssetsNarrativeDetails Intangible Assets (Narrative) (Details) Details http://www.coopercos.com/role/IntangibleAssetsTables 40 false false R41.htm 2407402 - Disclosure - Debt (Schedule of Debt) (Details) Sheet http://www.coopercos.com/role/DebtScheduleOfDebtDetails Debt (Schedule of Debt) (Details) Details http://www.coopercos.com/role/DebtTables 41 false false R42.htm 2407403 - Disclosure - Debt (Narrative) (Details) Sheet http://www.coopercos.com/role/DebtNarrativeDetails Debt (Narrative) (Details) Details http://www.coopercos.com/role/DebtTables 42 false false R43.htm 2408401 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.coopercos.com/role/IncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) Details http://www.coopercos.com/role/IncomeTaxes 43 false false R44.htm 2409402 - Disclosure - Earnings Per Share (Schedule of Earnings Per Share) (Details) Sheet http://www.coopercos.com/role/EarningsPerShareScheduleOfEarningsPerShareDetails Earnings Per Share (Schedule of Earnings Per Share) (Details) Details http://www.coopercos.com/role/EarningsPerShareTables 44 false false R45.htm 2409403 - Disclosure - Earnings Per Share (Schedule of Stock Options to Purchase Common Stock Not Included in Diluted Net Income Per Share Calculation) (Details) Sheet http://www.coopercos.com/role/EarningsPerShareScheduleOfStockOptionsToPurchaseCommonStockNotIncludedInDilutedNetIncomePerShareCalculationDetails Earnings Per Share (Schedule of Stock Options to Purchase Common Stock Not Included in Diluted Net Income Per Share Calculation) (Details) Details http://www.coopercos.com/role/EarningsPerShareTables 45 false false R46.htm 2410402 - Disclosure - Share-Based Compensation Plans (Schedule Of Compensation Expense And Related Income Tax Benefit For Share-Based Awards) (Details) Sheet http://www.coopercos.com/role/ShareBasedCompensationPlansScheduleOfCompensationExpenseAndRelatedIncomeTaxBenefitForShareBasedAwardsDetails Share-Based Compensation Plans (Schedule Of Compensation Expense And Related Income Tax Benefit For Share-Based Awards) (Details) Details http://www.coopercos.com/role/ShareBasedCompensationPlansTables 46 false false R47.htm 2411402 - Disclosure - Stockholders' Equity (Schedule of Changes in Accumulated Other Comprehensive Income (Loss))(Details) Sheet http://www.coopercos.com/role/StockholdersEquityScheduleOfChangesInAccumulatedOtherComprehensiveIncomeLossdetails Stockholders' Equity (Schedule of Changes in Accumulated Other Comprehensive Income (Loss))(Details) Details http://www.coopercos.com/role/StockholdersEquityAnalysisOfChangesInAccumulatedOtherComprehensiveIncomeLossTables 47 false false R48.htm 2411403 - Disclosure - Stockholders' Equity (Share Repurchases) (Details) Sheet http://www.coopercos.com/role/StockholdersEquityShareRepurchasesDetails Stockholders' Equity (Share Repurchases) (Details) Details http://www.coopercos.com/role/StockholdersEquityAnalysisOfChangesInAccumulatedOtherComprehensiveIncomeLossTables 48 false false R49.htm 2411404 - Disclosure - Stockholders' Equity (Dividends) (Details) Sheet http://www.coopercos.com/role/StockholdersEquityDividendsDetails Stockholders' Equity (Dividends) (Details) Details http://www.coopercos.com/role/StockholdersEquityAnalysisOfChangesInAccumulatedOtherComprehensiveIncomeLossTables 49 false false R50.htm 2413402 - Disclosure - Fair Value Measurements (Schedule Of Financial Assets And Liabilities Measured At Fair Value On A Recurring Basis Using Level 2 Inputs) (Details) Sheet http://www.coopercos.com/role/FairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingLevel2InputsDetails Fair Value Measurements (Schedule Of Financial Assets And Liabilities Measured At Fair Value On A Recurring Basis Using Level 2 Inputs) (Details) Details http://www.coopercos.com/role/FairValueMeasurementsTables 50 false false R51.htm 2414402 - Disclosure - Employee Benefits (Schedule of Components of Net Periodic Pension Costs) (Details) Sheet http://www.coopercos.com/role/EmployeeBenefitsScheduleOfComponentsOfNetPeriodicPensionCostsDetails Employee Benefits (Schedule of Components of Net Periodic Pension Costs) (Details) Details http://www.coopercos.com/role/EmployeeBenefitsTables 51 false false R52.htm 2414403 - Disclosure - Employee Benefits (Narrative) (Details) Sheet http://www.coopercos.com/role/EmployeeBenefitsNarrativeDetails Employee Benefits (Narrative) (Details) Details http://www.coopercos.com/role/EmployeeBenefitsTables 52 false false R53.htm 2415401 - Disclosure - Contingencies (Details) Sheet http://www.coopercos.com/role/ContingenciesDetails Contingencies (Details) Details http://www.coopercos.com/role/Contingencies 53 false false R54.htm 2416402 - Disclosure - Business Segment Information (Schedule of Segment Information) (Details) Sheet http://www.coopercos.com/role/BusinessSegmentInformationScheduleOfSegmentInformationDetails Business Segment Information (Schedule of Segment Information) (Details) Details http://www.coopercos.com/role/BusinessSegmentInformationTables 54 false false R55.htm 2416403 - Disclosure - Business Segment Information (Schedule of Identifiable Assets By Segment Information) (Details) Sheet http://www.coopercos.com/role/BusinessSegmentInformationScheduleOfIdentifiableAssetsBySegmentInformationDetails Business Segment Information (Schedule of Identifiable Assets By Segment Information) (Details) Details http://www.coopercos.com/role/BusinessSegmentInformationTables 55 false false R56.htm 2416404 - Disclosure - Business Segment Information (Schedule of Net Sales To External Customers By Country Of Domicile) (Details) Sheet http://www.coopercos.com/role/BusinessSegmentInformationScheduleOfNetSalesToExternalCustomersByCountryOfDomicileDetails Business Segment Information (Schedule of Net Sales To External Customers By Country Of Domicile) (Details) Details http://www.coopercos.com/role/BusinessSegmentInformationTables 56 false false R57.htm 2416405 - Disclosure - Business Segment Information (Schedule of Long-Lived Assets By Country Of Domicile) (Details) Sheet http://www.coopercos.com/role/BusinessSegmentInformationScheduleOfLongLivedAssetsByCountryOfDomicileDetails Business Segment Information (Schedule of Long-Lived Assets By Country Of Domicile) (Details) Details http://www.coopercos.com/role/BusinessSegmentInformationTables 57 false false R58.htm 2417401 - Disclosure - Subsequent Event (Details) Sheet http://www.coopercos.com/role/SubsequentEventDetails Subsequent Event (Details) Details http://www.coopercos.com/role/SubsequentEvent 58 false false All Reports Book All Reports coo-20160430.xml coo-20160430.xsd coo-20160430_cal.xml coo-20160430_def.xml coo-20160430_lab.xml coo-20160430_pre.xml true true ZIP 76 0000711404-16-000030-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000711404-16-000030-xbrl.zip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